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Abstract
Murine embryonic stem (ES) cells have provided researchers with a useful tool 
to investigate genome function and the consequences of genome mutation. One 
mutational approach is gene-targeting, this involves the introduction of DNA 
sequences of choice, precisely, to almost any location in the target genome by 
homologous recombination.
At present, most gene-targeting strategies introduce DNA constructs that derive 
from plasmids. Plasmids can stably propagate up to approximately 30 kb of DNA. 
Therefore, this size limit may place a restriction on the range of mutations that may be 
made to a genome using a single plasmid-derived gene-targeting construct alone. To 
overcome this limitation, multiple rounds of sequential gene-targeting experiments 
may be performed, however such an approach may be too lengthy to be practicable. In 
order to address this current limitation with gene-targeting a novel strategy was tested, 
implementing Cre-/ojc site-specific recombination (SSR) technology and the bacterial 
artificial chromosome (BAG) vector system.
Two sequential gene-targeting events in murine E14Tg2a ES cells (HPRT") 
were performed at separate locations to chromosome 11. The aim of gene-targeting 
was to create an interval on chromosome 11 that included a single copy of the murine 
alpha-globin locus, between the hetero-specific lox sites, loxP and Iox511, an interval 
of approximately 64 kb. To this end the first targeting event delivered 
/0x577/hygromycin/I See \Hox511 sequences and the second event frtll See 
I/5'hprt//0jc/Yneomycin sequences.
ES cells that were confirmed to have correctly undergone the two desired 
targeting events (double-targeted) were then assessed to determine whether these 
events had occurred to the same chromosome 11 (in cis), as desired, or to the alternate 
copies of chromosome 11 (in trans). This assessment involved restricting DNA from
in
the double-targeted ES cell lines with the rare-cutting restriction endonuclease I See I 
and resolving the products of this restriction by pulsed field gel electrophoresis. This 
analysis identified two in cis lines (CAT-A3 and CAT-B3) and an in tram line (CAT- 
C10).
The double-targeted ES cell lines were then further characterised to determine 
whether the hetero-specific lox sites they harboured would participate in Cre-mediated 
SSR. The positive result of this analysis was the generation of ES cell clones that were 
hemizygous for the alpha-globin locus, a deletion of 64 kb. Hemizygous ES cell clones 
were obtained from the CAT-A3 and CAT-B3 ES cell lines, as predicted, but not from 
the CAT-C10 line, although all the lines tested showed evidence of SSR occurring.
In parallel to achieving the interval between loxP and Iox511 in ES cells, a 
BAG, harbouring the alpha-globin locus, was similarly modified with lox sites using 
recombination-mediated cloning. The aim of the BAG modification was to create an 
interval between lox sites in the BAG identical to that achieved in the ES cells. The 
BAG was targeted sequentially with two separate constructs, 
lox511/kanamycin/lox511/HSVtk and then blasticidin/foxP/Thprt/I See l/frt. The 
correct targeting of the BAG was verified by restricting its DNA with a panel 
restriction endonucleases. The lox sites were then tested in an in vitro analysis with 
purified Cre recombinase and found to be competent to participate in SSR reactions.
The modified BAG was co-electroporated with a Cre expression plasmid into 
the CAT-A3 and CAT-B3 ES cell lines, previously characterised as targeted in cis, 
with the aim of exchanging the interval sequences in the ES cell with those of the 
BAG. The ultimate aim of such an exchange would be to deliver any combination of 
mutations that would be previously engineered to the BAG interval, to that of the ES 
cell, by a single SSR event. This experimental approach should expedite and facilitate 
the mutational analysis of gene loci. To generate comparative data the result of SSR 
between the modified BAG and an in tram targeted ES cell line (CAT-C10) was also 
assessed.
IV
The selection for the desired exchange involved reconstruction of an Hprt 
minigene and exclusion of a thymidine kinase gene, cells which haboured these events 
could therefore be selected for in HAT and ganciclovir supplemented media 
respectively. ES cell clones generated from both of the in cis lines tested (CAT-A3 and 
CAT-B3) had the correct selection resistance profiles, thus indicating that the desired 
exchange had been achieved in these clones. Additionally, Southern blot analysis from 
the DNA from these clones was consistent with the achievement of the desired 
exchange. However, the results obtained from clones generated from the in tram line 
(CAT-C10) were not consistent with their predicted genetic arrangement following 
SSR with the modified BAG.
Thus far similar experimental approaches have been implemented to exchange 
smaller intervals of 1 to 5 kb and have been termed recombinase mediated cassette 
exchange (RMCE). However the experiments described within this thesis are the first 
test whether the same rationale may be applied to larger intervals. The strategy 
described and tested in this thesis has therefore been termed large interval RMCE 
(HRMCE).
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In 2001 the completion of the human genome draft sequences were 
announced (Venter et al., 2001; Lander et al., 2001). Current estimates on the 
number of genes range between 30,000 to 45,000 and the functional 
characterization of each gene is predicted to increase our understanding of 
fundamental biological processes and aid the development of novel diagnostic and 
therapeutic methods in medicine. The characterization of gene function in this 
context is termed 'functional genomics'.
Functional genomics investigations seek to generate data that establish a 
causative link between specific DNA sequences and the role they play in generating 
a phenotype. Historically, most functional genomics investigations have relied on 
the collation of data generated from in vitro and in vivo studies. However, as whole 
genome sequencing projects progress and the field of bioinformatics develops more 
robust tools for sequence analysis, contemporary functional genomics 
investigations increasingly integrate data from '/« silico* research. In light of this 
novel line of investigation the necessity to perform in vitro and in vivo studies is 
discussed.
The development of in silico approaches now means that it is possible to 
search the sequence of an entire genome to find sequences that may represent novel 
genes. Sequence annotation programmes, such as GenomeScan (Yeh et al., 2001),
Genscan (Burge and Karlin, 1997), Genie (Reese et al., 2000) and Genotator 
(Harris, 1997), aim to predict novel genes ab initio using search algorithms based 
on the recognition of known gene associated sequences. Sequence annotation 
programmes commonly search for gene associated sequences such as open reading 
frames and splice-site consensus sequences or aim to identify other specific base 
compositions that relate to function, such as CpG islands. The collation and 
integration of data from homology-based studies (e.g. Genewise) and ab initio 
methods (e.g. Genscan) is underway with the Ensembl genome database project 
which aims to provide a comprehensive annotation of the human genome sequence 
(Hubbard et al., 2002).
The availability of the entire genome sequence data from a growing number 
and variety of species, most notably the human and mouse, are continually 
broadening the capabilities of in silico research. At present however, the 
capabilities of comparative in silico functional genomics are unable to distinguish 
those divergences in sequence homology that are critical to determining phenotype, 
from those without functional significance. This is especially limiting to the 
investigation of sequences that control gene expression, such as enhancers and 
repressers, which remain largely uncharacterised.
The functional consequence of inter-species sequence divergences within 
regions of coding homology is simplified since there exists an encoded product 
whose function may be tested. This should determine the effect, if any, that the 
sequence divergence has on the ability of the encoded product to perform its normal 
function. In comparison, the ability to evaluate the sigificance of sequence 
divergences between non-coding sequences is made more problematic due to the 
absence of an encoded product. This includes sequences that regulate gene 
expression and therefore the study of these sequences using an in silico approach is 
less informative.
Furthermore, exclusive of sequences that encode proteins or are known to 
direct gene expression, the in silico approach is unable to identify sequences that 
may have novel function. This is especially relevant to the discovery and
investigation of sequences that regulate gene expression. Although some enhancers 
and repressers have been characterised, it is probable that most have yet to be 
discovered (Lomvardas and Thanos, 2002; Tautz, 2000; Macfarlane, 2000). 
Therefore without this information it remains impossible to identify these 
sequences ab initio, or perform homology based searches for them. Since a 
comprehensive knowledge of the elements that affect gene expression is necessary 
for the complete characterization of genome function, the production of in vitro and 
in vivo data are particularly relevant to the discovery and functional characterisation 
of sequences that control gene expression.
The current in silico approaches therefore incur two main shortcomings: a 
reliance on existing data to characterise the function of a sequence and a 
dependency on the hypothesis that homology between sequences indicates shared 
function. The computational assignment of gene sequences is therefore currently 
regarded as putative. The assignment of function to a sequence that has been 
identified by in silico methods is still most reliably validated by the generation of 
data from conventional in vitro and in vivo studies. Therefore the genetically 
modified organism will remain as a key tool for investigative functional genomics 
and validation in the emerging in silico research era.
1.2 Genetically modified organisms
The most accurate approach to the investigation of genome function is to 
observe how the genome determines phenotype within its natural in vivo 
environment. However, in some cases, for example the investigation of the human 
genome, this approach may not always be ethical or practicable. This becomes 
especially relevant if experimentation is required to verify a hypothesis, or if the 
system under study is so complex that it require subdivision to clarify the analyses. 
To overcome these obstacles model systems, of whole organisms or cell lines, are 
used. The implementation of a model system often permits the investigator to 
evaluate genome function within a simpler context and in a system that is more 
amenable to experimentation.
An organism with an altered genome is termed a genetically modified 
organism (GMO). In terms of technology, there are two main features of a GMO. 
The technology implemented to manipulate the genome (as discussed later in 
Section 1.2.2) and the technology applied to generate an in vivo phenotype from the 
altered genome (see below).
1.2.1 The range of species and uses of GMOs
GMOs have been generated from an extensive range of prokaryotic and 
eukaryotic species, at both the uni- and multi-cellular level. Species that are popular 
to model human genetics usually share equitable physiology, however the 
application of GMOs is not limited to this area. The application of current GMO 
species include: creating models to test pharmacologicals (Rudolph and Mohler, 
1999); xenotransplantation (Logan, 2000); creating bioreactors (Larrick and 
Thomas, 2001; Janne et al., 1994); the creation of modified animal and plant 
species for consumption and nutrition (van der Meer et al., 2001); in addition to 
creating models to study gene function and human disease (Jonkers and Berns, 
2002; Bucan and Abel, 2002; www.mgu.har.mrc.ac.uk; 
www.biomednet.com/databases/currbiol/mko/dataset.exe). In addition to plant 
species other species that are commonly utilised for some of the purposes listed 
above include: Bos Taurus (Piedrahita, 2000); Brachydanio rerio (Patton and Zon, 
2001); Caenorhabditis elegans (Jorgensen and Mango, 2002); Drosophila 
melagonaster (St Johnston, 2002); Mus musculus; Ovis aries; Rattus rattus (Jacob 
and Kwitek, 2002); Sus scrofa (Wheeler and Walters, 2001); Tympanuchus cupido 
(Sang, 1994); Xenopus laevis.
The mouse (Mus musculus) has, in particular, proven to be an attractive in 
vivo model. In addition to its equitable physiology and ease of animal husbandry, 
the other appealing feature of the mouse as an animal model is its genetics. The 
mouse has a high sequence identity and orthologous sequence alignments to the 
human genome. Recently the draft sequence of the mouse genome was published 
and this powerful new resource marks a new era in the way in which experimental 
genetics can be done.
The generation of a murine line or murine cell line harbouring an altered 
genome may be performed by a variety of methods, including: microinjection of a 
single-cell embryo (Gordon and Ruddle, 1981); embryonic stem (ES) cell 
contribution within a blastocyst (Gossler et al., 1986; Robertson et al., 1986). The 
research efforts that focussed on transferring these two methods to other species 
were largely unsuccessful. However, with the emergence of nuclear transfer 
technology (Campbell et al., 1996) it is now theoretically possible to extend the 
production of GMOs to any species that produces oocytes, thereby broadening the 
application of GMOs for medicine and research (Colman, 1999).
1.2.2 An overview of common methods of genome manipulation used to 
generate GMOs
The other necessary component for the production of a GMO is genome 
manipulation. Methods of genome manipulation are extremely varied but can be 
discussed in terms of the level of control the investigator retains on determining the 
mutation generated. Mutagenic approaches, that are completely random, exert 
control over neither the manipulation made, nor its location. Examples of random 
mutagenic approaches include the use of radiation, such as X-rays (Steward and 
Nusslein-Volhard, 1986), or chemical mutagens, such as ENU (Haffter et al., 1996; 
Nolan et al., 2000). Less random approaches control the manipulation that is 
delivered to the genome but not the location of the manipulation, for example the 
use of viral (Boris-Lawrie and Temin, 1993; Kovesdi et al., 1997), retroviral 
(Hanazono et al., 2001; Janson and During, 2001) and transposon (Izsvak et al., 
2000) based vectors and transgenes. Less random still is the use of gene-trap 
vectors (Cecconi and Meyer, 2000), whose initial application was the identification 
and report of transcriptionally active genes and so control over the manipulation 
and some control over the location is retained. Ultimately though, gene targeting 
provides the ability to control both the location and the nature of the manipulation 
made. Gene targeting describes technology to direct sequences of choice, precisely, 
to almost any location in the genome, in cells that support homologous 
recombination, for example murine embryonic stem cells.
Therefore ES cells are particularly useful, their ability to undergo 
homologous recombination and support gene targeting makes their genome 
amenable to genetic modification. Subsequently, generating a mouse model 
organism can then be used to assess the phenotypic consequences of modifications 
to the genome.
1.3 Murine embryonic stem cells and gene-targeting
Murine embryonic stem (ES) cell lines are immortal and can be derived 
from the inner cell mass of pre-implantation blastocysts (Evans and Kaufrnan, 
1981; Martin, 1981). ES cells are termed pluripotent due to their unique ability to 
become any cell type of the developing embryo and eventually adult organism 
(Nagy et al., 1990). The ability of ES cells to contribute towards the germ-line in 
chimaeric mice was first demonstrated in 1984 (Bradley et al., 1984). The 
subsequent inheritance of the ES cell genome can be achieved by breeding germline 
chimeras, first to generate heterozygous mice and then by inter-cross to generate 
homozygous animals.
In addition protocols have been developed to differentiate ES cells along a 
variety of cell lineages (for reviews see: Rathjen and Rathjen, 2001; Wobus, 2001; 
Rossant, 2001). For example, neuronal (Tropepe et al., 2001), cardiomyogenic 
(Kolossov et al., 1998), hepatic (Jones et al., 2002) and heamatopoietic cell lineages 
(Suzuki and Nakano, 2001) may be derived. Alternatively somatic cell lineages 
may be derived from transgenic mice generated from ES cells. The first report of 
using ES cells to transmit a manipulated genome through the germline was in 1986 
(Gossler et al., 1986) and this rationale now forms the bases for the routine 
generation of a large proportion of murine GMOs. Thus, the investigation of the 
manipulated ES cell genome can be diversely studied, both in vivo and in vitro.
As outlined previously, many strategies of genome manipulation exist, with 
each providing the investigator various levels of control over the manipulation 
made (see Section 1.2.2) and most of these strategies may be applied to manipulate 
the ES cell genome. However, it is the ability of murine ES cells to mediate
homologous recombination that makes them amenable to the most precise form of 
genetic manipulation currently possible, namely gene targeting.
The gene-targeting process is commenced with the design and production of 
a DNA molecule capable of integrating to a specific location within a genome. This 
DNA is commonly termed a 'targeting vector' or 'targeting construct' and the 
location to which it is targeted may be known as either the 'target' or 'target site'. 
The targeting vector integrates specifically to its target in the genome by virtue of 
regions of sequence homology contained within the targeting vector to the target 
site. These regions are often termed 'homology arms' and enable the targeting 
vector to participate in homologous recombination. The integration of a targeting 
vector to a target site by homologous recombination is known as 'targeting'.
Gene targeting in ES cells was first demonstrated in 1987 to create a 
functional HPRT gene (Thomas and Capecchi, 1987; Doetschman et al., 1987) and 
again in 1988 to mutate HPRT (Doetschman et al., 1988), a manipulation that was 
subsequently the first demonstration of a germline transmission of a gene-targeted 
event (Koller et al., 1989).
It is possible to precisely integrate targeting constructs to most regions of 
the genome, although the efficiency with which targeting constructs integrate may 
vary. The main factor that reduces gene-targeting efficiency is the propensity of the 
targeting vector to undergo random integration into the target genome, by a process 
of illegitimate recombination. The integration of the targeting vector to any other 
genome location other than its target can be considered as a random integration 
event.
The likelihood that a targeting vector will integrate at random is largely 
unpredictable but may be affected by its composition. The most influential factor is 
the nature and extent of the homology that exists between the targeting vector and 
the target site. It has been shown that any decrease of isogenicity between the 
homology arms and target site sequences can reduce targeting efficiency in ES cells 
(te Riele et al., 1992). The length of the homology arms also has an effect, with 
larger arms usually increasing targeting efficiency (Deng C, 1992).
Therefore, following the introduction of the targeting vector to the ES cells, 
usually by electroporation, it is necessary to determine whether targeting has 
occurred or whether the targeting vector has integrated to a random genomic 
location, or indeed whether the genome remains unchanged.
1.3.1 Isolating and identifying gene-targeting events
There are several possible outcomes of introducing a gene-targeting 
construct to ES cells by electroporation. The desired outcome is of course the 
targeted integration of the gene-targeting construct to the required target location, 
mediated by homologous recombination. However, alternatives to this outcome 
include cell death, or the generation of untargeted cells, by either the gene-targeting 
construct not entering the cell or the inability of the gene-targeting vector to stably 
integrate into the genome once inside the cell. Alternatively, the gene-targeting 
vector may integrate into the cell genome, not at the target site as desired, but 
instead at a random location by illegitimate recombination. There are various ways 
to ensure that cells harbouring these undesired events are eliminated in order to 
isolate a population of ES cell clones that harbour the desired targeting event.
In order to distinguish those cells that have integrated the gene-targeting 
vector into their genome from those whose genome remains unchanged, it is 
possible to include a positive selection marker in the vector. These markers usually 
take the form of a gene and are included in the gene-targeting vector during its 
construction. The positive selection marker is usually located between the 
homology arms of the gene-targeting vector, in order to maximise the probability of 
its incorporation to the genome during targeting. The incorporation of the gene- 
targeting vector into the target genome permits the stable expression of the positive 
selection marker gene and this confers resistance to a supplement (usually an 
antibiotic) that is subsequently added to the cell culture media following 
electroporation. Therefore those cells that harbour the gene-targeting vector in their 
genome survive the addition of the supplement and those cells without the vector 
die.
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The gene-targeting vector may also integrate undesirably to a random 
location in the target genome by illegitimate recombination. Illegitimate 
recombination events may integrate the entire gene-targeting vector and in these 
cases the use of a positive selection marker does not distinguish those cells that 
have targeted from those cells that harbour a random integration of the gene- 
targeting vector. The analysis of DNA derived from clones in such a mixed 
population may determine those that are targeted from those that are not. Analyses 
such as PCR around the target site or a Southern blotting screening strategy would 
indicate whether the gene-targeting construct was present at the target site or not, 
since the DNA from clones that harbour a random integration event would appear 
unchanged at the target site.
However the ability to target some locations in the genome may be less 
feasible than for others. Genome locations that are less amenable to gene-targeting 
may therefore be difficult to identify with a positive selection strategy alone, due to 
an overwhelming number clones generated by random integration events. To 
overcome this problem it may be possible to screen a large number of clones (500 
to 1000) in order to identify a targeted clone in the population, however a more 
practical approach is to use a strategy of positive negative selection (PNS). PNS 
employs a positive selection marker (as described above) and another marker, 
usually a gene, whose presence within the genome can be selected against. In other 
words, a supplement to the cell culture media is able to kill those cells that harbour 
the negative selection marker.
The successful outcome of a targeted integration of a PNS gene-targeting 
vector is the integration of the positive selection marker into the genome and the 
exclusion of the negative selection marker. This is achieved by placing the negative 
selection marker outwith the homology arms during the construction of the gene- 
targeting vector. Therefore upon homologous recombination those sequences 
between the homology arms are integrated into the genome (i.e. the positive 
selection marker) and those outside the homology arms are excluded from 
integration (i.e. the negative selection marker). Since random integration by
illegitimate recombination usually integrates the entire gene-targeting vector into 
the genome then in these instances both the positive and negative selection marker 
are integrated. Thus, when selection is applied to the cell culture media those cells 
harbouring the negative selection maker, and therefore a random integration of the 
gene-targeting vector, die and those cells harbouring a targeted integration survive.
A PNS strategy therefore enriches a population of clones that harbour the 
gene-targeting vector for those that harbour the vector at the target site, and 
although enrichment may not be absolute (between 80 and 100 %), the PNS 
strategy makes it easier to identify the desired targeted clones than with a strategy 
using positive selection alone. Additionally, PNS may be used as a means of 
distinguishing the level of homologous recombination from the level of illegitimate 
recombination for the specified targeting construct.
An example of a typical PNS strategy involves the construction of a gene- 
targeting vector with the positive selection marker situated between the homology 
arms of the vector and the thymidine kinase gene as the negative selection marker, 
outside the arms. Following electroporation, the positive marker is first selected for, 
which isolates the population of cells that have incorporated the targeting vector 
into their genome, whether targeted or random. Next, those cells that harbour a 
random integration of the gene-targeting vector are removed from the population by 
their sensitivity to the addition of gancilovir (GANG) to the ES cell media, due to 
the presence of the thymidine kinase gene in their genome (Mansour et al., 1988). 
This ability to select against the presence of the thymidine kinase gene has been 
used in the design of the strategy presented within this thesis.
The other selection strategy relevant to the strategy presented within this 
thesis is the reconstruction of the HPRT minigene, which is discussed in Section 
1.5.1 (a).
1.4. The size of gene-targeting vectors
To date, most gene-targeting constructs have been plasmid derived. This is 
largely due to the historical, robust and widely practiced methods for the
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propagation and manipulation of plasmid vectors. Conventionally DNA vector 
construction in E. coli has been largely mediated with restriction endonuclease 
based methods (Sambrook et al., 1989) and this remains the case, although recently 
methods that implement PCR based cloning techniques have emerged (Akiyama et 
al., 2000).
The use of plasmid vectors restricts the size of DNA that may be propagated 
in a single molecule. The upper threshold for the stable and efficient replication of 
most plasmids is approximately 25 to 30 kb. The use of plasmid derived targeting 
constructs therefore places restrictions on the design of the targeting construct, 
which in turn restricts the range of manipulations that may be made to the ES cell 
genome by gene-targeting alone.
1.4.1 The evolution of large vectors and their applications in genome 
manipulation
Transgenesis describes evolving technology that mediates the production of 
a transgenic organism. The term 'transgenic' was initially used to describe adult 
mice that had inherited an altered genome in every cell by the germline 
transmission of additional gene sequences or 'transgenes' (Gordon and Ruddle, 
1981; Costantini and Lacy, 1981). However, the addition of gene sequences is not a 
pre-requisite for the term transgenic, since organisms that have had gene sequences 
deleted or replaced (Detloff et al., 1994) (known as 'transgenic knock-outs' 
(Barinaga, 1994), or re-located (Buchholz et al., 2000) have been described as 
transgenic.
The early transgenic studies of the 1980s used randomly inserted plasmid 
based vectors (up to 15 kb in size). These revealed that both the components of a 
transgene and the nature of the genome surrounding its insertion site could modify 
the transgene's expression. The effects that the chromosomal location may have on 
the expression of a transgene have since been termed 'chromosomal position 
effects' and they present a major obstacle in generating the desired expression from 
a transgene.
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During the 1980s studies were beginning to elucidate genomic sequences 
that appeared to act in cis and could regulate gene expression at a distance. These 
sequences were termed 'enhancers'. It was therefore hypothesized that the absence 
of enhancer sequences from a transgenic vector was the factor responsible for the 
lack of robust transgene expression at any given locus. To overcome this problem 
two approaches were taken, either the gene of interest was studied and mutated at 
its normal position in the genome (with gene-targeting approaches) or vectors larger 
than plasmids were employed as transgenes.
1.4.2 YAC transgenes and transgenic rescue studies
In an effort to overcome chromosomal position effects with small randomly 
integrated transgenes, vectors that were capable of maintaining large genomic 
inserts were tested for their ability to function as transgenes. It was hoped that by 
using large vectors, regions of sequence, that would normally flank the transgene at 
its usual genome location, would be integrated along with the transgene and that 
these sequences would include all of the required enhancer elements necessary for 
the transgene's expression. The aim of using such large vectors was to achieve 
position-independent expression of the transgene. In addition it was anticipated that 
this approach would facilitate the discovery of distant regulatory sequences, since 
the transgene provided a discrete region of genomic sequence for analysis.
Early attempts at implementing transgenesis in mice with larger vectors 
achieved the desired position-independent expression, initially using YACs as the 
vector of choice (Forget, 1993; Lamb and Gearhart, 1995; Peterson et al., 1997; 
Peterson et al., 1995). In addition to achieving robust transgene expression, YAC 
transgenesis also became the method of choice to study enhancers and other 
elements that affected gene expression at a distance in cis (Peterson et al., 1993). 
The integrated YAC transgene provided a discrete genomic region that could be 
evaluated for sequences necessary to provide position-independent expression. 
Concurrently, gene-fimction was being investigated by producing knock-out and 
other mouse mutations and investigating the resulting phenotype. The YAC 
transgene approach was used in conjunction with knock-out and mutation studies to
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determine whether sequences in the transgene were capable of reversing (or 
rescuing) the mutated phenotype to generate a wild-type animal. These strategies 
were termed 'transgenic rescue experiments'. The extent to which a transgene was 
able to rescue a mutated phenotype, was not always complete, giving rise to 
partially-rescued phenotypes (Lakshmanan et al., 1998; Slee et al., 1999). Therefore 
the value of a 'rescue experiment' is dependent on rigorous experimental analysis 
in order to verify the process. This includes the characterisation of the mutation that 
causes the mutated phenotype, which is made more problematic if the mutation is 
unmapped or generated by the random mutation of the test genome. Following 
characterisation of the mutation the rescued phenotype requires rigorous 
assessment, to ensure that all of the mutated characterisitcs are reversed.
However, the most significant disadvantage related to the use of YACs for 
transgenic rescue experiments is the amount of characterisation that must be 
performed in order to determine the nature of the transgene insertion. It is necessary 
to determine whether any undesirable re-arrangements or fragmentation of the YAC 
have occurred, and also to determine whether the transgene is present as a single 
copy, both at the site of integration and genome wide. The reason for undertaking 
such extensive characterisation is largely due to the inherent instability of the YACs 
molecule (as discussed later) and can therefore be overcome by using alternative 
large vector transgenes.
The alternative vectors to the YAC, that are competent to propagate large 
genomic inserts include: the PI artificial chromosome (PAC); human or 
mammalian artificial chromosomes (HACs or MACs); and bacterial artificial 
chromosomes (BACs). The following section discusses BACs and their advantages 
over the other artificial chromosome systems, most notably YACs, since, thus far, 
YACs have been the large vector of choice for genome manipulation.
1.4.3 The development of the BAC vector
The BAC system is based on the E. coli F-factor, which is a single copy 
plasmid that exists in supercoiled circular form in host bacterial cells (Shizuya et 
al., 1992). There are three main advantages of using BACs rather than other large
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vector systems, the first is the availability of genomic libraries from a wide variety 
of species, secondly the relative stability of BACs makes them easy to handle in the 
laboratory and applicable for high-throughput systems and thirdly since BACs are 
harboured in E. coll this renders them amenable to sequence modification by 
homologous recombination, see Section 1.4.5
The development of the BAG system was in part driven by the Human 
Genome Project (HOP) as a means to easily construct robust and manageable 
genomic libraries and physical maps for genomic sequencing (Monaco and Larin, 
1994). The ability to construct libraries in BAG vectors that ensure coverage of the 
entire genome in question with individual clones that faithfully represent the 
original genome sequence was therefore an important advance.
Before the development of BACs, YAC libraries were commonly used for 
genome mapping. However the large percentage (40 to50%) of chimaeric (Green et 
al., 1991; Libert et al., 1993) and unstable (Dunford et al., 1993; Neil et al., 1990; 
Schmidt et al., 1994) YAC clones hindered the usefulness of these libraries. 
Although it has since been shown that BAC clones containing tandemly repeated 
DNA may be highly unstable (Song et al., 2001) and the development of 
recombination deficient YAC host strains does reduce the levels of chimersim and 
re-arrangement that occur (Chartier et al., 1992; Haldi et al., 1994; Kohno et al., 
1997; Palmieri et al., 1997).
BAC libraries are commonly produced by cloning single fragments 
generated either by the products of whole genome partial restriction or physical 
shearing into a replicative BAC vector backbone. The current generation of BAC 
libraries produce BACs that average in size between 100 kb to 150 kb. However, 
BACs have the capacity to maintain much larger fragments of genomic DNA, for 
example, during the characterisation of a chicken BAC library, the largest BAC that 
was identified stably maintained a cloned insert of 700 kb (Zimmer and Verrinder 
Gibbins, 1997).
A number of BAC cloning vectors are available. The addition of the lacZ 
gene to the original pBAClOSL created pBeloBACl 1 and its derivative pECBACl.
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EcoRl fragments are easily cloned into pECBACl and pBeloBACll accepts 
Hindlll to BamUl fragments. The second generation of pBeloBACll vectors 
includes pEBACl and pEBACHO and the Rosewell Park Cancer Institute (RPCI) 
uses BAG vector pBACe3.6. BAG libraries have been constructed from a wide 
variety of species, with databases accessible from: http://informa.bio.caltech.edu/; 
http://www.resgen.com/ intro/libraries.phpS; http://hbz.tamu.edu/bacindex.html; 
http://www.chori.org/bacpac/libraryres.htm.
1.4.4 BAC transgenesis
A number of studies have now obtained functional data from transgenic 
BAC studies. Most of these studies have been conducted with transgenics produced 
from the random integration of microinjected BAC DNA into fertilized mouse 
oocytes. The first reported experiment of this type being analysis of the Clock 
genes for circadian rhythm (Antoch et al., 1997). Since this study other groups have 
found success using BAC vectors to rescue mutations.
BAC transgenesis has been implemented in the investigation of tissue and 
organ development, e.g. the 'Granulation rescue and developmental marking of 
juxtaglomerular cells using "piggy-BAC" recombination of the mouse ren locus' 
(Mullins et al, 2000). This study exemplifies the use of BAC transgenes not only to 
rescue a mutated phenotype but also mark a set of tissues in order to study their 
progression throughout development. The mutant phenotype for the homozygous 
Ren-1 null knock-out mouse was successfully rescued by a 145 kb BAC transgene. 
The BAC contained the Ren-1 gene, which had been previously altered by 
homologous recombination in E. coli to introduce the IRES-(3geo sequences, in 
order to mark those cells that express Ren-1. The implementation of a breeding 
programme, between Ren-1 null mutants and mice homozygous for the inserted 
BAC transgene, produced in vivo mouse models with a range genotypes. The 
resulting phenotypes generated a comparative data set that furthered the 
understanding of the function of the Ren-1 gene.
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BAG rescue has been applied to aid the mapping of genes within naturally 
occurring deletions in mice, e.g. 'Physical localization of the mesoderm 
development (mesd) functional region' (Wines et al., 2000). The investigators in 
this study took a subset of deletions on mouse chromosome 7 that were known to 
affect mesoderm development and isolated a number of murine BACs to create a 
contig library that spanned this region, a distance of approximately 1.3 Mb. The 
investigators then tested the BACs to see which of them was capable of rescuing 
the mutant phenotype. This resulted in a discrete region of approximately 75 kb 
being defined, which was then investigated for expressed sequences. This generated 
candidate genes responsible for rescuing the mutant phenotype. In this way the 
identification and mapping of a candidate gene responsible for a mesoderm 
development, within a 1.3 Mb deletion, was simplified and facilitated by BAG 
transgenic rescue.
BAG transgenesis has also been implemented to verify candidate genes 
thought to be responsible for human diseases, e.g. 'TBXl is responsible for 
cardiovascular defects in velo-cardio-facial/DiGeorge syndrome' (Merscher et al., 
2001). Velo-cardio-facial/DiGeorge syndrome is caused by deletions of 1.5 Mb to 3 
Mb in humans at 22qll. The deletion of a candidate gene, TBXl, was thought to 
play a crucial role in generating the human disease phenotype. However, without a 
naturally occurring deletion in mice that mimicked the human disease phenotype 
this theory was difficult to test. Therefore the investigators engineered the 
equivalent of the 22qll deletion, using Cre/lox technology, in mice. They 
engineered a 1.5 Mb deletion on mouse chromosome 16 at the locus equivalent to 
the human deletion, this resulted in the production of a number of hemizygous 
genes. A BAG containing the human sequence of the candidate disease-related 
gene, TBXl, was introduced to these mice by breeding. The BAG partially rescued 
the disease phenotype in the mice, thereby providing support to the theory that the 
deletion of TBXl contributes to the velo-cardio-facial/DiGeorge disease phenotype 
in humans.
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BAG transgenesis has been implemented to determine the dominance of 
disease loci, e.g. Transgenic rescue of the tattered phenotype by using a BAG 
encoding Ebp' (Means et al., 2001). The tattered phenotype in mice is thought to be 
equivalent to the mutation that causes the X-linked dominant disease, 
chondrodysplasia punctata (CDPX2). Human females that are heterozygous at the 
CDPX2 locus, display skin, hair, craniofacial and skeletal abnormalities and 
cataracts, but affected males are not observed. This pattern suggests that the disease 
is prenatal lethal in the hemizygous state in humans, as is the tattered phenotype for 
mice. The molecular basis of the phenotype in humans and mice was established as 
arising from a mutation of the emopamil-binding protein gene (Ebp) and the 
investigators of this study wished to eliminate the possibility that this mutation was 
dominant-negative. The investigators generated data that demonstrated that the 
transgenic expression of a wild-type murine Ebp protein, from a single 125 kb 
murine BAG transgene, was sufficient to fully rescue the tattered phenotype of 
males and heterozygous females, which carried the mutated Ebp gene. This 
observation argued against a dominant-negative mechanism in heterozygous 
tattered females and verified the role of Ebp in generating the disease phenotype.
The studies detailed above implement transgenesis by introducing the BAG 
DNA by oocyte micro-injection. Thus far however, there has been no report of 
transgenesis arising from the electroporation of BACs into ES cells, at either 
random genomic locations or as part of a gene-targeting strategy.
1.4.5 BAC stability and handling
The stability of BAC DNA is in part due to the fact that they are harboured 
in recombination-deficient E. coli host strains. Most commonly the DH10B strain is 
used, whose genotype is: F~araD139 A(ara, leu)7697 klacX74 galU galK rpsL 
deoR <t>80d/acZ AMIS endAl nupG recAl mcrA A(w/r hsdRMS mcrBC ) (Grant et 
al., 1990). The presence of the mcrA genotype marker and deletion of mcrBC and 
mrr makes this strain suitable for cloning DNA that contains methylcytosine and 
methyladenine. DH10B is receptive to large vectors due to the presence of the deoR
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mutation. Therefore, both prokaryotic and eukaryotic genomic DNA can be cloned 
effectively into vectors harboured in DH10B.
BAG DNA can be reliably purified from the E. coli bacterial chromosome 
using methods similar to those for plasmid isolation, although yields of BAG DNA 
are significantly lower due to their single or low copy status within the host 
bacterial cell. In contrast, it is difficult to isolate YACs free of yeast genomic DNA, 
giving rise to problems during YAC library production (as mentioned previously) 
and the introduction of YAC DNA to ES cells (Choi et al., 1993; Davies et al., 
1992; Davies et al., 1993; Jakobovits et al., 1993; Lamb et al., 1993; Pearson and 
Choi, 1993; Strauss et al., 1993) or oocytes (Montoliu et al., 1994; Schedl et al., 
1996;Schedletal, 1993).
Since the average BAG size is less than 200 kb it may be possible to analyse 
the cloned insert by restriction and gel electrophoresis alone, thereby obviating the 
requirement for pulsed field gel and Southern Blot analysis, which are a necessity 
for larger vector constructs such as YACs and HACs. The ease with which BAG 
DNA can be maintained, purified and analysed contributes a significant advantage 
of BACs over YACs and HACs. The BAG has therefore become the vector of 
choice for genome sequencing and whole genome library contig assembly using 
STS and EST mapping (Hubert et al., 1997; Johnson et al., 1999; Kirn et al., 1996; 
Osoegawa et al., 2000) due to the practicable scale-up of BAG propagation and 
analysis for high-throughput applications.
1.4.6 BAC modification by homologous recombination
BACs are harboured in the E. coli bacterium and so methods of homologous 
recombination mediated cloning can be implemented to manipulate any part of the 
vector or cloned insert. Homologous recombination has been routinely used to 
manipulate YACs (for a review see Duff and Huxley, 1996), therefore the 
establishment of comparable techniques for BAC modification was necessary to 
enable their equivalent application. This is currently made possible by 
recombination-mediated cloning.
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In the broadest terms recombination mediated cloning utilizes homologous 
recombination pathways, in various strategies, to manipulate any DNA molecule 
that can be propagated within the E. coll bacterial cell. These include: the E. coli 
chromosome; plasmids; BACs and PACs. These approaches do not rely on the 
presence of suitable restriction sites and can therefore be used to insert, delete or 
substitute DNA sequences at any desired position on the target DNA molecule. 
Consequently, the limitations that apply to conventional cloning techniques are 
alleviated. Several methodologies have evolved to perform recombination mediated 
cloning, however these can be categorized according to the recombination pathway 
that is used, namely recA or recE/recT or red.
In E. coli the major pathway of general homologous recombination 
mechanism is initiated by cooperation between RecA (the most conserved strand 
invasion protein in evolution) and the multi-functional RecBCD enzyme complex, 
which is capable of vigorous exonuclease activity (Kowalczykowski et al., 1994).
Methods that utilize recA recombination are based on two-step modification 
protocols. The application and efficiency of this approach is dependent on using 
large regions of homology, 400 bp or greater, harboured on a purpose-built 
targeting plasmid, the efficiency of the counter selection procedure and the nature 
of the provision of RecA. The recA gene could be omitted if a RecA+ E. coli host 
strain is used, although providing RecA in tram from the targeting plasmid permits 
the use of common BAG hosts that are recA, such as DHIOB, and also limits the 
recombinogenic window thereby limiting the possibility of any undesirable 
rearrangements in the target molecule.
X.W. Yang first demonstrated the modification of a BAG by a two-stage 
recA mediated method utilizing a temperature sensitive targeting plasmid and tet 
counter selection (Yang et al., 1997). RecA-dependent BAG modification has since 
been applied to study the murine renin locus (Payne et al., 1999; Mullins LJ, 2000) 
and improved by using rpsL counter selection to study the beta-globin locus (Imam 
et al., 2000). Further developments include the expression of recA from a separate 
plasmid (Lalioti and Heath, 2001).
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Alternatives to the recA recombination strategies are those that utilize the 
recElrecT pathway (equivalent to the pathway used by the A. red genes). These 
methods require much smaller regions of homology, between 40 to 60 bp. The 
targeting molecule is usually double-stranded linear DNA, which can be most 
conveniently generated entirely by PCR. Targeting is achieved in a single step, with 
the provision of the recombination proteins encoded from either a separate 
recombination plasmid or from the relevant genes that have been targeted to the E. 
coli chromosome.
The evolution of recE/recT dependent methods has mainly occurred within 
three different groups. The first group to establish a method was F. Stewart's group 
in EMBL, Heidelberg (Zhang et al., 1998) and in subsequent publications coined 
the term 'ET-cloning' to describe methods using the recE/recT recombination 
pathway. Subsequently methods evolved from P.A. loannou's group in The 
Murdoch Institute, Melbourne (Narayanan et al., 1999), using the term 'GET 
Recombination' and from researchers at The National Cancer Institute-Frederick, 
Maryland within D. Court's and N.A. Jenkins and N.G. Copeland's groups (Yu et 
al., 2000).
One of the aims of improving recombination mediated cloning strategies has 
been to optimise the expression of the genes that drive the homologous 
recombination reaction in an attempt to increase targeting efficiencies. A second 
aim was to generate strategies to control the 'window of recombination activity' to 
limit the undesirable recombination of the target molecule at locations other than 
the target. These developments are discussed in detail below.
The discovery of the RecET pathway originated from work by Clark and co- 
workers who found evidence for multiple recombination pathways in E. coli (for 
review see Clark and Sandier, 1994). By blocking the RecBCD pathway in E. coli 
by producing recBC mutants it was possible to identify further mutations that could 
induce the recE or recF pathways thereby restoring recombination proficiency.
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The sbcA mutation is known to suppress the recBC phenotype by activating 
the expression of the recE/recT operon, encoded by part of the Rac prophage 
integrated into E. coll K12 strains (Clark and Sandier, 1994; Clark et al., 1984; Hall 
et al., 1993). In order to use the recET pathway to perform homologous 
recombination in any E. coli strain, a plasmid was developed that could recapitulate 
the recombination status of sbcA recBC mutants (Zhang et al., 1998). This plasmid 
was pBAD-ETy, it has a truncated recE gene under the inducible control of the L- 
arabinose inducible pBAD promoter (Guzman et al., 1995) and red constitutively 
driven from the EM7 promoter. The redy gene in this plasmid was driven by the 
Tn5 promoter to recapitulate recBC status, since it inhibits the action of the 
RecBCD exonuclease, thereby inhibiting the degradation of double-stranded linear 
fragments.
Further publications by the Stewart group sought to optimise the parameters 
of the ET-cloning procedure. It was determined that the A, equivalent genes for recE 
and recT, namely reda (or exo) and redfi (or bet) respectively, could replace the 
function of the bacterial genes and mediate recombination with equal efficiency. 
The resultant plasmid was pBADccpy, in which a is under the control of the 
inducible pBAD promoter (Guzman et al., 1995) and (3 driven from the EM7 
promoter. As above, y is driven by the Tn5 promoter (Muyrers JP, 1999). This 
plasmid was applied to the modification of BACs (Muyrers JP, 1999) and 'BAG 
Trimming' (Hill et al., 2000). By coordinating a and (3 under pBAD control and 
placing y under the separate constitutive control of the EM7 promoter pBAD- 
RedGam was generated and used to drive the introduction of point mutations to 
BACs using a two-step procedure with sacB-neo second step counter selection 
(Muyrers et al., 2000).
The construction of the pR6Kl 16/BADocpy recombination plasmid included 
the introduction of the high copy R6K origin andpirlJ6, which is required for its 
replication (Haffter et al., 1996). This plasmid was found to be more efficient at 
mediating DNA sub-cloning than any of the previously described plasmids (Zhang 
et al., 2000).
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At a similar time loannou's group developed the pGETrec plasmid, which 
was derived from A.F. Stewart's plasmid pBAD24-trecET, by the addition of y 
gene (Narayanan et al., 1999). pGETrec differs from pBAD-ETy since all the genes 
on the former are under the inducible control of the pBAD promoter. The aim of 
co-ordinating their expression in this way was to control both the induction of the 
recET pathway and the inhibition of recBCD nuclease activity. This system has 
been applied to introduce mutations to BACs harbouring the p-globin locus, to 
recapitulate disease mutations (Nefedov et al., 2000) and to introduce GFP reporter 
constructs (Orford M, 2000).
A different approach than that of using a plasmid harbouring the genes 
necessary for recombination, was the use of E. coli strains engineered to harbour 
the genes for inducible homologous recombination on the E. coli chromosome. 
These strains have been termed in the literature as 'hyper-recombinogenic strains', 
since they perform homologous recombination with high efficiency and are 
exemplified by strains KM22, DY329 and YZ2000. KM22 was constructed by 
replacing the recBCD genes on the E. coli chromosome of strain ABl 157, with the 
A, genes reda and redft, under the control of the bacterial promoter P)ac (Murphy, 
1998). The intended use of KM22 was to facilitate the manipulation of the E. coli 
genome, as was the production of strain DY329 (Yu et al., 2000), which has the
Q C*7
A, genes a(3y under the control of the temperature sensitive cl represser. However, 
the utility of such strains for the modification of DNA molecules other than the 
chromosome was apparent and demonstrated by the manipulation of BAG DNA 
(Lee et al., 2001; Swaminathan et al., 2001). In addition, the combination of a 
plasmid expression system, pR6K116/BAD/recT, with the hyper-recombinogenic 
E. coli strain YZ2000, was demonstrated as capable of sub-cloning the neomycin 
selection marker from a background of mouse ES cell genomic DNA (Zhang et al., 
2000).
The advantages of using hyper-recombinogenic strains over plasm id-based 
expression of the recombination genes are four-fold: the systems that use the A, 
recombination genes seem to be 50- to 100-fold more efficient for genes expressed
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from the chromosome rather than from a plasmid; a further drug selectable marker 
is available to select for the introduction of mutations to the target molecule since it 
is not required to select for the presence of a recombination plasmid; the problem of 
plasmid incompatibility between the target and recombination plasmid are 
circumvented; and the inducible expression from the E. coli chromosome is less 
leaky than the inducible plasmid systems developed thus far (Lee et al., 2001).
In addition to the development of highly efficient E. coli strains that utilise 
the recET pathway, the other advantages that exist in using this pathway rather than 
the recA pathway and associated strategies are: that the targeting molecule may 
easily be generated by PCR, since the technique is efficient with 40 to 60 
nucleotides of homology; and that currently protocols exist that can deliver point 
mutations and small deletions to the target molecule without the concomitant 
introduction of selection markers, thus increasing the variety of mutations that can 
be made and investigated.
In summary the technology exists to rapidly and efficiently make any 
desired modification to a BAG molecule that would facilitate the functional 
investigation of the coding, structural or regulatory elements contained within the 
cloned insert. In the context of the strategy developed within this thesis, the use of a 
BAG vector permitted the structural and regulatory elements of the alpha-globin 
locus to be encompassed in a single vector. Additionally, the use of the BAG 
presents the opportunity to use recombination mediated cloning strategies to 
flexibly manipulate the alpha-globin locus in an unprecedented manner.
1.5 The use of site-specific recombination systems for genome manipulation.
Typically site-specific recombination (SSR) is mediated between two 
specific sequences of DNA, known as recombination sites. The SSR reaction is 
catalysed by a recombinase protein that recognizes these sites and mediates the 
exchange exclusive of any other proteins or ATP. SSR systems of this kind include 
Crz-loxP (Abremski and Hoess, 1984), FLP->/ (McLeod et al., 1986) and the less 
commonly applied A, int system (Nash et al., 1987).
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The Cre-/ojt system originates from the PI bacteriophage and its functions 
within the phage are to: circularise the phage following infection; monomerise 
plasmid dimers during lysogenic phage replication; and integrate the phage genome 
to the bacterial chromosome site loxB (Hoess et al., 1982). It is therefore surprising 
that this system, which has evolved to manipulate the genome of a phage, is able to 
manipulate megabases of eukaryotic genome and effect chromosome engineering 
(as discussed below). However, to date the most widely applied SSR system for 
mammalian genome manipulation has been Cre-lox.
Cre is a 38 kDa recombinase and its recognition site is a 34 bp sequence, 
termed loxP. The central 8 bp of the lox sequence is known as the spacer region and 
gives the lox site directionality, as shown in Fig. 1.1 (Hoess et al., 1986). The 
remainder of the lox sequence forms two 13 bp inverted repeats at either side of the 
spacer region. Cre recombinase catalyses site-specific recombination (SSR) 
between lox sites of identical sequence (Sternberg, 1981; Sternberg and Hamilton, 
1981; Sternberg et al., 1981). The variety of manipulations that can be performed 
by SSR are shown in Fig. 1.2. As a point of nomenclature, flanking sequences with 
lox sites that have the same orientation is commonly referred to as 'floxing' (with 
frt sites it is known as 'flirting''), again see Fig. 1.2.
Cre-/ojc has been diversely applied to manipulate eukaryotic genomes. The 
largest manipulations made with Cre-/ox have been on the scale of chromosomal 
translocations, deletions and inversions of megabases of DNA, as discussed below. 
The initial applications of Cre-/o;c however, manipulated smaller regions of DNA, 
as discussed in Section 1.5.2.
1.5.1 Chromosome engineering
Chromosome engineering is possible by combining gene-targeting with site- 
specific recombination (SSR) technology. The potential of Cre-lox technology to be 
able to manipulate large regions of a eukaryotic genome in vivo was first 
established when the deletion, inversion and duplication of a 3 cM region in ES 

















































































































































































































































































































































































































































































































































































































































































































































































































































































were sequentially introduced on separate gene-targeting vectors and then transient 
expression of Cre from an expression cassette mediated the deletion. Since then, 
similar Cre-/o;c engineered chromosomal manipulations have been reported, in 
addition to translocations between non-homologous chromosomes (Smith et al., 
1995; Van Deursen J, 1995). The development of the selection strategy that enabled 
these re-arrangements to be isolated was a key development in the field of 
chromosomal engineering. Still widely implemented, this method reconstructs the 
HPRT human minigene.
1.5.1 (a) Reconstruction of the HPRT minigene
In the mouse the constitutively expressed X-chromosome-linked HPRT 
(hypoxanthine phosphoribosyltransferase) gene is 33 kb long and contains nine 
exons (Melton et al., 1984). The gene is nonessential in cell culture and in mice, 
although in humans HPRT deficiency causes Lesch-Nyhan syndrome (Lesch and 
Nyhan, 1964).
The inactivation of the HPRT gene can be selected for in ES cells with 6- 
thioguanine (6-TG) supplemented media (Valancius and Smithies, 1991), whilst a 
functional HPRT gene is selected for using hypoxanthine-aminopterin-thymidine 
(HAT) supplemented cell culture media (Doetschman et al., 1987).
Modifications were made to the human HPRT sequence to produce a 
minigene competent to restore HPRT function in a stable and position independent 
manner in murine ES cells (Reid et al., 1990). Since the selection of the HPRT 
minigene requires that endogenous function is first ablated, an HPRT-deficient ES 
cell line was created. The E14 male ES cell line, derived from 129 mice, was 
mutated to produce an ES cell line with ablated HPRT function. This line was 
demonstrated to be germline competent and termed E14TG2a (Hooper et al., 1987; 
Thompson et al., 1989). No spontaneous reversion of the HPRT ablated phenotype 
was detectable, due to the mutation being a deletion that encompasses the promoter 
and first two exons. The E14TG2a line enabled a targeting construct containing an 













































































































































































































































































































































































































































































































































































































































































endogenous HPRT function (Selfridge et al., 1992).
A loxP site was cloned into intron 3 to further modify the Reid et al, 1990 
minigene without compromising HPRT function (Smith et al., 1995). This enabled 
the two regions of the HPRT gene either side of the loxP site to be separated and 
then brought together by Cre-mediated SSR to reconstitute a functional gene. The 
reconstruction of the 5' region of the HPRT minigene with the 3' region of the 
minigene by SSR about the loxP site was first demonstrated by Smith et al in 1995 
to mediate a non-homologous chromosomal translocation (Smith et al., 1995).
1.5.1 (b) Current applications Cre-mediated chromosome engineering
CrQ-lox mediated chromosomal re-arrangement has been used effectively to 
mimic the following conditions and disease phenotypes: human acute myeloid 
leukaemia (AML) (Buchholz et al., 2000) and other cancers arising from 
chromosomal translocation, e.g. lymphoblastic leukaemias (Rabbitts et al., 2001); 
Beckwith-Weidman syndrome (Cleary et al., 2001); synpolydactyly (Zakany and 
Duboule, 1996); DiGeorge syndrome (Puech et al., 2000).
The ability to produce megabase chromosomal inversions has been applied 
to create balancer chromosomes for ENU mutagenesis screens, the aim of which is 
to identify recessive mutations (Zheng et al., 1999).
1.5.2 Conditional alleles
The positioning of two identical lox sequences, in the same orientation with 
respect to one another, creates a floxed interval that may be deleted by Cre- 
mediated SSR, as illustrated in Fig. 1.2. Cre-mediated SSR has been shown to be 
capable of deleting floxed intervals with efficiency in ES cells. This facet was 
initially implemented to remove undesirable sequences, such as selection markers, 
from gene-targeting constructs, thereby removing sequences that may generate 
artefactual results. However Cre-mediated deletion of targeted sequences has been 
further implemented in strategies of gene mutation (Brault et al., 2001; Chang et al., 
1999; Tomita et al., 2000; Wagner et al., 2000).
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In order to understand gene function one avenue of investigation is to ablate 
the function of a gene by deleting its sequence either in part or entirely from the 
genome and then study the resulting phenotype. The organism that results from 
such mutations is commonly referred to as a 'knock-out'.
Knock-out mice may be created by removing a number of exons critical to 
the function of the gene by gene-targeting. However, the assessment of the knock- 
out phenotype from such mutations should also include a rigorous assessment of its 
genome, to ensure that the remaining gene sequences do not provide any residual 
function. To conclusively remove any residual gene function one solution would be 
to create a deletion of the entire gene. In some cases this may be impractical with 
gene-targeting methods due to the size of the gene and achieved more easily with 
Cre-/o* technology. However, the deletion of entire genes may concomitantly 
remove sequences that affect the expression of other genes.
A major obstacle that may be encountered during the functional assessment 
of a knock-out phenotype is lethality due to the mutation, present in every cell of 
the embryo, disrupting the normal developmental path of the organism. This 
presents a problem if the aim of the investigation is to study the consequences of 
ablated gene function in the adult organism alone.
To circumvent this problem, strategies were developed that could restrict the 
mutation of a gene in a spatio-temporal manner to a population of cells in which its 
expression had functional relevance. The ability to restrict ablation or mutatgenesis 
of a gene in a spatio-temporal manner was achieved by the development of 
conditional alleles. Conditional alleles can be generated by gene-targeting in ES 
cells and include genes whose sequences are either entirely floxed, or genes that 
have had critical exons floxed. These ES cells can then be used to generate 
transgenic mice that should not be functionally compromised and so develop into 
adult mice harbouring the floxed allele.
In parallel, transgenic mouse lines were developed in which the expression 
of Cre recombinase may be controlled in a spatio-temporal manner, due to the 
expression of Cre from a suitably restricted promoter. The promoter may be
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restricted due to its expression being exclusive to a specific tissue type (Gu et al., 
1994) or to a stage of development or both (http://www.mshri.on.ca/nagy/cre.htm). 
In addition, fusion of the promoter to tet operator sequences (St-Onge et al., 1996) 
or fusion of Cre recombinase to hormone receptor domains (Kellendonk et al., 
1996; Zhang Y, 1996), permits the temporal induction of the recombinase. As an 
alternative to transgenic lines, Cre may also be delivered by injection of the 
relevant tissue with an adenovirus vector carrying Cre (Wang et al., 1996).
The inter-cross of a transgenic Cre mouse with a mouse harbouring afloxed 
allele should generate double-mutant progeny. The double-mutants undergo SSR, 
following Cre expression or induction, to delete thefloxed interval thereby deleting 
either a gene or critical exons, to cause the mutation. The phenotype of the resulting 
mice may be then analysed. The use of conditional alleles is implemented most 
advantageously to circumvent the problem of embryonic lethality, due to the 
mutation of a gene critical to development. Thus conditional alleles permit the 
investigation of a gene's function in the relevant tissue within an adult model 
organism.
1.5.3 Recombinase Mediated Cassette Exchange (RMCE)
Deletion of conditional alleles is achieved by floxing sequences with 
compatible lox sites, in direct orientation with respect to each other, as illustrated in 
Fig. 1.2 and outlined above. In contrast, the use of variant or hetero-specific lox 
sites, permits the directional exchange of a similarly floxed interval, see Fig. 1.2. 
The common term for such a reaction is recombinase mediated cassette exchange 
(RMCE).
Recently, Cre-lox and FLP-^? recombinase systems have been applied to 
mediate the directional exchange of small (1-2 kb) cassettes of DNA in strategies 
that share the same rationale and have been termed recombinase mediated cassette 
exchange (RMCE) (Bouhassira et al., 1997), segmental genome replacement 
(Bethke and Sauer, 1997) or double-reciprocal cross-over (Bode 1997). The 
rationale behind these experiments is summarised in Fig. 1.2 and for convenience 
will be referred to as RMCE.
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RMCE involves the use of a SSR system, ¥LP-frt and Cre-lox have been 
cited in literature thus far (Bode et al., 2000). SSR sites are used to flank the 
interval to be exchanged as shown in Fig. 1.2. The recombination sites are hetero- 
specific in order to promote inter- rather than intra-molecular SSR. RMCE was first 
demonstrated using the FLP-frt SSR system, using wild-type frt and a hetero- 
spedficfrt generated by mutation (Schlake and Bode, 1994), and since that time the 
published use of the FLP-frt system has been by Bode and colleagues. The Cre-lox 
system was initially found to be more suitable for cells in culture due to its 
thermostability and may explain the limited application of the FLP-Jrt system thus 
far, although more thermostable FLP recombinase variants have become available 
(Buchholz et al., 1998; Rodriguez et al., 2000). Since the initial 1994 publication 
two further reports from Bode and colleagues have demonstrated the application of 
the YLP-frt RMCE system, most notably in 1998 when RMCE was first applied in 
ES cells (Seibler et al., 1998).
In 1997 two labs independently reported the use of different RMCE 
strategies utilizing Cre-lox, with loxP and Iox511 sites. The term 'RMCE' was 
coined by Bouhassira and was implemented with a 'plug and socket' method of 
selection (Bouhassira et al., 1997). In the same year Sauer used a different selection 
strategy to implement 'segmental genome replacement' and in 1999 was the first to 
implement RMCE in ES cells using the Cre-/o;c system and tested a variety of 
selective procedures (Soukharev et al., 1999)
The majority of reported RMCE experiments use the Cre-/ax SSR system, 
with loxP and Iox511 (Hoess et al., 1986) being the hetero-specific sites of choice. 
However the low incidence of SSR between loxP and Iox511 in some cases has led 
to the use of another lox variant, Iox2722 (Kolb, 2001), or more recently the Iox66 
and Iox72 pair (Zhang and Lutz, 2002). The research group headed by Bouhassira 
was the first to report the use loxP and loxSll in a tandem arrangement (Bouhassira 
et al., 1997), but then altered their strategy to arrange the sites in an inverted 
orientation (Feng et al., 1999). The inverted orientation was chosen in order to 
eliminate the possibility of deleting the interval between the hetero-specific lox sites
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should SSR between them occur (see Fig. 1.2), thereby, in theory, increasing the 
likelihood of generating an RMCE event.
The efficiency of the RMCE reaction is reported by most studies to be high 
and affected by the selection strategy employed. However, the application of 
RMCE between studies has little similarity and so a comparison of their efficiencies 
has little relevance.
Sauer was the first to use a Cre-lox strategy to introduce DNA into a pre- 
designated site in a complex mammalian genome by SSR (Sauer and Henderson, 
1988) (see previous discussion). Sauer then went on to compare the efficiencies of 
using either an RMCE replacement strategy or single lox site insertion approach. 
The RMCE strategy was found to be 20-fold more efficient than the equivalent 
system with just a single lox site and furthermore the RMCE approach was shown 
to be more efficient than the level of illegitimate recombination (Bethke 1997). The 
study used two rounds of selection, the first selection identified those cells that had 
taken up the RMCE construct, the second the RMCE event itself, based upon 
selection markers within the RMCE construct. The results were that from 
populations of cells that had taken up the RMCE DNA construct, 2% to 10% 
underwent the desired RMCE event. In a separate investigation, it was 
demonstrated that RMCE events could be identified from populations of cells 
shown to have taken up the RMCE construct by screening alone (Soukharev et al., 
1999). This study further exemplified the efficiency of the RMCE reaction and 
demonstrated that selection markers need not be incorporated within the RMCE 
construct. However, when two-stage selection strategies are used in conjunction 
with an RMCE approach, for example PNS, three different research groups have 
obtained RMCE efficiencies of 100% (Feng et al., 1999; Seibler et al., 1998; 
Soukharev et al., 1999).
The application of RMCE to study a biological system has been most 
prolifically reported by a research team headed by Bouhassira. This group utilizes 
the plug and socket RMCE approach in order to investigate the genes and 
chromatin regulatory elements, associated with the alpha (Esperet et al., 2000) and
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beta-globin loci (Walters et al., 1999). Thus far, the other biological application of 
an RMCE strategy has been to direct the insertion of transgenes to transcriptionally 
permissive loci (Kolb, 2001).
Thus far, there has been no published report describing RMCE offloxed or 
flirted intervals of more than 5 kb.
A recent advance in Cre-/ox technology applied directed molecular 
evolution to alter the specificity of the Cre recombinase to produce a panel of novel 
enzymes with corresponding unique recognition sites with very little cross- 
reactivity to the wild-type Cre-loxP/lox5JJ system (Buchholz and Stewart, 2001). 
The new Cre-lox variant systems could extend the use of RMCE strategies, for 
example in order to replace loci that are located on different chromosomes or on the 
same chromosome at distances that necessitate the use of two independent RMCE 
events.
In summary, the Cre-/ox system has been demonstrated to have the capacity 
to effectively and flexibly manipulate a large size range of DNA, from a complex 
and organized genome (for a review see Yu and Bradley, 2001).
1.5.4 Large interval RMCE
In essence the strategy developed within this thesis attempts to perform 
RMCE using a larger interval between the hetero-specific lox sites. For this reason 
a consideration of the efficiencies from the RMCE experiments reported thus far, 
may be informative to predictions on the efficiency of mediating a larger exchange. 
However, the mechanism by which a small interval RMCE event occurs may be 
different to the progression of a large interval RMCE, in which case, a comparison 
of efficiencies would be of little value.
Thus far, there have been some considerations on the factors that affect the 
efficiency of Cre-lox mediated eukaryotic genomic manipulations (Zheng et al., 
2000). One possible explanation for the reduced efficiencies that are encountered 
with some chromosomal engineering strategies, may be the existence of higher 
orders of nuclear organization in eukaryotic cells. The organisation of the
33
chromosomal environment harbouring the lox sites may restrict its availability to 
the Cre recombinase or restrict its participation in SSR by restricting the motility 
and flexibility of the DNA (Vooijs et al., 2001). It was therefore necessary, in the 
context of this strategy, to determine whether the efficiency of the desired 
replacement event would be so low as to be unrecoverable, or whether the large 
interval RJVICE event would occur with efficiency comparable to those encountered 
with chromosomal engineering strategies using equivalent intervals.
1.5.4 (a) The strategy developed in this thesis for large interval RMCE
The strategy developed within this thesis combines technology from 
chromosomal engineering studies and large vector transgenesis, in order to develop 
technology to study functional genome elements in their normal genomic context. 
Gene-targeting and Cre-mediated SSR, were combined with the BAG vector system 
in a large interval RMCE strategy. The development of this strategy serves as a 
preliminary investigation towards the segmental replacement of the ES cell 
genome. An outline of the strategy for achieving the large interval RMCE event is 
illustrated in Fig. 1.3.
This thesis describes the progress on developing the large interval RMCE 
strategy, using the alpha-globin locus as a test region. The strategy utilizes Cre- 
mediated SSR between hetero-specific lox sites targeted to the ES cell genome and 
the genomic insert cloned into a BAG. Therefore, with reference to Fig. 1.3, the 
circular molecule represents the participation of the BAG, whilst the linear 
molecule represents the ES cell locus. As shown in Fig. 1.3, at one end of the 
interval, reconstruction of HPRT occurs around the loxP sites and at the other end 
the thymidine kinase is excluded from the genome upon Iox511 SSR. The execution 
of the desired RMCE event should therefore be possible by selecting the ES cells 
on the basis of their resistance to HAT and ganciclovir supplemented media.
1.6 The alpha-globin locus as a test locus
Haemaglobin is the protein tetramer that carries oxygen in mammalian 



















































































































































































































































































































































































































































































































































































protein subunits. The genes that encode the alpha and beta globin proteins are each 
clustered at spatially distinct loci, an arrangement that is thought to be the result of 
the duplication from a common ancestral locus. In humans the alpha-globin locus is 
located on chromosome 16 and the beta-globin locus on chromosome 11, whilst in 
mice the alpha-globin locus is on chromosome 11 and beta-globin locus is on 
chromosome 7.
The human and murine alpha-globin loci have several structural and 
functional similarities (see Fig. 1.4). Each cluster contains the same number of 
alpha-globin genes, which are arranged 5' to 3' in the order in which they are 
expressed during development. In both humans and mice, alpha-globin gene 
expression is erythroid-specific, occurring at the embryonic (Q, or fetal and adult 
stages (a 1 and a2) of development. The alpha-globin gene cluster also includes 
another gene, theta (0), which is transcribed at low levels and whose function is 
unknown, although it is established that it does not contribute to the haemaglobin 
tetramer (Clegg, 1987; Marks et al., 1986). Additionally, a region of considerable 
synteny that exists between humans and mice extends 5' of the alpha-globin gene 
cluster and most notably, even though the alpha-globin genes have an erythroid- 
specific expression, this region includes genes that have constitutive and extensive 
expression patterns (Kielman et al., 1993).
Primers that were identified from the conserved sequences between humans 
and mice were used in a reverse transcriptase PCR analysis and were able to 
identify three genes whose synteny was conserved 5' of the alpha-globin locus. 
These genes were named after their relative position to the locus as: Distl (distal), 
Midi (middle) and Proxl (proximal). Interestingly, in both humans and mice the 
Distl and Proxl genes are transcribed on the same strand but in an opposite 
direction to that of Midi and the genes of the alpha-globin cluster (Kielman et al., 
1996).
In the mouse, the Distl gene, also known as Rhbdfl (MGI: 104328), has a 
cDNA sequence which suggests it has receptor activity and it is expressed strongly 
in epithelial rich tissues (Vickers et al., 1993; Kielman et al., 1996). The Midi gene
36
has been characterised and found to encode the enzyme N-methylpurine-DNA 
glycosylase and as such was renamed Mpg (MGI: 97073) (Engelward et al., 1993; 
Kielman et al., 1995), it is expressed at high levels in the testis. The Proxl gene, 
also known as Phg (MGI: 84809) has a constitutive expression pattern and is 
therefore thought to encode a house-keeping gene, although its function has not 
been definitively established (Kielman et al., 1996). The human homolog of Proxl, 
hProxl, is also known as C16orf35 or-14 (Vyas et al., 1995).
The conservation of sequences 3' of the alpha-globin locus between humans 
and mice is less apparent, with the only identifiable conserved sequences being 
repetitive elements related to retroviral sequences. In humans, the first gene 
encountered 3' of the alpha-globin locus is located at a distance of 11.5 kb and is 
LUC7L. However in the mouse the orthologue of LUC7L is found on chromosome 
17. Thus far, the identification of putative regulatory sequences within this 3' 
region has been unsuccessful (Flint et al., 2001).
1.6.1 Diseases associated with the alpha-globin locus
Under normal circumstances transcription from the alpha-globin locus is co- 
ordinated with that of the beta-globin locus to generate a normal haemaglobin 
tetramer. However, there are various anaemias that occur due the disproportionate 
amount of either alpha- or beta-globin protein sub-units, which leads to the 
formation of abnormal haemoglobin proteins that have an inability or inefficiency 
to either associate or dis-associate from oxygen. These are the thalassemias. Alpha- 
thalassemias are characterised by an abundance of beta-globin proteins, the result of 
which is the formation of unstable haemaglobin tetramers, which have a decreased 
efficiency for oxygen transport. This form of anaemia is referred to as microcytic 
anaemia (in contrast to macrocytic anaemia e.g. sickle-cell anaemia), since the 
erythrocytes are visibly normal despite their reduced functional competency (Higgs 
etal., 1989).
The abundance of beta-globin proteins in alpha-thalassemias may be due to 
the over-expression of the beta-globin genes or (more commonly) a deficiency in 











































































































































































































































































































































































































































































































































































































by a mutation or deletion of one of the genes from the alpha-globin cluster. 
However other inherited alpha-thalassemias have been presented for which all of 
the alpha-globin genes are intact and yet little or no alpha-globin protein is 
produced. In these cases large deletions 5' of the alpha-globin locus were detected 
and thought to cause the thalassemic condition (Higgs et al., 1989).
1.6.2 Regulation of the alpha-globin locus
The characterisation of four naturally occurring, inherited deletions, that 
cause oc-thalassemia in humans, demonstrated that a region 5' of the cluster is 
required for the correct expression of the alpha-globin genes (Hatton et al., 1990; 
Liebhaber et al., 1990; Romao et al., 1991; Wilkie et al., 1990). All of these 
deletions leave the structural genes intact and by mapping the deletions a minimal 
region that was present in each was defined, it extended for 20.4 kb and was 
approximately 30 kb 5' of ^-globin. The chromatin structure in this region was 
extensively characterised and this identified four erythroid-specific DNasel 
hypersensitive sites (HS) located 8 (HS-8) kb, 10 (HS-10) kb, 33 (HS-33) kb and 40 
(HS-40) kb upstream of ̂ -globin's messenger RNA cap site (Higgs et al., 1990).
The HS with the greatest influence on alpha-globin expression was 
demonstrated to be HS-40 (Jarman et al., 1991). This study determined that the 
smallest region required to stimulate the production of human alpha-globin mRNA 
in mouse erythroleukemia (MEL) cells, following their terminal differentiation, was 
a fragment of 350 bp, which contained HS-40. This 350 bp region was also shown 
to contain several transcription factor binding sites: four GATA-1 sites; four CAC 
boxes; two AP-1/NF-E2 sites; and one AG box (Kielman et al., 1994). Studies then 
determined that transgenes containing human alpha-globin genes linked to this 350 
bp fragment containing HS-40, could express the alpha-globin genes in a tissue- 
specific and developmentally regulated pattern of expression in transgenic mice 
(Sharpe et al., 1992; Sharpe et al., 1993).
Other studies created stable interspecific hybrids in MEL cells by 
introducing human chromosome 16 into these cells and then assessing them for the
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level of human alpha-globin gene expression. The result was that human alpha- 
globin genes were expressed, although at levels lower than the endogenous mouse 
genes (12 % to 56 % of mouse globin levels) (Higgs et al., 1998). In this same 
system the effect on human alpha-globin gene expression of replacing a 1 kb 
fragment containing HS-40 with a neomycin gene, was tested. The neomycin gene 
was flanked by frt sites, which enabled its deletion following FLP recombinase 
expression. MEL cells with either the neomycin present or FLP-deleted, from 
human chromosome 16, demonstrated a severe down-regulation in the expression 
of human alpha-globin genes (Bernet et al., 1994).
Therefore, the conclusion from these studies was that HS-40 was the 
element necessary and sufficient to regulate human alpha-globin expression.
The investigation of the murine alpha-globin sequence, with a homology- 
based search, was used to locate the murine equivalent of HS-40. This investigation 
discovered sequence homology 26 kb 5' of murine ^-globin and this site co- 
localised with a HS and as such was termed HS-26 (Kielman et al., 1994). The 
functional equivalence of HS-40 and HS-26 was further suggested by their 
conserved location between humans and mice within intron 5 of the Proxl gene 
(Kielman et al., 1996).
HS-26 co-localises with several transcription factor binding sites conserved 
bewteent HS-40 and HS-26, these include: three GATA-1 sites; one CAC box; two 
AP-1/NF-E2 sites; and one AG box (Kielman et al., 1994). In comparison with HS- 
40, this is one less GATA-1 and three less CAC box transcription factor binding 
sites.
To determine whether HS-40 and HS-26 were functionally equivalent, a 350 
bp fragment containing HS-26 was linked to the globin genes of the human locus 
and then introduced to MEL cells. This investigation determined that HS-26 was a 
much weaker enhancer for human-globin genes than HS-40, however this study 
suggested that this could be due to an incompatibility between the murine and 
human sequences, rather than an inability of HS-26 to act as an enhancer
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(Bouhassira et al., 1997). The same study investigated the effects of replacing the 
350 bp region containing HS-26, with a neomycin gene and this was achieved by 
gene-targeting in ES cells. The effect of this mutation was assessed in murine 
chimeras (note, no report of germline transmission was made in this study). Each 
chimeric mouse harboured a population of erythrocytes that appeared thalassemic, 
which suggested that HS-26 is required for alpha-globin regulation. However it was 
not possible to truly establish the extent to which HS-26 controls globin expression 
since the level of chimerism was an unknown in this study. Furthermore, the effects 
of the neomycin gene, located within intron 5 of Proxl, were not established, 
neither on the regulation of the alpha-globin genes nor on the expression of Proxl 
(Bouhassira et al., 1997).
Most of the evidence, as outlined above, suggested a functional equivalence 
between HS-40 and HS-26. However, since the knock-out of HS-26 had not 
generated conclusive data, a more definitive study on the effect of deleting HS-26 
on alpha-globin expression was undertaken. HS-26 and the transcription factor 
binding sites associated with it were replaced with a floxed neomycin gene, a 
replacement of 1.3 kb. This study was anticipated to be equivalent to that of Bernet 
et al., 1994, in which the HS-40 was deleted with a resulting down-regulation of 
human alpha-globin gene expression. However, upon deletion by SSR of the floxed 
neomycin gene (that replaced HS-26) the anticipated elimination of murine alpha- 
globin gene transcription did not occur. The mRNA expression from the alpha- 
globin genes persisted to between 50 and 80% of normal levels (Anguita et al., 
2002). This study therefore concluded that other, as yet uncharacterised elements, 
contribute to control the expression of the alpha-globin genes in the mouse. 
Furthermore, this study exemplifies the requirement for the in vivo verification of 
sequence-homology based functional assignments.
Clearly the results from the deletion of HS-40 (Bernet et al., 1994) and the 
deletion of HS-26 (Anguita et al., 2002) do not demonstrate the same reduction in 
the expression of the alpha-globin genes, for the human and mouse alpha-globin 
gene cluster respectively. However it should be noted that deletion of the HS-40
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region is performed in MEL hybrid cells and not in human ES cells which would 
provide a more comparable in vitro study to that of the HS-26 knock-out. This 
experimental difference may account for the different phenotypes generated for 
each of the knock-outs. Alternatively, it could be that HS-40 and HS-26 are indeed 
not functionally equivalent. This would be consistent with the difference in their 
transcription factor binding site repertoire, which is probably a reflection of the 
different environments in which the human and mouse alpha-globin loci reside.
Differences between the human and mouse loci include: the position of the 
locus in the genome, the human alpha-globin locus lies very close to the telomere, 
whilst the mouse locus is interstitial (Higgs et al., 1989); the human alpha-globin 
promoters are associated with CpG islands but the mouse promoters are largely 
devoid of CpG islands (Flint et al., 2001); and the mouse alpha-globin promoters 
contain GATA-1 binding sites, but their human orthologues do not (Flint et al., 
2001).
1.6.3 The application of large interval RMCE to study the alpha-globin locus
Thus far, investigations on the alpha-globin locus have not fully established 
the mechanism by which the alpha-globin genes are regulated during development. 
Furthermore, questions still remain that relate to whether the conservation of 
sequence homology between humans and mice, specifically within the putative 
regulatory region 5' of the transcribed globin gene cluster, is indicative of 
sequences that have a conserved function.
To summarise the studies discussed in section 1.6.2, in humans, a 350 bp 
region around HS-40 was demonstrated, by its removal, as essential for the normal 
expression of the human alpha-globin genes. In contrast, in mice, the 350 bp region 
around HS-26, which exhibits sequence homology to that around HS-40, does not 
seem to be essential for transcription of the murine alpha-globin genes. These 
studies could indicate that for sequences that regulate gene expression, equivalent 
function can not be always be inferred by the conservation of sequence homology. 
However, this conclusion should be tempered with the consideration that the
42
experimental conditions of each of these studies was not equivalent and could 
therefore contribute to the unexpected difference in the knock-out phenotypes.
In order to achieve a better comparison of the function of HS-40 and HS-26 
further investigaton of the human and mouse loci are required, preferably with 
studies that are performed under more comparable conditions. The large interval 
RMCE strategy developed within this thesis is tested in murine ES cells and 
therefore to have a comparable human system the human alpha-globin locus would 
require investigation in human ES cells. Although, murine ES cells do not express 
alpha-globin, upon in vitro erythroid differentiation the resultant cell types have 
been shown to express all of the alpha-globin genes (Lindenbaum and Grosveld, 
1990) and this protocol for differentiation could be applied to human ES cells. The 
knock-out of the HS-40 region from human ES cells may achieve a more accurate 
report on the consequences of this mutation, since it would be studied on a more 
usual genomic background of human chromosomes. This is unlike the existing 
study which examines the knock-out phenotype in differentiated MEL cells on a 
genomic background of murine chromosomes (Bernet et al., 1994).
However the knock-out of HS-40 in human ES cells could be achieved by 
conventional gene-targeting technology and was not therefore behind the 
motivation to develop a strategy of large interval RMCE. It was anticipated that the 
benefit of developing a large interval RMCE in order to generate knock-out 
mutations of either HS-40 or HS-26, was the increased level of flexibility with 
which these putative regulatory regions could be mutated, above that possible with 
conventional gene-targeting.
The existing knock-out mutations of either HS-40 or HS-26 were made by 
replacing approximately 1 kb of sequence, which included the HS site and 
associated transcription factor binding sites, but may have also included other, as 
yet uncharacterised sequences necessary for the correct transcription of the alpha- 
globin genes. Additionally the knock-out studies thus far on HS-40 and HS-26 left 
sequences within the putative regulatory domain, which may have contributed to
43
the mutant phenotype, thereby complicating the analysis of the data from such 
studies.
Therefore the aims of the developing the large interval RJVICE strategy were 
to enable a more precise and flexible mutational approach to investigate the alpha- 
globin locus, or indeed any given locus and to enable the mutational analysis of a 
region without the concomitant introduction of any other sequences, thereby 
permitting the accurate report of the intended mutation. Instead of a 1 kb deletion 
with a selection marker, RMCE could permit the mutation of the individual 
transcription factor binding sites, with mutations as small as individual base-pairs 
possible, without the concomitant introduction of any other sequences. 
Additionally, any number or combination of mutations could be rapidly made to the 
BAG vector by homologous recombination in the E. coli cell and then delivered in 
one SSR event to the ES cell interval, thereby expediting the investigation of the 
locus by removing the requirement for lengthy experiments with successive rounds 
of gene-targeting. For example, it would be possible to add transcription factor 
binding sites around HS-26 to make it equivalent to the HS-40 region in humans. If 
the HS-40 and HS-26 regions are indeed functionally distinct, this anlysis may 
determine those sites that are critical to this functional difference.
Since the inception of this thesis RMCE has been demonstrated on a scale of 
1 kb to 5 kb. This interval would be adequate to encompass the HS-40 or HS-26 
region. However, the advantage of developing a strategy of large interval RMCE 
that can potentially replace 50 kb to 100 kb of sequence, are that both the regulatory 
region and the transcribed genes of the locus may be manipulated within a single 
vector and transferred to the ES cell interval in one SSR event.
For example, it may be desirable to determine the effects of a mutation 
within the putative regulatory region on the transcribed alpha-globin genes and this 
could be traced by introducing different fluorescent markers to tag the expression of 
each of the different alpha-globin genes. To perform such a study by conventional 
gene-targeting would require several rounds of gene-targeting. Alternatively it may
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be desirable to mutate the putative regulatory region and co-ordinately mutate those 
sequences that would respond to the mutation in the transcribed genes. For example 
a mutation that would cause the expression of the embryonic globin gene alone 
could be generated and the sequences required to activate the fetal and adult genes 
with this mutated regulatory region could be determined.
Finally, the use of a large interval RMCE strategy would permit the 
exchange of the murine or human alpha-globin locus into human or murine ES cells 
respectively, which have been previously engineered to undergo the RMCE 
exchange. The ability to exchange the loci in this way would be informative on the 
way in which the cellular environment may affect any mutation made to the locus.
The application of large interval RMCE to study alpha-globin gene 
expression therefore has a number of advantages over conventional genomic 
manipulation strategies.
1.7 Thesis outline
The results chapters contained within this thesis describe the establishment 
of the desired large interval RMCE event in murine ES cells. Chapter 2 describes 
the establishment of a double-targeted ES cell line by the sequential targeting of 
two gene-targeting vectors containing sequences that mediate and select for the 
large interval RMCE event. Chapter 3 describes the characterisation of the double- 
targeted ES cell lines, in order to determine whether each vector is targeted to the 
same allele of the alpha-globin locus, on chromosome 11. Additionally, Chapter 3 
describes the functional assessment of the lox sites. Chapter 4 describes the 
targeting of the BAC, harbouring the alpha-globin locus, by recombination 
mediated cloning, in order to introduce sequences that enable it to participate in the 
desired large interval RMCE event. Finally, Chapter 5 reports the experimental 




EMBRYONIC STEM CELL TARGETING
2.1 Introduction
This chapter describes the generation of a marine ES cell line capable of 
participating in the large interval RMCE strategy, developed within this thesis. This 
was achieved by two successive gene-targeting events in the E14Tg2a ES cell line. The 
murine alpha-globin locus was chosen as a test locus. Collaborators, Doug Higgs and 
Christina Tufarelli, supplied the DNA and complete sequence data of pBAC 14567, 
which consist of the BAG cloning vector pBeloBACl 1 and a Hindlll cloned insert of 
approximately 70 kb of murine 129 genomic DNA that encompassed the entire alpha- 
globin locus. The cloned insert in pBAC 14567 was thereofore isogenic with the DNA 
of the ES cell line that was targeted. The availability of sequence data facilitated the 
design of targeting constructs and the subsequent screening strategies that established a 
targeted event.
The murine alpha-globin locus consists of genes, pseudogenes and sequences 
that are necessary to regulate gene expression from the locus. The most influential of 
these regulatory sequences are thought to be clustered together in a region the Major 
Regulatory Element (MRE), which is marked by a DNase I hypersensitive site, termed 
HS-26 (Kielman et al., 1994). The MRE and structural genes of the alpha-globin locus 
span a genomic region of approximately 70 kb.
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To mediate the RMCE of the entire locus, targeting of a loxP and a Iox511 site, 
at positions at either end of the locus, were necessary. The locus spans a region of 70 
kb and so targeting of the hetero-specific lox sites necessitated two, sequential targeting 
events with separate constructs.
The first targeting event delivered the Iox511 site within a targeting construct 
containing the sequences, /ojc577/hygromycin/I See \llox511, into the E14Tg2a ES cell 
line (HPRT"). The hygromycin gene was used to select for ES cells that had stably 
incorporated the targeting construct into the genome. The hygromycin gene wasfloxed 
with Iox511 sites to enable it to be deleted by Cre-mediated SSR and therefore permit 
its subsequent use as required following large interval RMCE. The use of the I See I 
restriction site will be discussed in detail later (see Chapter 3).
The second targeting event delivered the loxP site, as part of the frtll See 
I/5'hprt//0xP/neomycin cassette. As above, the use of the I See I site will be discussed 
later, as will thQfrt site (see Chapters 3 and 5 respectively). The incorporation of this 
cassette was selected for using G418 supplemented media, that selected for the 
presence of the neomycin gene. The 5'hprt/hxP sequences derive from the hprf 
A3 /loxP cassette (Smith et al., 1995), but will be referred to as 5'hprt/loxP throughout 
this thesis. The 5'hprt//ox/> cassette underwent Cre-mediated SSR with a /0xP/3'hprt 
(loxP/hprt~A5 ) cassette to reconstruct a functional hprt minigene, which was shown to 
be capable of conferring resistance to HAT selection in HPRT" ES cells (Smith et al., 
1995). The loxP site therefore had a dual role in the context of the strategy developed 
within this thesis: along with the Iox511 site, the loxP site defined the interval 
exchanged during RMCE and additionally it mediated the reconstruction of the hprt 
minigene, which was implemented as part of the selection strategy for the large interval 
RMCE event.
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2.2 The positions of the target sites
As mentioned above, two targeting events were performed, which raises the 
issue of nomenclature in order to specify the sites that were targeted. To address this 
issue, the target site for the first targeting event, which delivered /oj577/hygromycin/I 
See \llox511, was defined as 'downstream', which describes its location as downstream 
or 3' to the last structural gene of the alpha-globin locus. Whilst the second targeting 
event, which delivered frt/l See I/5'hprt//ojcP/neomycin, was defined as 'upstream1 , to 
describe its location as upstream or 5' of the MRE region of the alpha-globin locus. 
Fig. 2.1 summarises the nomenclature, position and orientation of the targeting 
constructs whose construction and targeting is detailed in this chapter.
An important feature of large interval RMCE over conventional genome 
engineering technology is that the relevant recombination sites and selection markers 
can be located at positions outwith the locus of interest. This therefore reduces the 
potential of these sequences to interfere with the normal functioning of the locus of 
interest, thereby permitting a more reliable phenotypic report of any mutations 
purposefully made to the locus. For these reasons, careful consideration was given to 
choice of the location for each of the target sites.
2.2.1 Positioning the target site downstream of the alpha-globin locus
The inspection of the alpha-globin sequence data determined that the terminal 
functional sequence of the alpha-globin locus was the structural gene, 3' theta (3'0), as 
depicted in Fig. 2.1. Sequence inspection also determined that the region downstream 
of theta was devoid of any known gene sequences or sequences known to be associated 
with gene regulation. It was therefore decided to target the /ox5/7/hygromycin/I See 
\llox511 recombination cassette 6.9 kb downstream of theta's terminal exon 3. It was 
anticipated that this position would not conflict with either the normal functioning of 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.2.2 Positioning of the target site upstream of the alpha-globin locus
The choice of the target site for the frt/l See I/5'hprt//oxP/neomycin 
recombination cassette was determined by the position of the HS-26 site. HS-26 
was found to be located within intron 5 of Proxl, a known constitutively expressed 
gene (Bouhassira et al., 1997). It was therefore important that targeting of the>f/I 
See I/5'hprt//0jtP/neomycin recombination cassette should not compromise the 
expression of Prox. It was not possible to target 5' of Prox, thereby including it 
within the RMCE interval, since it was juxtaposed by just 150 bp with the MPG 
gene. Therefore the risk existed that targeting 5' of Prox would either disrupt its 
expression due to promoter interference, or disrupt the expression of MPG by 
similar means. The disruption to either Prox or MPG could potentially have resulted 
in the lethality of the ES cells, either during cell culture or development, if they 
were used to generate chimeras by blastocyst contribution. It was therefore decided 
that thefrt/l See I/5'hprt//ox/Vneomycin construct would be targeted into intron 6 of 
the Prox gene, which lies approximately 1 kb 5' of the HS-26 site.
Following the choice of the target site locations it was decided to generate 
the homology arms of the targeting vectors by PCR. This made full use of the BAG 
DNA and sequence information provided by collaborators D. Higgs and C. 
Tufarelli.
2.3 Generating the homology arms for targeting by PCR
The homology arms for each of the targeting vectors were generated by 
PCR, as described in Appendix IV. The BAG harbouring the alpha-globin locus 
(pBAC 14567) was used as a template for most of the PCRs (except for UpLHA, 
which was amplified from E14Tg2a DNA, see Appendix IV.e for details). The 
BAG DNA was used as a template if possible, in order to reduce the chance of non- 
specific amplification due to non-homologous primer annealing.
Further considerations on the PCR conditions included using Pfu turbo, a 
polymerase with an enhanced proof-reading ability (Lundberg et al., 1991) and the 
implementation of low cycle numbers during the PCR. These precautions were
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taken to reduce the risk of introducing mutations to the homology arms during 
cycling. Mutations introduced during PCR cycling would have decreased the 
isogenicity between the homology arms of the targeting vector and that of the target 
site, which may have lead to a decrease in targeting efficiency (Deng C, 1992). In 
addition the introduction of mutations during PCR would have been transferred 
undetected to the target site and may have created an unintentional mutated 
phenotype.
The low cycle numbers created difficulties in generating sufficient PCR 
products for subsequent cloning procedures to build the targeting vectors. However, 
the construction of the targeting vectors was facilitated due to the implementation 
of non-compatible restriction sites in their construction design. The plasmid cloning 
vector, pBS(KS+) was restricted with non-compatible enzymes, in preparation for 
the insertion of a PCR product that had been similarly restricted with the equivalent 
enzymes. The restriction sites at the ends of each PCR product were generated by 
including the necessary sequences for their creation at the 5' end of each primer 
pair. This approach reduced the number of background colonies that were generated 
from the ligation between the plasmid and the PCR products and allowed the 
orientation of cloned PCR product to be pre-determined.
The homology arms for each targeting construct were first built into a 
plasmid before the recombination cassettes, which were constructed in parallel, 
were introduced, (see Figs. 2.2 and 2.6). The PCR strategy was designed in each 
case to construct homology arms that were flanked by a Not I and a Sal I site. At the 
centre of the each homology arm pair was a BamHl site, which was created from 
sequences originating from the primers used for their generation. This site was the 
position into which the relevant recombination cassette was introduced. Either the 
Not I or Sal I site was used to linearise the completed targeting vector, prior to its 
electroporation into ES cells.
The use of BamHl, Sal I and Not I restriction sites to clone the targeting 
constructs therefore placed a constraint on the target site that was selected, since it 
was required to be devoid of these sequences. Therefore for both target sites a
51
genomic region, of approximately 5 kb, that lacked BamHl, Not I and Sal I sites 
was selected.
2.4 Targeting the Iox511/hygromycinfl See UloxSll construct downstream of 
the alpha-globin locus
The aim of the first targeting event was to deliver /0*577/hygromycin/I See 
\llox511 to the target site downstream of the alpha-globin locus. The construction of 
the targeting vector is illustrated in Fig. 2.2. At the point of electroporating the 
targeting vector containing /ox577/hygromycin/I See Ulox511, the orientation the 
loxP site, that would be subsequently delivered upstream of HS-26, was 
unconfirmed. This is because the construction of the frtll See 
l/5'hprt/loxP/nGomycin construct was incomplete at that time. Therefore to retain 
flexibility for subsequent targeting events both orientations of the 
/ax57//hygromycin/I See \llox511 constructs, were electroporated, they are each 
illustrated as CP# 47 and CP# 48 in Fig. 2.2.
5 x 107 E14Tg2a ES cells were electroporated with 75 jug of Not I linearised 
targeting vector for each of CP# 47 and CP# 48. Following electroporation cells 
were plated at densities of 2.5 x 106 , 1.25 x 106 and 6.25 x 105 per 10cm petri dish. 
48 hours after electroporation hygromycin selection was added to the culture media.
Colonies that appeared after 12 days in hygromycin selection were picked 
into 96 well plates. Three 96 well plates were picked for each of the targeting 
constructs. Plates were cultured to adequate density and then split 1:2, one plate 
was frozen and one was used to prepare DNA. DNA was prepared from the 96 well 
clones and screened for targeting by Southern blot analysis. Fig. 2.3 illustrates the 
Southern blotting screening strategy for the /0*5/7/hygromycin/I See \llox511 
construct and Fig. 2.4 shows the results of the analysis for CP#48.
Following the preliminary screening of 96 well DNA a few clones were 
selected for further Southern blot analysis to confirm that that the desired targeting 
event had occurred, see Fig. 2.5. The targeting efficiency for CP# 47 was 18% and 
for CP# 48 was 15%, of hygromycinR clones that were determined as targeted by
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Fig. 2.2 Construction of the ES cell targeting vectors CP#47 and CP#48, which 
contain the sequences for /0je577/hygromycin/I See HloxSll
Oligos Z6205 and Z6207 were annealed to form a double-stranded DNA fragment that contained two 
Iox511 sites (in the same orientation as each other) and 5' single-stranded overhanging ends that 
permitted its ligation into a BamHl restricted site. The annealed oligos were ligated into BamHl restricted 
pBS(KS+) and the resulting colonies were screened by colony hybridisation, with 5' 32P labelled Z2605 
as the probe. The orientation of the loxSll sites was determined by sequencing with T3 and T7 primers 
(see Fig. 2.3a). The resultant plasmids with alternative orientations of the inserted oligos were termed 
CP#20 and CP#21. A BgUl fragment from pHA58 (AJHS#948) was generated, which included the 
hygromycin resistance gene, driven by the murine phosphoglycerate kinase (PGK) promoter and the 
necessary polyadenylation addition sequences. This Bgftl fragment was ligated into CP#20, which had 
been previously restricted with at a unique BgUl site, created within the Z6205 and Z6207 oligos. The 
orientation of hygromycin gene was determined by sequencing with T3 and T7 primers and the resulting 
plasmid termed CP#41a (see Fig. 2.2b). Oligos A4128 and A4129, which contained the sequence of the I 
See I restriction site, were annealed and ligated into BgUl partially restricted CP#41a. Introduction of the I 
See 1 site was screened by colony hybridisation, with 5' 32P labelled A4128 as the probe. The positive 
plasmids were pooled and termed CP#41b (see Fig. 2.2c), this pool represented a mixture of plasmids 
with the possibility of harbouring the I See I site at either side of the hygromycin gene, however the 
precise location of the I See I site in the final targeting vector was determined by sequencing (see below). 
The homology arms for this targeting vector were built into a separate plasmid. DnLHA was the PCR 
product from primers D6624 and D6625 (see Appendix IV.g) and was restricted with Sail and BamHl 
and then ligated into a similarly restricted pBS(KS+) plasmid to generate CP#44 (see Fig. 2.2d). Next, 
CP#44 was BamHl and Notl restricted and the PCR product from primers D6626 and D6627, which 
generated DnRHA (see Appendix IV.h), was similarly restricted and cloned into this site to give CP#45 
(see Fig. 2.2e). CP#45 was then BamHl restricted at the unique site created between the DnLHA and 
DnRHA and the 1.6 kb BamHl fragment from CP#41b, containing the /ox5///hygromycin/I See \llox5U 
sequences, ligated into this site. The orientation of the inserted BamHl fragment was determined by Sphl 
and Stul restriction and the orientation of the Iox511 sites and the location and of the I See I site was 
confirmed by sequencing with primers F1346 and F1347. The two alternative orientations of the loxSll 
sites with respect to the homology arms were obtained and termed, CP#47 or 'HYG-3' (see Fig. 2.2f) and 
CP#48 or 'HYG-4 1 (see Fig. 2.2g).
Fig. 2.2 Construction of the ES cell targeting vectors CP#47 and CP#48, which 
contain 70x57 7/hygromycin/I See \llox511







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Southern blotting. The Southern blot data indicate that clones Al, A9, E7 and F5 
from CP#48 (HYG-4/Plate2) harboured the desired targeting event.
2.5 Targeting the frtfl See I/5'hprt//ox:/>/neoniycin construct upstream of the 
alpha-globin locus
The aim of the second targeting event was to deliver frtll See 
I/5'hprt//ox:P/neomycin sequences to the target site upstream of the alpha-globin 
locus. Once the construction of this targeting vector was completed (as described in 
Fig. 2.6), the orientation of the loxP site was determined by sequencing and found 
to be 5'ATAACTTCGATAT GCATACAT ATATCGAAGTTAT3' with respect to 
the 5' to 3' orientation of the alpha-globin locus sequences, as illustrated in Fig. 
2.1.
At the point of electroporation, although considered highly unlikely, the 
possibility existed that loxP and Iox511 sites could undergo Cre-mediated non­ 
specific SSR to delete the entire RMCE interval. The earliest studies on loxP and 
Iox511 suggested that SSR between these hetero-specific lox sites occurred 
infrequently (Hoess et al., 1986). However other evidence suggested that SSR 
might occur between the loxP and Iox511 sites if the level of Cre activity was 
sufficient (Y. Cherifi, pers. comms., Centre for Genome Research Staff Seminar, 
Edinburgh University, 1999), or if the environment of the lox site contained 
palindromic repeats (Mlynarova et al., 2002). Although these reported experiments 
were not directly comparable with the large interval RMCE developed in this thesis, 
precautions were taken to minimize the effects of non-specific SSR. This was done 
since deletion of the interval was predicted to be a significant obstacle to the 
recovery of the desired large interval RMCE event, as it would prevent the interval 
from persisting, whether it had been exchanged or not.
In order to mediate a deletion of the interval the hetero-specific lox sites 
would have to be in a direct orientation with respect to one another. Therefore, to 
eliminate the possibility of generating a deletion it was decided to target the second 
construct in such a way as to achieve an inverted orientation of the lox sites. The
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Fig. 2.5 Southern blotting on putatively targeted clones obtained from 
electroporation of E14Tg2a with CP#48 (from 96 well plate HYG-4/Plate 2)















Lane 1, E14Tg2a; Lane 2, clone Al; Lane 3, clone A9; Lane 4, clone E7; Lane 5, clone F5.
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Fig. 2.6 Construction of the ES cell targeting vector CP#11, which contains frt/I 
See I/5'hprt/neomycin
Fig. 2.6a








inverted orientation should produce an inversion of the locus rather than a deletion, 
should non-specific SSR occur. It was predicted that the inversion reaction would 
be reversible, with equal probability, the consequence of which would be that 
roughly 50 % of the clones would harbour an inverted locus and 50 % should be 
normal. In order to distinguish these alternative genomic arrangements Southern 
blotting could be used.
As described previously, the first targeting event generated lines that 
harboured both orientations of the /0jt577/hygromycin/I See \Jlox511 constructs. To 
produce a cell line with the required inverted lox orientation when targeted wither// 
I See I/5'hprt//wP/neomycin, a clone targeted with the CP#48 targeting vector was 
therefore required.
The targeting vector containing the frtll See I/5'hprt//oxP/neomycin 
targeting construct was targeted into Clone A9 from HYG-4/Plate 2 to generate a 
double-targeted ES cell line in which the lox sites were in an inverted orientation 
with respect to one another.
The homology arms used to target the frt/l See I/5'hprt//or/Yneomycin 
recombination cassette were generated by PCR. The alpha-globin sequence residing 
in pBAC 14567 terminated just 199 bp upstream of the desired target site for the 
frtll See I/S'ttprt/Vox/Vneomycin recombination cassette. Therefore there was a lack 
of alpha-globin sequence information from pBAC 14567 in order to design one of 
the primers necessary to PCR generate a 2.5 kb fragment for the left homology arm 
(UpLHA). To overcome the limitation of sequence availability the project 
collaborator, D. Higgs, provided the upstream sequence of a contig cosmid to 
pBAC 14567. Additionally the cosmid DNA was used as a template to generate the 
probe, UpLP (see Appendix IV.a), which was used to screen the Southern blots for 
this targeting vector.
The ES cell line HYG-4/Plate2/Clone A9 was electroporated with 50 ^g of 
Sal I linearised targeting DNA. 5 x 107 cells were electroporated and then plated at 
densities of 2.5 x 106/10cm dish and 1.25 x 106/10cm dish, in culture media with
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G418 selection added. After 10 days of selection G418R colonies were picked into 
96 well plates.
The 96 well plates were cultured and split 1:2, one plate was frozen and one 
used to prepare DNA for Southern blot analysis. The screening strategy for thefrt/l 
See I/5'hprt//ox/Vneomycin construct is shown in Fig. 2.7, whilst the 96 well 
screens are shown Fig. 2.8a and Fig. 2.8b. The targeting efficiency for CP# 11 into 
HYG4-A9 was 22%, of G418R clones that were shown to have targeted by 
Southern blotting. Clones suspected of being double-targeted were termed 
"Completed Alpha-globin Targeted (CAT)- clone number", e.g. CAT-A3. Four 
CAT clones from the 96 well DNA screen were selected for further Southern blot 
analysis to confirm that the desired targeting event had occurred, see Fig. 2.9.
2.6 Summary of ES cell targeting
This chapter has described the generation of double-targeted 'CAT' ES cell 
line, by the sequential targeting of /ox577/hygromycin/I See \Jlox511, followed by 
frtll See I/5'hprt//0jtP/neomycin into an E14Tg2a ES cell line. The generation of 
these ES cell lines was part of the development of a strategy of large interval 
RMCE. The aim of targeting was to deliver hetero-specific lox sites, in an inverted 
orientation, into the ES cell genome at positions that would flank a single-copy of 
the alpha-globin locus, thereby creating an interval of approximately 64 kb.
However, due to the diploid nature of E14Tg2a cells there exist two copies 
of the alpha-globin locus, each residing on chromosomes 11. Therefore providing 
each targeting event occurred independently of each other, it was anticipated that 
50% of the CAT clones would have targeted both constructs to the same 
chromosome and 50% would have targeted the constructs to alternate 
chromosomes. The large interval RMCE strategy depends upon both constructs 
being targeted to the same chromosome, in order to generate an alpha-globin locus 
that is flanked by both hetero-specific lox sites. The following chapter describes the 
further characterisation of the CAT clones in order to determine their targeting 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 2.9 Southern blotting on selected double targeted CAT ES cell lines














Fig. 2.9c Kpnl digest hybridised with DnLP Fig. 2.9d BamHl digest hybridised with DnRP
Hindlll 123456 Hindlll 123456











CHARACTERISATION OF THE DOUBLE-TARGETED 
EMBRYONIC STEM CELL LINES
3.1 Introduction
The murine ES cells, whose targeting is described in Chapter 2, are diploid. 
Therefore two allelic copies of the alpha-globin locus exist within these cells, one 
copy residing on each of chromosomes 11. Chapter 2 described the sequential 
targeting of two constructs into these murine ES cells. The aim of targeting was to 
introduce hetero-specific lox sites at positions in the genome in order to flank one 
of the allelic copies of the alpha-globin locus. Consequently, this required that the 
constructs were targeted to the same chromosome, that is targeted in cis. However, 
due to the diploid nature of these cells, the possibility existed that the second 
targeting event may target the alternate chromosome, that is, the chromosome that 
was not targeted with the first targeting construct. Clones targeted on alternate 
chromosomes, in this manner are termed as targeted in trans.
In order to achieve the large interval RMCE event it was essential that the 
participant double-targeted ES cells were targeted in cis. Assuming that each 
targeting event had occurred independently, then the double-targeted clones should 
represent a population of clones that harboured the in cis and the in trans targeting 
arrangements in equal proportions. It was therefore apparent that the double- 
targeted clones would require analysis to distinguish those that harboured the 
desired in cis arrangement of the targeting constructs from those that did not. The 
Southern blot analysis described in Chapter 2 does not distinguish the nature of
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targeting in this respect and so this chapter describes the analysis that was 
performed on a selected number of double-targeted CAT ES cell clones in order to 
assign in cis targeting.
This chapter also describes the functional analysis of the lox sites included 
within the targeting constructs. The results of these analyses were anticipated to 
further verify the assignment of in cis targeting.
Finally, the results of the analyses described in this chapter informed the 
selection of the cell lines chosen to participate in the large interval RMCE event, as 
described in Chapter 5.
3.2 The strategy used to identify in cis double-targeted ES cell lines
The size of the interval created between constructs targeted in cis, as 
desired, was determined by sequence inspection to be approximately 64 kb. The 
generation of this 64 kb interval as a restriction fragment and its subsequent 
detection by Southern blot analysis formed the basis of the strategy implemented 
here to identify in cis targeted clones. To affect this strategy, the restriction sites 
necessary to generate the interval fragment were included in the design and 
construction of the targeting constructs.
Crucial to the success of this strategy was the generation of the entire 
interval as a restriction fragment, which would only be possible if the necessary 
restriction sites were present within the targeting constructs alone and absent from 
the interval. The occurrence of restriction sites within the interval would flaw this 
strategy since they would prevent the generation of the 64 kb diagnostic fragment.
The requirement to select an enzyme that did not restrict within the interval 
excluded the majority of those with recognition sequences of 6 to 8 bp, since they 
were present within the interval, as determined by sequence inspection. The variety 
of restriction endonucleases that could be used was therefore significantly limited.
Ultimately, to ensure that restriction occurred within the targeting constructs 
alone, here and for the future application of this strategy to other genomic locations,
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the rare-cutting restriction endonuclease I See I was chosen. The restriction 
endonuclease I See I is also known as Omega-nuclease (Colleaux et al., 1988; 
Thierry et al., 1991). This enzyme has an 18 bp recognition sequence and so the 
probability of its occurrence at random is once per 6.9 x 10 10 bp or once per 20 
human genomes (Monteilhet et al., 1990). This ensures that the probability of its 
occurrence within a genome, outwith its targeted delivery, to be extremely unlikely. 
Therefore the likelihood of an I See I recognition site within the interval generated 
by in cis targeting was considered to be highly unlikely. Further, inspection of the 
sequence provided no evidence for the occurrence of this site within the interval.
In order to detect a restriction fragment of 64 kb it was necessary to separate 
the restricted genomic DNA by pulsed field gel electrophoresis (PFGE).
3.2.1 Southern blot analysis of restricted CAT genomic DNA separated by 
PFGE
Four of the double-targeted CAT lines were selected at random for analysis. 
Assuming that the sequential targeting events had occurred independently of each 
other then this sample size ensured that the probability of assigning at least one of 
the lines as targeted in cis would be above 90 %. The lines chosen were CAT-A3, 
CAT-B3, CAT-C6 and CAT-C10. Genomic DNA from each line was prepared for 
restriction and subsequent PFGE separation according to standard methods (see 
Appendix I).
The restriction strategy implemented here to analyse the CAT clones was 
designed to provide evidence for either in cis or in trans targeting. It was apparent 
that restriction of genomic DNA from the CAT clones with I See I alone would 
only provide a diagnostic restriction fragment to indicate in cis targeting and not in 
trans. Therefore in addition to restricting with I See I another enzyme was required 
that would generate restriction fragments to indicate in trans targeting.
The inspection of the alpha-globin sequence from the pBAC14567 sequence 
data determined that Not I did not restrict within the interval and so this enzyme 
was used, either alone or in combination with I See I, to generate restriction 
fragments that could be detected to indicate whether in cis or in trans targeting had
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occurred. The Not I and I See I restriction sites and predicted restriction fragments 
are shown in Fig. 3.1.
The restricted DNA was separated by PFGE, blotted and then hybridised, 
first with the DnLP probe (see Appendix IV), which is homologous to sequences 
downstream of the alpha-globin locus and internal to the RMCE interval (the results 
are shown in Fig. 3.2). The filter was then stripped and subsequently hybridised 
with a neomycin probe (supplied by Stephen Meek), which is homologous to the 
neomycin sequence within thefrt/l See I/5'hprt//ojcP/neomycin upstream targeting 
vector (the results are shown in Fig. 3.3). The location of both probes and the 
fragments they detect is illustrated in Fig. 3.1.
3.2.2 Interpretation of the PFGE results
Fig. 3.1 illustrates how the interval restriction fragment of 64 kb (fragment 
A) can be detected with both the DnLP and the neomycin probe, for clones that 
have targeted in cis and undergone I See I restriction. This band is clearly visible in 
Fig. 3.2 and Fig. 3.3 for clones CAT-A3 and CAT-B3, restricted with a 
combination of Not I and I See I. This would therefore provide positive evidence to 
suggest that CAT-A3 and CAT-B3 have been targeted in cis.
The presence of fragments, other than fragment A, for clones CAT-A3 and 
CAT-B3 in Fig. 3.2 and Fig. 3.3, were interpreted as additional evidence to support 
their assignment as in cis targeted clones. For instance, clones CAT-A3 and CAT- 
63 shared equivalent banding patterns with respect to the fragments that appear to 
be greater than 200 kb in size. These fragments are thought to represent fragment B 
(see Fig. 3.1). Fig. 3.2 shows the detection of fragment B with the DnLP when the 
DNA is restricted with either Not I alone, or in combination with I See I. In 
contrast, Fig. 3.3 shows the detection of fragment B, by the neomycin probe, only 
when DNA is restricted with Not I alone. As shown in Fig. 3.3, fragment B is not 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 3.2 PFGE blot hybridised with DnLP





Not I Notl/ Not I N°'V Not I NotV Not I NotlJ
The figure shows the results of hybridising restricted DNA from the CAT double-targeted ES cell 
lines with DnLP. DNA from each line was restricted with either Not I alone, or with a combination of 
Not I and then sequentially with I See I. The results were assessed for evidence of a 64 kb fragment 
arising from the in cis targeting of I See I sites within the targeting vectors (see Fig. 3.1). The letters 
indicating the detected fragments correspond with the annotations used in Fig. 3.1. The fragments 
that are generated with Not I restriction alone are thought to represent fragment B for each of the 
lines, however for clarity these fragments are not indicated. Only those fragments generated with a 
combination of Not I and I See I have been indicated with their corresponding fragment letter. Clones 
CAT-A3 and CAT-B3 show the presence of a fragment that corresponds to the fragment between in 
cis targeted I See I sites, i.e. fragment A from Fig. 3.1, indicating that these clones have targeted in 
cis. Clone CAT-CIO demonstrates the absence of fragment A, but the presence of an -100 kb 
fragment, thought to represent fragment D from Fig. 3.1, which provided a positive indication of in 
trans targeting for this line. CAT-C6 does not demonstrate the presence of either fragments A or D 
and therefore presented an ambiguous result with respect to targeting. The fragments that appear to be 
above 200 kb in size are thought to represent fragment B arising from in cis targeted clones, CAT-A3 
and CAT-B3. In contrast, an in trans targeted clone was predicted to generate fragment C (see Fig. 
3.1), as indicated for the CAT-C10 clone.
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Fig. 3.3 PFGE blot hybridised with the neomycin probe
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The figure shows the results of hybridising restricted DNA from the CAT double-targeted ES cell 
lines with the neomycin probe. DNA from each line was restricted with either Not I alone, or with a 
combination of Not I and then sequentially I See I. The results were assessed for evidence of a 64 kb 
fragment arising from the in cis targeting of I See I sites within the targeting vectors (see Fig. 3.1). 
The letters indicating the detected fragments correspond with the annotations used in Fig. 3.1. The 
fragments that are generated with Not I restriction alone are thought to represent fragment B for each 
of the lines, however for clarity these fragments are not indicated. Only those fragments generated 
with a combination of Not I and I See I have been indicated with their corresponding fragment letter. 
Clones CAT-A3 and CAT-B3 show that the same fragment is detected with the neomycin probe that 
was detected with DnLP (see Fig. 3.2), which is thought to represent the fragment between in cis 
targeted I See I sites, i.e. fragment A from Fig. 3.1. The detection of this fragment with the neomycin 
probe thereby provides additional evidence that these clones have targeted in cis. Clone CAT-C10 
demonstrates the absence of fragment A and, in contrast to Fig. 3.2, the absence of fragment D 
aswell. This demonstrates that the neomycin probe detects only the chromosome targeted with/rt/I 
See II 5'hprt//ojcP/neomycin and therefore detects only fragment C (as indicated), which is consistent 
with the assignment of this line as in trans. Similarly the fragment originating from the untargeted 
allele for the in cis lines (CAT-A3 and CAT-B3), is not detected with the neomycin probe, as 
demonstrated by the non-detection of fragment B. This contrasts with Fig. 3.2, since fragment B 
from the untargeted allele is detected with DnLP. As for the CAT-C6 clone, consistent with Fig. 3.2, 
the results provide no evidence to establish its targeting arrangement.
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The reason that fragment B went un-detected following a combination of 
Not I and I See I restriction was due to the inability of the neomycin probe to detect 
the untargeted chromosome. The neomycin probe detected only the neomycin 
sequence from the frt/l See I/5'hprt//ox/Vneomycin upstream targeting vector, 
which resides on the targeted chromosome (see Fig. 3.1 and Fig. 3.3), therefore 
since fragment B arises from the untargeted chromosome it is undetected by the 
neomycin probe. In contrast, the DnLP hybridises with alpha-globin sequences, and 
is therefore competent to detect both the targeted and untargeted chromosome. 
Following Not I restriction alone, the targeted and untargeted chromosomes 
generate fragment B, which is detected by DnLP (see Fig. 3.2). However upon 
using a combination of Not I and I See I restriction, the 64 kb I See I fragment 
(fragment A) is generated from the targeted chromosome and fragment B is 
generated from the untargeted chromosome and both are detected by the DnLP.
In summary, the correlation of predicted fragment sizes for in cis targeted 
clones to those evident in Figs. 3.2 and 3.3 for clones CAT-A3 and CAT-B3 
resulted in their assignment as targeted in cis.
The data from Figs. 3.2 and 3.3 were further inspected to determine whether 
the remaining clones, CAT-B6 and CAT-CIO, could be assigned as targeted in 
trans. Fig. 3.1 shows that with Not I restriction alone, the DnLP and the neomycin 
probe were predicted to detect fragment B for the in trans targeted clones. As 
shown in Figs. 3.2 and 3.3, a fragment of this size is present for both the CAT-C6 
and CAT-CIO clones with Not I restriction alone. However, with respect to the 
banding patterns evident with a combination of Not I and I See I restriction these 
clones differ.
Fig. 3.1 predicts that the DnLP should detect fragments from in trans 
targeted clones of approximately 210 kb (fragment C) and 90 kb (fragment D) upon 
a combination of Not I and I See I restriction. The data in Fig. 3.2 suggest that these 
fragments are present for CAT-CIO but not CAT-C6, providing a positive 
indication of in trans targeting for clone CAT-CIO, but not CAT-C6. The absence 
of fragments C and D from the CAT-C6 clone was inexplicable at the time,
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however it was anticipated that some error had occurred with the restriction digest 
or preparation of the DNA from this clone.
The data in Fig. 3.3 further suggested that the CAT-C10 clone had targeted 
in trans. The neomycin probe was competent to detect only the chromosome that 
had been targeted with the frtll See I/5'hprt//o;t/Yneomycin targeting vector, as 
shown in Fig. 3.1. Therefore upon a combination of Not I and I See I restriction the 
neomycin probe may detect only fragment C. The presence of fragment C and 
absence of fragment D from clone CAT-C10 was therefore predicted. Fig. 3.3 
indeed shows the absence of the 90 kb fragment D and this result further confirmed 
the assignment of the CAT-C10 line as targeted in trans.
The analysis of the CAT-C6 clone provided no evidence to enable its 
assignment as either in cis or in trans targeted and so was eliminated from any 
further investigation in this respect.
The fragment thought to represent fragment A for clones CAT-A3 and 
CAT-B3 does not appear to be identical for these two clones. The fragment for 
clone CAT-B3 appears more diffuse. The preparation of DNA for restriction and 
subsequent PFGE, from ES cells embedded in agarose plugs, includes a stage 
whereby the plugs are digested with proteases to remove DNA-associated proteins. 
The incomplete digestion with proteases may affect the motility of the restriction 
fragments during PFGE due to the persistence of DNA-associated proteins and so 
for the CAT-B3 cell line this may be the reason that the fragment appears more 
diffuse.
The PFGE data also showed that fragments B and C appeared to be larger 
than their predicted size of 240 and 210 kb respectively. The size of fragments B 
and C were predicted from the position of Not I sites identified from the published 
mouse sequence data (http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/mapsdb.cgi? 
org=mouse&chr=l 1). However the difference in the position of the Not I sites from 
the published sequence and those experienced for the double-targeted CAT ES 
cells, that originated from the E14Tg2a line, may represent polymorphisms and 
thereby explain the difference in fragment sizes experienced. Alternatively, the
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parameters for which the PFGE was performed were set to resolve fragments 
between 10 kb and 100 kb and therefore the size assessment of fragments above 
this interval may not be accurate.
3.3 Testing whether the hetero-specific lox sites in the CAT lines are functional
The analysis described above identified two candidate in cis targeted lines to 
participate in the large interval RMCE experiment, namely CAT-A3 and CAT-B3. 
CAT-C10 was assigned as targeted in tram. These lines were further tested to 
establish whether the lox sites they harboured were functional.
In order to test the functionality of the lox sites, their ability to undergo 
Cre-mediated SSR with the test plasmid, CP#98, which is shown in Fig. 3.4, was 
investigated. CP#98 includes the 3' region of the hprt gene, which upon SSR with 
the loxP site in thefrtA See I/5'hprt//0jt/Vheomycin upstream targeted construct is 
capable of reconstructing a functional hprt gene. Additionally CP#98 includes a 
loxSll site, which was included to investigate whether the efficiency of 
reconstructing the hprt gene in the in cis targeted clones would be different to that 
of the in trans targeted clone.
The loxP and Iox511 sites in CP#98 were orientated such that upon SSR 
with an in cis targeted clone it would be possible for the 3' region of the hprt gene 
to replace the interval that encompasses the alpha-globin locus, as illustrated in Fig. 
3.5a. In contrast, the replacement of the alpha-globin locus in an in trans targeted 
clone by SSR with CP#98 should not be possible. However, it was anticipated that 
HATR clones could be generated from an in trans targeted clone by Cre-mediated 
insertion of the entire CP#98 plasmid via its loxP site into the loxP site of the frtA 
See I/5'hprt//0jcP/neomycin upstream targeted construct. This event would 
reconstruct the hprt minigene and provide HATR , as illustrated in Fig. 3.6a. It is 
important to note however, that the in cis targeted clones could also undergo 
insertion of CP#98 to generate HATR clones, and more significantly this would not 
be concomitant with replacement of the alpha-globin interval.
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Fig. 3.4 Construction of CP#98, a plasmid used to test the functionality of the \ox 
sites in the double-targeted CAT ES cell lines
Oligos W2186 and W2187 were designed to include an frt site, an I See I site and BamHl compatible 
ends. They were annealed and then ligated into AJHS#924 (see Fig. 3.4a), which had been previously 
restricted with BamHl. The resulting colonies were screened by colony lift, using 32P labelled W2187 as a 
probe. Positive clones were sequenced with T7 and T3 primers to establish the orientation of the oligos. 
The plasmid containing the desired orientation of oligos W2186/W2187 was termed CP#51 (see Fig. 3.4 
b) and harboured the following arrangement: loxP - 3'HPRT - BamHl destroyed - I See I -frt - BamHl. 
Oligos F22433 and F22434 were designed to introduce a Iox511 site between the BamHl and Kpn\ site in 
CP#51. By designing the oligos with one end compatible to BamHl and the other to Kpnl the orientation 
of the inserted oligos was assured. Additionally, the oligos were designed to introduce a unique Ncol site, 
which was subsequently used to screen for their presence. CP#51 was BamHl and then Kpn I restricted 
and the annealed F22433/F22434 oligos inserted. The oligos destroyed the original BamHl and Kpnl sites 
and introduced a new BamHl site to create a cassette that could be isolated by BamHl restriction alone. 
The Ncol site was used to screen the resulting colonies, however positive plasmids were additionally 
sequenced to verify the integrity of the Iox511 site. The desired arrangement was: loxP - 3'HPRT - 
BamHl destroyed - I See I -frt - BamHl destroyed - Iox511 - Ncol - BamHl - Kpnl destroyed (see Fig. 
3.4c). The lox sites were arranged in an inverted orientation, consistent with the hetero-specific lox sites 
targeted to the CAT ES cell lines, which would therefore permit the deletion of the entire alpha-globin 
locus from an in cis targeted line upon Cre-mediated SSR.
Fig. 3.4 Construction of CP#98, a plasmid used to test the functionality of the 
lox sites in the double-targeted CAT ES cell lines









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































To distinguish HATR clones arising from the deletion of the hetero- 
interval (as described in Fig. 3.5a) from those that had inserted 
CP#98 via the loxP site (as described in Fig. 3.6a), the drug resistance profiles of 
the clones were tested, followed by Southern blot analysis.
As illustrated in Fig. 3.5a, it was predicted that the HATR clones generated 
from the in cis targeted lines (CAT-A3 and CAT-B3) would delete both the 
hygromycin and neomycin selection markers and therefore be HYGS and G418 S . In 
contrast, the HATR clones generated from the in trans targeted clone (CAT-C10) 
were predicted to be HYGS but G418R, due to the presence of the neomycin gene in 
the genetic arrangement, as shown in Fig. 3.6a. It was therefore predicted that the 
status of resistance to G418 of the HATR clones generated could be used to 
distinguish those for which the test plasmid had mediated the deletion of the 
interval from those that had inserted CP#98 via the loxP site.
The drug resistance profiles of the HATR clones generated from both the in 
cis and in trans targeted clones were therefore tested, by selecting the clones 
independently in media supplemented with HAT, G418 or hygromycin. A selection 
of HATR clones that gave the predicted resistance profiles were then investigated 
by Southern blot analysis to determine their genetic arrangement. This was 
performed to determine whether the drug resistance profiles of the HATR clones 
accurately represented their predicted genetic arrangement, thereby providing an 
indication of the efficiency with which CP#98 either deleted the globin interval or 
inserted via the loxP site to generate HATR clones.
3.3.1 Experimental details
The plasmid used to express Cre (CP#99) was constructed as shown in Fig. 
3.7. and tested independently for its ability to function in ES cells (H. Priddle, pers. 
comms., Centre for Genome Research, Edinburgh University, 2000).
75 ^g of supercoiled test plasmid (CP#98) and 50 fig of supercoiled Cre 
expression plasmid (CP#99) were co-electroporated into 5 x 107 cells for each CAT
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Fig. 3.7 Construction of the Cre expression plasmid, CP#99
A plasmid that could express Cre constitutively within ES cells was generated in order to test the function 
of the lox sites within the CAT lines and to provide Cre for the desirable large interval RMCE 
experiment. The CreEBD gene fusion sequences were PCR amplified with Pfu Turbo from CP#93 
(pNPKCreERc) with primers B8141 and B8146 (see Fig. 3.7a). B8141 and B8146 included sequences to 
generate £coRI sites at either end of the resulting PCR fragment. The PCR product, containing the 
CreEBD sequences, was therefore £coRI restricted and then ligated into £coRI restricted CP#15 (AS#575 
pCAGSIP). The desirable orientation of the insert was determined by Bamtil restriction and the resulting 
plasmid termed CP#64 (see Fig. 3.7b). The integrity of the CreEBD sequence, following PCR 
amplification with Pfu Turbo, was determined by sequencing the entire ~ 2kb fragment with a series of 
overlapping primers (see Appendix III) and generating a contig alignment of the resulting sequence data. 
This sequence was then compared to the published sequence from F. Stewart's web page (see Appendix 
III) to ensure that no mutations had been introduced during the PCR that may compromise the activity of 
the CreEBD gene fusion (data not shown). To produce a constitutively expressed Cre recombinase gene 
the EBD region of the gene fusion was removed (see Fig. 3.7c) by restriction. This was achieved by 
partial restriction with £coRI, followed by complete restriction with 5s/WI and then end-filling and re- 
ligation (performed by Helen Priddle).














cell line tested. The in cis lines chosen for test were CAT-A3 and CAT-B3 and the 
in trans line was CAT-CIO.
Following electroporation cells were cultured for 24 hours and then plated at 
varying densities and HAT selection added to the culture media. After 12 days in 
selection the number of colonies was counted to establish the efficiency of 
generating HATR clones for each line. The colonies were then picked into 96 well 
plates and cultured to adequate density before being split for freezing, DNA 
preparation or drug resistance profiling. This experiment was repeated three times 
for each line to obtain reliable frequencies to represent the efficiency of generating 
HAT clones. A selection of clones generated from the final experiment (III) were 
analysed by Southern blotting. Fig. 3.8 summarises the results of the drug resistance 
profiles and the frequency of generating HATR clones for each line.
A sample of HATR clones from Experiment III, generated from the CAT-A3 
and CAT-B3 in cis lines and the CAT-CIO in trans line, were selected for Southern 
blot analysis. Genomic DNA was restricted either with Spe I or Sph I and then 
hybridised with DnRP or UpLP respectively. The predicted genomic arrangement 
of clones that would be generated from in cis targeted lines is illustrated in Fig. 3.5, 
whilst the predicted genomic arrangement of clones that would be generated from 
in trans targeted clones is illustrated in Fig. 3.6. The results of the Southern blot 
analysis are shown in Fig. 3.9 and Fig. 3.10, for clones generated from either the in 
cis or in trans lines respectively.
3.4 Interpretation of the results from testing the lox site functionality
The results generated from co-electroporating selected CAT lines with 
CP#98 and CP#99 were assessed to determine whether they verified the assignment 
of these clones as targeted in cis or in trans, as determined by the analysis based 
upon I See I restriction. Additionally it was assessed whether this strategy could be 









































































































































































































































































































































































































































































































































































































































































3.4.1 Comparing the efficiency of generating HATR clones between in cis 
targeted and in trans targeted lines
The data in Fig. 3.8 show that for each independent experiment the lines 
assigned as in cis targeted (CAT-A3 and CAT-B3) consistently generated HATR 
colonies at a higher frequency than for the CAT line that had been assigned as 
targeted in trans (CAT-C10). The reliability of these frequencies was based upon 
the consistency with which HATR clones were generated, which were at 
frequencies of between 2 to 5 colonies per 1 x 104 cells (with the exception of the 
CAT-A3 line for Experiment III, see below). In addition, the frequency of 
generating a HATR colony from the CAT-C10 clone was consistently less than 1 
per 1 x 104 cells.
The cause of the reduced efficiency with which the CAT-A3 line generated
•p
HAT clones for Experiment III was not definitively established, however it was 
noted that these cells were multiplying at a slower rate than for the CAT-B3 line, 
which may be attributed to a mycoplasm contamination of the cells during this 
experiment. A contamination of the CAT-A3 line in this manner may have reduced 
their efficiency to survive HAT selection, thereby reducing the efficiency with 
which HATR colonies were generated.
The difference in the efficiencies of generating HATR clones between the in 
cis and in trans lines had been anticipated based upon the reported findings of 
Bethke and Sauer (Bethke and Sauer, 1997). Bethke and Sauer conducted an 
experiment to determine whether the insertion of an entire plasmid by a single SSR 
event (see Fig. 1.2c) would occur with the same efficiency as an RMCE event (see 
Fig. 1.2e). In the experiment, the target plasmid was the same harbouring both loxP 
and Iox511 sites, between which was an interval of approximately 3 kb. However, 
the test plasmids differed: one contained the equivalent loxP and Iox511 sites, 
creating an interval of approximately 4 kb, which was used to test the efficiency of 
the RMCE event; the other test plasmid was identical in all respects, except that it 
contained just a loxP site and was therefore used to test the efficiency with which 
the plasmid inserted into the target. Bethke and Sauer found that the RMCE event,
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using the plasmid with loxP and loxSll, was recovered with a 20-fold greater 
efficiency than the insertion event, using the plasmid with loxP alone. They argued 
that the reason for the difference in the efficiencies was based upon the likelihood 
for the reverse SSR event occurring in each case. They reasoned that the insertion 
of the test plasmid, with the loxP site alone, by a single SSR event would occur as 
efficiently as its excision from the target, again by a single SSR event. However, 
the implementation of hetero-specific lox sites, with the RMCE test plasmid, 
provided the opportunity for a different outcome: following insertion of the RMCE 
test plasmid via either loxP or Iox511, a second SSR event could mediate the 
reverse excisive reaction, however the possibility also existed that the second SSR 
could occur between the other pair of lox sites and thereby generate a RMCE event. 
Furthermore, Bethke and Sauer argued that the reverse reaction to RMCE would be 
an extremely unlikely event. This was based upon their supposition that the RMCE 
event was reciprocal and would therefore generate a plasmid that harboured the 
target interval of 3 kb. In order to reverse the RMCE event, this reciprocal molecule 
would then have to compete with 'a vast excess' of the original targeting plasmid 
and Bethke and Sauer considered the likelihood that this would occur to be 
extremely low. Therefore the reverse reaction for RMCE was reasoned to be 
extremely unlikely, whilst integration and its reverse reaction of excision, were 
considered to be of equal likelihood.
The consequences of altering the exposure time to Cre activity on 
integration/excision systems should therefore be less influential on determining 
their SSR products, compared with a RMCE system. The integration/excision 
system would be predicted to reach equilibrium of inserted and excised genetic 
products, in equal proportions, which would then become stabilised in the absence 
of Cre. However, since the reverse reaction to RMCE is predicted to be extremely 
unlikely, the prolonged exposure of Cre within a RMCE system would therefore be 
predicted to favour the generation RMCE events. Therefore RMCE systems present 
a greater capacity to increase the yield of desired products compared with 
integration/excision systems.
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With respect to the experiments described in this section, the production of 
HAT clones from the in tram line was predicted to follow equivalent dynamics to 
the integration of the plasmid by a single SSR event via the loxP site. The deletion 
of the interval was predicted to be equivalent to the RMCE event, outlined by 
Bethke and Sauer, due to the greater likelihood of a double SSR event, involving 
both the loxP and Iox511 sites. Therefore, in accordance with the findings of Bethke 
and Sauer the deletion of the globin locus, in the in cis lines, appears to be more 
efficient than the generation of HATR clones by integration of CP#98 into the in 
trans line.
It was predicted therefore that the HATR clones that were generated from 
the CAT-C10 line would arise from the integration of the entire CP#98 plasmid via 
its loxP site into the loxP site within the frtl I See I/S'liprt/fox/Yneo upstream 
targeting construct and that their drug resistance profiles would therefore reflect this 
arrangement. Similarly the HATR clones from CAT-A3 and CAT-B3 were 
predicted to have drug resistance profiles that reflected the deletion of the interval 
encompassing the entire alpha-globin locus.
3.4.2 Drug resistance phenotypes from HATR clones generated from the in cis 
and in trans targeted lines
As shown in Fig. 3.8 the drug resistance phenotypes for CAT-A3, CAT-B3 
and CAT-C10 were determined for Experiments I and III, but not for Experiment II, 
since contamination prevented this assessment.
The data in Fig. 3.8 show that the majority of the HATR clones generated 
from the CAT-A3 and CAT-B3 lines had drug resistance phenotypes that were 
consistent with the predicted phenotypes of clones that would be generated from in 
cis targeted lines (i.e. HATR, G418 S and HYGS). In fact, of those clones that gave a 
drug resistance phenotype, over 90 % had drug resistance phenotypes consistent 
with being generated from in cis targeted lines. This was taken as a strong 
indication that these clones were targeted in cis.
Those clones that gave unexpected drug resistance profiles from the putative 
in cis lines were clones A7 (Experiment I) and F12 (Experiment III), which were
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unusually hygromycin resistant and clone C6 (Experiment III), which was 
unusually G418 resistant. Clones A 7 and F12 could be explained by the absence of 
Cre recombinase from these clones, which would be necessary to delete thzfloxed 
hygromycin gene. However, the sensitivity of both these clones to G418 and their
D
HAT status, would suggest that the Cre-mediated deletion of the alpha-globin 
locus had occurred within these clones, as illustrated in Fig. 3.4. It was therefore 
probable that Cre had been present and had mediated the deletion of 64 kb interval 
of the globin locus, but surprisingly not an interval of 1.8 kb to delete the 
hygromycin selection marker. However, the occurrence of these events at such a 
low frequency (5 x 10~6) negated their relevance to the assignment of in cis 
targeting and therefore excluded them from further investigation.
Clone C6 is unusually G418R, but HATR and HYGS, which would suggest 
that the entire CP#98 plasmid has inserted via the loxP site into the loxP site 
adjacent to 5'hprt, in an SSR event similar to that predicted to generate HATR 
clones from the in trans line, see Fig. 3.6. According to the data in Fig. 3.8, this 
event occurs at a very low frequency, at 5 x 10~6 . The verification of the genetic 
arrangement of clone C6 requires Southern blot analysis, however, if this clone 
does indeed represent an integration of CP#98, via loxP, then it appears that the 
deletion of the globin locus interval via the SSR event outlined in Fig. 3.5, occurs 
102 times more efficiently than the integration event, for in cis targeted lines. This 
is further consistent with the findings of Bethke and Sauer, as outlined above.
The generation of clone C6 (Experiment III) at a frequency of 5 x 10"6 
would suggest that the generation of HATR clones from the in trans line should 
occur with equivalent frequency, since they are generated from equivalent SSR 
events. However, although the frequency of generating HATR clones from the in 
trans line was lower than for the in cis lines, the frequency was significantly higher 
than 5 x 10"6, being 6 x 10~5 . This was not the only anomaly associated with the 
HATR clones generated from the in trans line. All of the HATR clones were 
sensitive to G418 supplemented media. The predicted genetic arrangement of 
HATR clones from the in trans line is shown in Fig. 3.6, which illustrates the 
persistence of the neomycin gene, thereby conferring resistance to G418
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supplemented media. The sensitivity of the HATR clones generated from the in 
tram lines to G418 was therefore confusing.
The drug resistance profiles for the HATR clones generated from the CAT- 
AS and CAT-B3 lines were consistent with their assignment as targeted in cis, 
however Southern blot analysis was performed on a selected number of clones to 
further verify this conclusion (see below). Clearly, the drug resistance profiles of 
the HATR clones generated from the CAT-C10 clone were not consistent with the 
predicted genetic arrangement following Cre-mediated SSR with CP#98, which is 
illustrated in Fig. 3.6, and it was hoped that Southern blot analysis would clarify the 
assessment of this line.
3.4.3 Interpretation of the Southern blot data from the HATR clone generated 
from the CAT lines assigned as targeted in cis
Eight HATR clones generated from the CAT-A3 clone and ten HATR clones 
from the CAT-B3 clone, that had the predicted drug resistance phenotype of HATR, 
G418S and HYGS, underwent Southern blot analysis to determine their genetic 
arrangement (see Fig. 3.9). Upon Sph I restriction and hybridisation with UpLP, the 
control untargeted ES cell DNA demonstrates the presence of a 9.3 kb fragment, 
whilst the CAT-B3 double-targeted line shows this fragment and an additional 
fragment of 13.2 kb (as predicted in Fig. 3.5b and c). Following SSR the 13.2 kb 
fragment should be absent, since the Sph I site within the neomycin gene should be 
removed upon deletion of this selection marker concomitant with the predicted 
deletion of the hetero-specifically^/ojceJ interval. Furthermore a fragment of 16.1 
kb should be generated by the occurrence of an Sph I site within the DnRHA (see 
Fig. 3.5d). This fragment is particularly evident of a deletion, more so than a 
fragment which would be created by a site in the 3'hprt region. This is because it is 
contingent on the Sph I site in the DnRHA being brought into proximity with the 
reconstructed hprt gene, which would only occur by the deletion of the entire 
interval as predicted. All of the clones generated from both CAT-A3 and CAT-B3 


































































































































































































































































































































































































































































































































































































































































































































































































































































































































fragment, which originates from the untargeted chromosome. These fragments are 
therefore consistent with the assignment of these lines as targeted in cis.
The conclusions drawn following the interpretation of the data for genomic 
DNA restricted with Spe I and hybridised with DnRP, are similar to those above. 
The untargeted DNA can be seen to demonstrate the predicted 6.5 kb fragment (see 
Fig. 3.5b) and following targeting the CAT-B3 clone demonstrates the presence of 
this fragment and a 3.6 kb fragment from the targeted /ojc577/hygromycin/I See 
\llox511 construct (see Fig. 3.5c). The HATR clones that are generated following 
SSR are predicted to retain the 6.5 kb fragment from the untargeted allele, lose the 
3.6 kb fragment and generate a new Spe I fragment of 8.4 kb. The generation of the 
8.4 kb fragment is dependent upon the deletion of the interval since the sites to 
generate this fragment reside in the region 3' of DnRHA and within the 5'hprt of 
I\\Q frtll See I/5'hprt//o;tP/neomycin targeting construct (see Fig. 3.5d). All of the 
clones generated from both CAT-A3 and CAT-B3 demonstrate the presence of this 
8.4 kb fragment, in addition to the 6.5 kb fragment which originates from the 
untargeted allele. These fragments are further consistent with the assignment of 
these lines as targeted in cis,
3.4.3 Interpretation of the Southern blot data from the HATR clone generated 
from the CAT lines assigned as targeted in trans
The HATR clone CAT-C10/A1, generated from the CAT-C10 (in trans) ES 
cell line in Experiment III, was assessed by Southern blotting. The predicted 
fragment changes are illustrated in Figs. 3.6b, c and d, whilst the results are shown 
in Fig. 3.10.
Fig. 3.6 predicts that the hygromycin gene will be deleted following the 
exposure of the CAT-C10 in trans line to Cre recombinase. This causes a 
concomitant change in the size of the Spe I fragment from the targeted 
chromosome, from 3.6 kb to 6.5 kb. In addition, the untargeted chromosome was 
predicted to remain unchanged and should also generate a Spe I fragment of 6.5 kb. 
The CAT-C10/A1 clone clearly shows the presence of the 6.5 kb fragment and the
Fig. 3.10 Southern blot analysis from the HATR clone generated from the co- 
electroporation of CP#98 and CP#99 into the CAT-C10 ES cell line 
(Experiment III)
A. CAT- 
Hindm WT B3 D7 Al
Fig. 3.10a DNA from the HATR clone 23.1 kb| 








Fig. 3.10b DNA from the HATR clone 





Fig. 3.10 shows the fragments detected when DNA from the HATR clone arising from the electroporation of the putatively 
assigned in trans line was co-electroporated with CP#98 and CP#99. WT indicates DNA from un-targeted El4Tg2a cells, 
CAT-B3 is the control double-targeted line, clone D7 is a HATR clone generated from the CAT-B3 line and was assessed as 
having undergone deletion of the alpha-globin interval (see Fig. 3.9, clone D7) and clone Al is generated from the CAT-C10 
clone. The CAT-CIO/AI clone is thought to represent a HATR clone generated by the insertion of the test plasmid CP#98, not 
concomitant with deletion of the alpha-globin interval (see Fig. 3.6 for the predicted fragment sizes). As predicted from Fig. 
3.6b, WT DNA generates fragments of 6.5 kb following Spel restriction, detected by DnRP, as shown in Fig. 3.10a. This 
fragment is reduced in size to 3.6 kb following targeting of die /ox57//hygromycin/1 See VloxS 11 construct (as shown for the 
CAT-B3 line) and increased back to 6.5 kb following deletion of the hygromycin gene (see Fig. 6.5d). As shown in Fig. 
3.10a, the CAT-CIO/AI clone shows the fragment sizes consistent with the deletion of the hygromycin gene and additionally 
does not demonstrate the presence of an 8.4 kb that is indicative of in cis derived HATR clones (see clone D7 above, as 
predicted in Fig. 3.5d). Fig. 3.1 Ob shows the fragments detected when DNA is restricted with Sph I and hybridised with 
UpLP, which are predicted in Fig. 3.6. The untargeted locus should generate a fragment of 9.3 kb (see WT lane), which is 
increased in size to 13.2 kb following targeting of thefrt/l See I/5'hprt//ox/Vneomycin construct (as shown for the CAT-B3 
line). The D7 control line was predicted to generate a 16.2 kb (see Fig. 3.5d), indicative of deletion of the alpha-globin 
interval by SSR, however this fragment is not evident, as it was in Fig. 3.9b. Additionally, a fragment of 18.4 kb that would 
indicate the insertion of the test plasmid CP#98 (see Fig. 3.6d) is not evident for the CAT-CIO/AI clone. Therefore the results 
for the Sphl restriction on the HATR clone generated from the in trans line do not confirm the predicted genomic arrangement 
described in Fig. 3.6d.
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absence of the 3.6 kb fragment, which is consistent with the deletion of the 
hygromycin gene, and furthermore demonstrates that Cre recombinase has been 
active in this clone. Additionally, the CAT-B3/D7 clone, which is included as a 
control, demonstrates the presence of the 8.4 kb Spe I fragment which arises 
following deletion of the alpha-globin locus (see Fig. 3.5d) and the 6.5 kb fragment 
from the untargeted chromosome (see Fig. 3.5 b). However, the analysis using Spe I 
restriction does not indicate whether the test plasmid, CP#98, has inserted via the 
loxP site to reconstruct the Hprt minigene, as predicted for this in trans line. To test 
this Sph I restriction was performed.
The results of the Sph I restriction analysis on the CAT-C10/A1 line were 
predicted to indicate whether this clone represented an integration of the test 
plasmid via its loxP site, into the loxP site within the upstream targeting construct 
(as shown in Fig. 3.6a). Figs. 3.6c and d illustrate that there should be a 
concomitant increase in the size of the Sph I fragment, from 13.2 to 18.4 kb, around 
the hprt minigene should integration occur. As the results in Fig. 3.10 demonstrate, 
this 18.4 kb fragment is not evident in the CAT-C10/A1 clone. The only fragment 
that is evident is that arising from the untargeted chromosome, of 9.3 kb (as shown 
in Fig. 3.6b). Clearly this is an anomalous result.
The results shown in Fig. 3.10, of Sph I restriction on the E14Tg2a (WT) 
and CAT-B3 control lines demonstrated the predicted fragments. However the 
results from the CAT-B3/D7 control clone are not in accordance with its predicted 
genetic arrangement, or the previous assessment of this line (see Fig. 3.9b). The 
data previously generated from this clone indicated that it had undergone deletion 
of the alpha-globin locus (see Fig. 3.5b), as predicted (see Fig. 3.5). However, in 
the analysis presented alongside the CAT-C10/A1 clone, in Fig. 3.10, the CAT- 
B3/D7 clone does not demonstrate the presence of the 16.1 kb fragment, which is 
indicative of the deletion event (Fig. 3.5), however the 9.3 kb fragment from the 
untargeted chromosome is detected. Taken together, the results for the CAT- 
C10/A1 clone and CAT-B3/D7 clone, in Fig. 3.10, would suggest that the Sph I
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analysis performed does not provide conclusive data that either verify, or exclude, 
the assignment of the CAT-C10 clone as targeted in trans.
3.5 Summary
A selection of four double-targeted CAT ES cell lines were further 
characterised to determine whether the targeting constructs, whose targeting was 
described in Chapter 2, had targeted to the same chromosome (in cis) or alternate 
chromosomes (in trans}. The initial analysis was to perform Southern blot analysis 
on genomic DNA from these lines restricted with I See I, which is a rare-cutting 
restriction endonuclease and whose sites were exclusively present within the 
targeting constructs. Therefore the generation of an I See I restriction fragment was 
exclusively dependent upon the constructs targeting in cis. The detection of the I 
See I fragment by Southern blot analysis, following PFGE, was used to putatively 
assign the CAT-A3 and CAT-B3 lines as targeted in cis and the CAT-C10 line as 
targeted in trans.
Following the putative assignment of the CAT lines in this manner, they 
were further characterised to verify that the hx sites they harboured, within the 
targeted constructs, were functional. This was achieved by co-electroporating a Cre 
expression plasmid and a test plasmid into the three CAT lines. The test plasmid 
contained loxP and loxSll sites, in an orientation that would permit the deletion of 
the entire alpha-globin locus, upon SSR with an in cis targeted clone. This analysis 
further verified the assignment of clones CAT-A3 and CAT-B3 as targeted in cis. 
This analysis did not however conclusively verify the assignment of the CAT-C10 
clone as targeted in trans.
The CAT-B3 line was selected to attempt the large interval RMCE 
experiment, which is described in Chapter 5. The CAT-A3 line was not selected 
due to its slow duplication rate experienced for this clone in Experiment III (see 
section 3.4.1).
Although the CAT-C10 clone generated data that contradicted its 
assignment as targeted in trans, it was still used as a comparative cell line for the
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large interval RMCE event, described in Chapter 5. It was hoped that the CAT-CIO 
line would generate interesting data, for comparison with the CAT-B3 line, which 





This chapter describes the genetic manipulation of the bacterial artificial 
chromosome pBAC 14567 in order to modify it in preparation for the large interval 
RMCE event, as described briefly in section 1.5.4(a) (see Fig. 1.3). pBAC 14567 
consists of the BAG cloning vector pBeloBAC 11 and a Hindlll cloned insert of 
approximately 70 kb of murine 129 genomic DNA. The cloned insert in 
pBAC 14567 encompasses the murine alpha-globin locus, commencing 1 kb 5' of 
the HS-26 sequence and terminating 10.2 kb 3' of last coding exon of 6, which is 
the terminal structural gene of the alpha-globin locus gene cluster (see Fig. 2.1).
The modification of pBAC 14567 involved targeting the cloned insert with 
hetero-specific lox sites, at positions that were equivalent to those targeted during 
the modification of the CAT ES cell lines, as described in Chapter 2. The cloned 
insert in pBAC 14567 was targeted by two distinct sequential targeting events, using 
recombination mediated cloning. The first targeting event delivered a construct, 
containing Iox511 sites, targeting 3' of the alpha-globin locus at the 'downstream' 
position in the pBAC 14567 (see Fig. 2.1 for nomenclature). In addition this 
recombination cassette contained a Herpes Simplex Virus thymidine kinase gene 
(HSV/A:). The isolation of clones targeted with this recombination cassette was 
aided by the inclusion of a bacterial kanamycin (kan) drug resistance gene as a
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selectable marker. The design and construction of this recombination cassette, 
termed lox51]/kan/hx511/HSVtk, is described in section 4.2.
Targeting of the recombination cassettes to pBAC 14567 was achieved by 
recombination mediated targeting (Zhang et al., 2000). Before a successful method 
was established a number of different approaches were attempted in order to 
generate the double-stranded linear targeting DNA fragment, which is necessary to 
this technique. These various attempts are described in section 4.3.
In addition, before targeting could commence, the recombination mediated 
targeting technique implemented here required the introduction of a recombination 
plasmid into the DH10B E. coli cells that harbour pB AC 14567. This plasmid 
carries genes that encode proteins that participate in, and drive homologous 
recombination, which is necessary for targeting to occur. A variety of 
recombination plasmids were tested and experimental success was finally achieved 
with pR6Ka(3y (gift from Francis Stewart). Following the production of 
recombinant bacterial colonies it was necessary to analyse the BAG DNA from 
these clones to establish whether targeting had occurred. Upon preparation of the 
BAG DNA for this purpose, it was discovered that the abundance of recombination 
plasmid in the DNA preparation made this analysis impossible. Therefore the E. 
coli cells were first required to be cured of the recombination plasmid before 
restriction analysis, to establish targeting, could be performed. These points are 
discussed in detail in sections 4.4 and 4.7.2.
Targeting of the lox511/kan/lox511/RSVtk recombination cassette to the 
downstream position was conclusively established by restriction analysis, as 
described in section 4.5. Recombination mediated cloning was then applied to 
target the second recombination cassette 5' of HS-26, to the 'upstream' position 
(again see Fig. 2.1 for nomenclature). This second targeting event delivered a 
recombination cassette containing the /oxP/Hprt ~A5' cassette, as described by 
Smith and colleagues in 1995 (Smith et al., 1995; Van Deursen J, 1995), termed 
within this thesis as loxP/yhprt. The isolation of clones targeted with this cassette 
was aided by the inclusion of a blasticidin (bsd) drug resistance gene as a selectable
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marker. This second recombination cassette also included anfrt site, the purpose of 
which will be explained later, in Chapter 5. The design and construction of the 
bsd/o*/V3'hprt/I See \lfrt recombination cassette is described in section 4.6 and its 
subsequent targeting is described in section 4.7. Finally, experiments to confirm 
that the lox sites targeted to the BAG are functional are described in section 4.8.
4.2 Design and construction of the BAC downstream targeting construct
The alpha-globin downstream position in pBAC 14567 was targeted with a 
loxSll/kan/hxSll/HSVtk recombination cassette. The purpose of including an 
HSV/& gene within this cassette was to use it as a negative marker in the selection 
strategy for the large interval RMCE event. The inclusion of the kanamycin gene 
was to facilitate the isolation of bacterial colonies harbouring targeted BACs. The 
purpose offloxing the kanamycin gene with Iox511 sites was to enable its excision 
and therefore its potential re-use as a selection marker for further modifications to 
the BAC, as desired. The in vivo or in vitro SSR between the Iox511 sites to excise 
the kanamycin gene would therefore leave a single Iox511 site, which would then 
be capable of participating in the large interval RMCE event. The construction of 
the lox511/kan/Iox51J/HSVtk recombination cassette is described in Fig. 4.1.
There were three important considerations concerning the targeting of the 
lox511/kan/lox5JJ/}iSVtk recombination cassette to the downstream position in the 
BAC. The first was that in order to affect negative selection the HSVM: gene needed 
to be excluded from the interval that would be exchanged during the large interval 
RMCE event. Thus, it was necessary to position the HSV/£ gene outwith the region 
flanked by the hetero-specific lox sites, loxP and Iox511 (refer to Fig. 2.1). The 
second consideration was that the orientation of the Iox511 sites targeted to the 
BAC were required to be in the same orientation, relative to the alpha-globin 
sequences, as the Iox511 sites delivered to the CAT ES cell lines by the 
70*577/hygromycin/I See \Jlox511 targeting vector, CP#48 (see section 2.4). The 
third consideration was to target the lox511/kan/lox511fHSVtk recombination 
cassette to the identical sequence in the BAC as was targeted in the CAT ES cell 
lines with the /ox5/7/hygromycin/I See \llox511 targeting vector. This was
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The Hindlll site in pKaX (CP#140) was first converted to a BamHI site, by linearising the plasmid 
with Hindill, creating blunt ends with Klenow polymerase and dNTPs, and then ligation with the 
BamHI linker NEB #1002 (see Fig. 4.la). The kanamycin gene was then excised as a BamRl 
fragment and cloned into the Bglll site of CP#20 (shown in Fig. 4.1b and whose construction is 
described in Fig. 2.2). The resulting plasmid, CP#24, is shown in Fig. 4.1c. AJHS#990 (Fig. 4.Id) 
contains the sequence for the HSV thymidine kinase gene (HSV/£), denoted as 'TK' above. A 
BamHI fragment, containing /ox577/kanamycin//0;t577 sequences, was generated from CP#24 and 
cloned into the BamHI site of AJHS#990. To confirm that the desired orientation of the loxSll 
sites, in relation to the HSV/& gene, was obtained, the DNA from colonies resulting from this 
ligation were sequenced. A plasmid with the desired orientation of the /0;t577/kanamycin//ax577 
insert was obtained and the Xhol site 5' of HSV/A; in this plasmid was converted to a BamHI site to 
give plasmid CP#37, as depicted in Fig. 4.1e.
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necessary in order to create a region that was flanked at identical genetic positions 
with hetero-specific lox sites in both the BAC and CAT ES cells, which would in 
turn permit the precise exchange of alpha-globin sequences during the large interval 
RMCE event.
4.3 Targeting the lox511/kan/lox511/HSVtk recombination cassette into the 
BAC
To produce a linear targeting DNA for recombination mediated targeting of 
HSV/& a number of different approaches were attempted before a successful 
strategy was found. The methods attempted are reported in this section.
4.3.1 PCR strategies for preparation of the targeting fragment
The first attempts to produce a linear targeting fragment were by PCR 
amplification. The PCR products were generated from the plasmid described in Fig. 
4.2 as the template. It was reported that the efficiency of recombination mediated 
targeting increases in direct relation to the size of the homology arms (Zhang et al., 
1998) and so the first pair of PCR primers, F1346 and F1347, were designed to 
produce homology arms of 300 bp either side of the lox511/kan/lox511/HSVtk 
recombination cassette (see Fig. 4.3). After several unsuccessful attempts to 
produce a PCR product a second set of primers, F53526 and F53527, were designed 
to yield 60 bp of homology either side of the recombination cassette. It was 
anticipated that the reduction in size of the PCR product would enable the PCR to 
be more efficiently optimised and reduce the chance of incorporating mutations into 
the homology arms, which could potentially be transferred undetected into the 
target site. The location of both primer sets is shown in Fig. 4.3.
A significant consideration when using PCR to produce the double-stranded 
linear DNA for recombination mediated targeting is that it has the potential to 
introduce random mutations into the amplified template by polymerase error. The 
introduction of a mutation to a component of a targeting cassette could interfere 
with its ability to function. For example, a mutation in the HSV/& gene could have 
compromised the activity of the thymidine kinase gene and thus its effectiveness as
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Fig 4.2 Construction of CP#38, the PCR template plasmid used to generate a 






CP#37 (see Fig. 4.1e) was partially restricted with BamHI and the 4 kb DNA fragment containing 
the lox511/kar\/lox511/HSVtk sequences cloned into the BamHI site in plasmid CP#45 (see Fig. 
2.2e) to create CP#38. The orientation of the inserted sequences relative to the ES cell targeting 
homology arms was determined by Bglll restriction analysis. The orientation of the Iox511 sites was 
then confirmed by sequence analysis with the oligonucleotides F1346 and F1347 (see Fig. 3.3) and 
determined to be consistent with the orientation of the Iox511 sites in ES cells targeted with CP#48.
98










The diagram illustrates the position of PCR primers used for the initial PCR based strategies to 
generate a linear targeting fragment. The PCR reaction was designed to amplify the TK 
recombination cassette and include homology arms at either side in order to the target the 
downstream position in the BAG cloned insert (3' to the alpha-globin gene cluster). Primer pair 
F53526 and F53527 were designed to generate -60 bp of homology for each arm and primer pair 
F1347 and F1346 -300 bp of homology.
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a negative selection marker. Alternatively, a mutation located within the homology 
arms of the targeting vector could prohibit homologous recombination, or at least 
reduce its efficiency and accuracy, and furthermore introduce unreported mutations 
to the target DNA molecule.
To reduce the chance of introducing mutations by polymerase error a 
polymerase with proof reading ability, Pfu Turbo, was used to perform the PCR 
reactions (Lundberg et al., 1991). Pfu Turbo is reported to have an error rate of 1.3 
x 10~6 mutations^p/duplication cycle (Cline et al., 1996). In addition to using a 
proof-reading polymerase the number of reaction cycles was kept to a minimum, 
between 15 and 25 cycles to reduce the probability of introducing mutations. This 
precaution made it difficult to optimise a PCR to generate enough product for 
subsequent electroporation.
Another disadvantage of using the PCR method was that the Dpn I 
treatment, used to digest the template plasmid from the PCR reaction contents 
(Zhang et al., 1998), was found to be inefficient. Therefore, unless the PCR 
products were gel purified, background colonies would arise from the 
electroporation of the PCR reaction, in which residual template plasmid persisted 
due to incomplete Dpn I restriction. The number of colonies arising from the 
template plasmid was always significant and made it necessary to replica plate large 
numbers of colonies to determine whether targeting had occurred (for the replica 
plating method see 1.6.8 (f) in Appendix I). A template plasmid contamination in 
the electroporated DNA resulted in colony numbers such that a targeted event could 
not be distinguished even when replica plating 300 colonies or more.
4.3.2 Restriction digest strategies for the preparation of the targeting fragment
A significant disadvantage of the PCR strategies was the inability to 
produce adequate quantities of DNA for electroporation. To overcome this problem 
the PCR template plasmid CP#38, see Fig. 4.2, was implemented in a partial 
restriction strategy. The enzymes Sac I and Kpn I were used to liberate a linear 
targeting DNA with approximately 0.5 kb of homology either side of the 
lox5Jl/kan/lox5J 7/HSV/A: recombination cassette. However, even when starting
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with 150 jag of plasmid DNA, it was not possible to obtain sufficient quantities of 
DNA, following two rounds of partial digestion and subsequent gel purification, to 
successfully target pBAC 14567.
4.3.2a The Asc I restriction strategy to generate the targeting fragment
An alternative restriction-based strategy was therefore implemented, this 
involved building the homology arms into a plasmid by the insertion of a pair of 
annealed complementary oligonucleotides of 120 bp. These oligonucleotides were 
designed to incorporate a BamHl site at their mid-point, used for the insertion of the 
lox511/kan/lox511/HSVtk cassette, and Asc I sites at their ends, which allowed the 
insertion of the oligonucleotides into a plasmid with a unique Asc I site. The 
strategy is summarized in Fig. 4.4. Although technically this approach was more 
tedious, it did have the advantage of eliminating the concerns previously discussed 
inherent in using PCR to generate the linear targeting fragment. The insertion of the 
lox5n/kan/lox511fHSVtk cassette into the BamHl site within the oligonucleotides 
created a plasmid that could then be Asc I restricted to liberate a linear targeting 
fragment, which included the recombination cassette bounded on each side by 60 
bp of homology necessary to target the downstream position of the alpha-globin 
locus in pB AC 14567.
4.4 Identifying targeted clones within a mixed population of kanamycin 
resistant colonies arising from the electroporation of the 
lox5n/kan/lox511/HSVtk cassette into E. coli cells harbouring pBAC14567
The electroporation of the Asc I linear targeting fragment containing the 
lox511/kan/lox511fHSVtk recombination cassette into E. coli cells harbouring 
pBAC 14567 generated kanamycin resistant colonies. These colonies required 
screening to identify those that harboured a targeted BAG molecule from those that 
arose from non-targeting events.
The kanamycin resistant colonies were screened by restriction analysis. 
DNA from 20 kanamycin resistant clones, chosen at random, was prepared
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Fig 4.4 Construction of CP#139, the plasmid used to generate an Ascl 
restriction fragment to target the lox511/kan/lox511/HSVtk cassette
Fig. 4.4b
Fig. 4.4a
The complementary oligonucleotides F53524 and F53525 were designed with 120 bp of homology 
to the downstream targeting position of the alpha-globin locus within the BAG cloned insert. In 
addition a BamHl site was included in their design at a position that was genetically identical to the 
BamHl site between the ES cell targeting homology arms (as shown in Fig. 2.2e). Thus, both the ES 
cell and BAG recombination cassettes were delivered to genetically identical positions in ES cells 
and pBAC 14567 respectively. F53524 and F53525 were annealed to create duplex DNA with Ascl 
compatible 3' single stranded ends. The annealed oligonucleotides were then ligated into the unique 
Ascl site of a plasmid, which had had an Ascl linker inserted between the Kpnl and Sad sites of 
pBS(KS+) (gift from Melville Richardson) to give plasmid CP#137 (see Fig. 4.1). Insertion of the 
oligonucleotides was screened for by colony hybridization, using 32P labelled F53525 as a probe. 
Positive clones were pooled, BamHl restricted and treated with alkaline phosphatase. By partial 
BamHl restriction a fragment containing the lox511/kan/lox511/HSVtk cassette was liberated from 
CP#37, this fragment was then ligated into the BamHl site within the oligonucleotides in CP#137. 
Plasmid miniprep DNA was prepared from 40 kanamycin resistant colonies arising from the ligation 
and screened by BamHl digest. 10 plasmids that gave BamHl fragments indicating that the 
lox511/kan/lox5Il/HSVtk cassette had been inserted were sequenced with T3 and T7 primers, in 
order to determine the orientation of the cassette relative to the targeting homology arms. One of 
these plasmids, 37/Asc-21 or CP#139 (see Fig. 4.4b) was found to have the required orientation of 
the cassette and was restricted with Ascl to produce a 4.5 kb linear BAG targeting fragment.
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separately from 5 ml overnight cultures by the BAG Quick Prep method (see 1.6.1 
(d)). The DNA was restricted with Spe I and the visualised results inspected for a 
fragment size increase of 6.5 kb to 10.4 kb as an indication of targeting, as shown in 
Fig. 4.5. However, upon visualization of the fragments arising from Spe I 
restriction, it was impossible to discern those fragments that arose from the BAG 
DNA due to an overwhelming abundance of the recombination plasm id, 
pR6K/BAD/ctpy/te/ (CP#114), in the BAG Quick Prep DNA preparation. 
Therefore, in order to perform an informative restriction analysis screen it was first 
necessary to eliminate the recombination plasmid from the kanamycin resistant 
colonies.
The recombination plasmid pR6K/BAD/apy/fc/ has a tetracycline resistance 
gene and so by removing tetracycline selection it was anticipated that the plasmid 
copy number within the cells would deplete with successive cell divisions. In order 
therefore to obtain E. coll clones that had eliminated the recombination plasmid 40 
kanamycin resistant colonies, selected at random, were re-streaked successively 
four times onto agar plates supplemented with kanamycin alone.
To then test whether the recombination plasmid had been eliminated the 40 
clones were replica plated, first onto agar plates with both tetracycline and 
kanamycin selection, and secondly onto plates with kanamycin selection alone. 
Those clones that grew on the second plate but not the first were predicted to have 
eliminated the recombination plasmid. 6 of the 40 clones were tetracycline sensitive 
and therefore indicated that the recombination plasmid had been eliminated. These 
6 clones were subsequently picked and grown overnight in a 5 ml culture for DNA 
preparation by the BAG Quick Prep method. The BAG DNA from these 6 clones 
was restricted with Spe I and upon visualisation it was conclusively established that 
all 6 had eliminated the recombination plasmid. Further, inspection of the Spe I 
fragment sizes determined that all 6 of the clones demonstrated the fragment size 
increase of 6.5 kb to 10.4 kb that indicated targeting (see Fig. 4.5). However, to 
conclusively determine whether targeting had occurred, and that no other unwanted 

























































































































































































































































































































































































































































































































































































































































scrutinise the BAG DNA from these clones, putatively assigned as targeted, by 
restriction analysis. This analysis is described in section 4.5 below.
The method of re-streaking colonies in order to eliminate the recombination 
plasmid was found to be both labour intensive and inefficient, a more efficient 
method to eliminate the plasmid was therefore required. The addition of NiCb to 
the E. coli growth media was therefore investigated as a selection for the loss of 
tetracycline resistance and its implementation is detailed in section 4.7.2.
4.5 Checking the integrity of pBAC14567/TK by restriction analysis
The thorough restriction analysis of the targeted pBAC14567/TK was 
necessary to determine primarily whether the correct integration of the 
lox511/kan/lox511/llSVtk cassette to the target locus and secondly, if the integrity 
of the entire alpha-globin locus had been maintained following recombination 
mediated targeting.
The unintentional re-arrangement of target DNA has been reported from 
studies using recombination mediated cloning. These re-arrangements most 
probably arise as a result of non-homologous intramolecular pairing, driven by 
persistent, high levels of recombination proteins. The pR6K plasmid was therefore 
developed with the aim of reducing the opportunity for undesirable recombination 
to occur by constraining recombination activity to a limited time period. This was 
achieved by placing the recombination genes under the transcriptional control of an 
arabinose inducible promoter. Additionally, the arabinose inducible plasmid based 
system makes E. coli strains, such as DH10B, that are genetically engineered to 
have low recombination competence in order to maintain large genomic library 
constructs, amenable to recombination mediated targeting.
The positions of the enzyme sites, the fragment sizes that arise before and 
after targeting are summarized in Fig. 4.5. Fig. 4.6 shows the results of restriction 
analysis on pBAC 14567 and pBAC 14567 following introduction of the 
lox5Jl/kan/lox511/HSVtk recombination cassette, termed pBAC14567/TK.
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Fig 4.6 Restriction analysis of pB AC 14567 targeted with the 
lox511/ksm/lox511/RSVtk recombination cassette to give pBAC14567/TK
1 kb 
ladder
EcoRl Kpnl Spel Xhol Xmnl ~
a a a















5 |ag of DNA from each BAG, prepared using the Magnesil method, was restricted with EcoRl, 
Kpnl, Spel, Xhol, and Xmnl. As shown: a indicates the untargeted BAG, pBAC14567 and b 
indicates pBAC14567 targeted with /ox577/kan//oxJ77/HSVf*, to give pBAC14567ATK.
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4.6 Design and construction of the BAC upstream targeting construct
Once the accurate delivery of the lox511/kan/lox511/HSVtk recombination 
cassette had been established the second recombination cassette was targeted. This 
section describes the design and construction of this second cassette, termed 
bsd//o*P/3'hprt/I See l/frt, and its targeted delivery to the upstream target position, 
5' of the alpha-globin locus in pBAC14567/TK, by recombination mediated cloning 
in E. coli.
The bsd/loxP/3'hprt/l See l/frt recombination cassette was constructed from 
a previously existing plasmid, pBS/mPGKhyg//0jc/Yhprt ~A5VI See l/frt 
(AJHS#1172). The sequence encoding the hygromycin gene was replaced with that 
of a blasticidin resistant gene (bsd), as depicted in Fig. 4.7. The blasticidin gene 
employed has both prokaryotic (EM7) and eukaryotic (murine phospho-glycerate- 
kinase, mPGK) promoters, to enable its selection in E. coli and murine ES cells 
respectively. A BamHl restriction fragment containing the sequences 
bsd/loxP/3'hprt/l See Vfrt, was then inserted into CP#7 (described previously in 
Fig. 2.6c), which contains the homology arms employed to target the upstream 
position in ES cells (see Fig. 2.1). Thus, the bsd//ojeP/3'hprt/I See l/frt BAC 
recombination cassette was positioned at the identical genetic location as thefrt/l 
See I/S'ttprt/fojc/Vneomycin ES cell recombination cassette, with respect to the 
alpha-globin locus. In addition, the orientation of the bsd//0jt/V3'hprt/I See l/frt 
cassette within the ES cell homology arms was verified by restriction digest and 
sequencing. This was done to ensure that the orientation of the loxP site targeted to 
the BAC sequence would be consistent with the orientation of the loxP site 
previously targeted to the ES cell upstream position (see section 2.5).
The blasticidin gene of bsd//ojt/V3'hprt/I See l/frt was notfloxed, in contrast 
to the kanamycin gene in the construction of the lox5Jl/kan/lox511/HSVtk cassette. 
The reason for this was that the bsd gene lies outwith the interval created by the 
hetero-specific lox sites in the BAC, which will be the interval exchanged in the 
desired large interval RMCE event, as described in Fig. 1.3. Therefore the bsd gene 
should not be transferred to the ES cell genome.
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Fig. 4.7 Construction of CP#113, the bsd//0Jt/V3'hprt/I See Mfrt recombination 

















CP#94 (HN381), shown in Fig. 4.7a, was restricted with EcoRV and Sphl and the 1.3 kb blasticidin 
gene fragment (mPGKpEM7bsdpA) gel purified, quantitated and ligated with the 5.4 kb EcoRV and 
Sphl fragment of AJHS#1172 (pPGKhyg//o*P/3'HPRT/I See \lfrt\ shown in Fig. 4.7b. The desired 
plasmid was screened for by BamHl restriction, with the correct plasmid having fragments of 3.7 
and 3.0 kb. The resulting plasmid was termed CP#109, as shown in Fig. 4.7c. The bsd//oxP/3'hprt/1 
See llfrt cassette, from CP#109, was then cloned into CP#7 (see Fig. 2.6c) to create a plasmid from 
which a linear targeting DNA could be produced, shown in Fig. 4.7d. This was achieved by 
restricting CP#109 with BamHl and ligating the resulting 3.7 kb fragment into BamHl restricted and 
alkaline phosphatase treated CP#7. Integration ofbsd/loxP/yhprtJ 1 See llfrt cassette was screened 
for by BamHl restriction and the desired orientation of the bsd//oxP/3'hprt/ I See llfrt cassette was 
determined by restriction with EcoRl, EcoRV, Xhol. The linear targeting DNA, required for 
recombination mediated targeting, was generated from CP#113 by restriction with Notl and Sail.
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Although, upon inspection of the pBAC14567/TK sequence it was evident 
that the loxP site within the BAG backbone was in a configuration such that Cre 
mediated SSR would delete the bsd gene and a small region, 70 bp of BAG vector 
backbone, from pBAC14567/TK, as described later in Fig. 4.10c.
An important consideration when designing the bsd//oxP/3'hprt/I See llfrt 
recombination cassette, to target pBAC14567/TK, was to match the orientation of 
the loxP site, with respect to the alpha-globin locus, to that of the loxP site in the 
frt/l See I/5'hprt//oxP/neomycin ES cell targeting construct (see section 2.5).
4.7 Targeting the bsd//ft*;P/3'hprt/I See llfrt recombination cassette into 
pBAC14567/TK
In order to generate a linear targeting fragment to target the 
bsd//oxP/3'hprt/I See l/frt recombination cassette, an 8.1 kb restriction fragment 
was generated by restriction of CP#113 by restriction at its unique Not I and Sal I 
sites. This generated homology arms at either side of the recombination cassette of 
approximately 2.5 kb (see Fig. 4.7). From 100 ug of CP#113, 260 ng of purified 
restriction fragment was obtained and then electroporated into arabinose induced, 
electrocompetent DHIOB harbouring both pBAC14567/TK and the recombination 
plasmid, pR6K/BAD/ct(3y/te/. In addition 10 pg of control plasmid of pBS(KS+) 
was electroporated in parallel to the same batch of electrocompetent cells.
After an hour of recovery cells were plated onto agar plates supplemented 
with blasticidin selection. Cells with a competency of 5 x 106 / pg DNA, as 
determined by ampicillin resistance, produced 171 blasticidin resistant colonies. 
Clones arising after 24 hours of incubation at 37°C were picked and replica plated 
onto agar plates with different antibiotic selections added, in order to isolate clones 
that harboured the desired targeting event.
4.7.1 Screening colonies arising from electroporation of the bsd//ftxP/3'hprt/I 
See llfrt recombination cassette
As discussed previously, following targeting, the resulting clones were 
required to be cured of the tetracycline resistance recombination plasmid,
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pR6K/BAD/a(3y/te/, in order to obtain a BAG DNA preparation that could be 
analysed by restriction analysis, to identify targeted clones.
4.7.2 Elimination of the recombination plasmid by culture with NiC122
The primary screen to isolate a targeted integration of the recombination 
cassette was by restriction digest. As previously discussed, restriction analysis 
necessitated the prior elimination of the pR6K/BAD/apy/te/ recombination plasmid 
(see section 4.4). To achieve this rapidly and effectively for hundreds of blasticidin 
resistant colonies required a better procedure to select for the loss of the tetracycline 
resistance marker that is carried on pR6K/BAD/ot(3y/te/. This was achieved by 
supplementing the agar and culture broth, in which the colonies were grown, with 
NiCb (see I.6.8(e)). This method has been reported to select for the loss of 
tetracycline resistance in E. coli more effectively than fusaric acid based selection 
(Podolsky et al., 1996).
20 of the 171 (see section 4.7 above) blasticidin resistant colonies were 
picked and cultured in 5 ml of broth overnight supplemented only with blasticidin. 
The following day 1 ml of the culture was used to inoculate broth supplemented 
with blasticidin and 5mM NiC^. The culture was grown overnight and a 100 jil 
plated onto agar plates supplemented with blasticidin alone. The colonies that arose 
were replica plated, first onto agar plates supplemented with blasticidin and 
tetracycline and secondly to plates supplemented with blasticidin and 5mM
DNA from each of the colonies, that survived on the blasticidin and Ni 
supplemented plates and that had therefore eliminated the recombination plasmid, 
was prepared by the BAG 'Quick Prep.' method. The DNA was then restricted by 
Spe I to identify targeting of the bsd//ox/)/3'hprt/I See \lfrt construct (see Fig. 4.8). 
The presence of a 4 kb fragment was taken to indicate targeting and this was 
evident from 1 1 of the 20 clones tested. All 20 clones demonstrated the absence of 
the recombination plasmid. A single clone was then chosen to perform more 

















































































































































































































































































































































































































4.7.3 Checking the integrity of pBAC14567/TK/3'HPRT by restriction analysis
The DNA from a single clone, that appeared to be targeted according to Spe 
I restriction analysis described above, was prepared by the Magnesil method. The 
DNA was restricted with Sma I, Spe I and Xho I, in order to confirm that targeting 
had occurred and to determine whether the integrity of cloned insert in the BAG 
had been maintained. The positions of the enzyme sites and the fragment sizes that 
arise before and after targeting are summarized in Fig. 4.8. The results in Fig. 4.9 
show the results of this restriction analysis on pBAC 14567, pBAC14567/TK and of 
DNA from the blasticidin resistant colony derived as above, which was termed 
pBAC14567/TK/3'HPRT.
The data clearly show that the targeted BAG has the fragments that indicate 
the required targeting events. Furthermore, there appears to be no evidence for any 
gross re-arrangements of the BAG cloned insert post-targeting.
4.8 In vitro Cre-mediated SSR analysis to confirm the functionality of the lox 
sites targeted to the BAG
Prior to the introduction of pBAC14567/TK/3'HPRT to the ES cell lines, it 
was important to establish whether the lox sites targeted to the BAG could 
participate in Cre-mediated SSR. This section describes the experiments performed 
to test the functionality of the loxP and Iox511 sites targeted to the cloned insert in 
the BAG.
A 10 jug sample of DNA from each of pBAC 14567, pBAC14567/TK and 
pBAC14567/TK/3'HPRT was tested by in vitro Cre analysis. At time intervals up 
to 30 minutes, aliquots of the in vitro Cre reaction were taken and 
phenol/chloroform extracted, precipitated and then resuspended in 20 ul of TE. 15 
V\ was used in a restriction digest (see section 4.8.1) and the remaining 5 jil was 
electroporated into electrocompetent DH10B and the resulting colonies studied (see 
section 4.8.2).
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Fig. 4.9 Restriction analysis of pBAC14567/TK targeted with the 
bsd//0jtP/3'hprt/I See Ufrt recombination cassette
1 kb 
ladder










5 ng of DNA from each BAC, prepared using the Magnesil method, was restricted with Kpnl, Spel, 
and Xhol, as shown: a indicates the untargeted BAC, pBAC 14567; b indicates pBAC14567/TK and 
c indicates pBAC14567/TK targeted with bsd//OA:P/3'hprt/I See llfrt, to give 
pB AC 14567/TK/3 'HPRT.
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4.8.1 Xho I restriction analysis on in vitro Cre reactions
The 15 |il aliquots of BAG DNA that had been used in the in vitro Cre 
reaction were restricted with Xho I. An outline of the predicted fragment sizes from 
Xho I restriction prior to and following Cre-mediated SSR is shown in Fig. 4.10. 
The results of the restriction analysis are shown in Fig. 4.11.
The colonies arising from the electroporation were replica plated to 
determine which selection markers had been deleted as a consequence of SSR 
between homologous lox sites.
4.8.2 Analysis of colonies arising from electroporation of the DNA products of 
in vitro Cre-mediated SSR
As mentioned above, 5 jul aliquots of the in vitro Cre reaction were 
electroporated into DH10B cells. The cells were allowed to recover and then plated 
onto agar supplemented with chloramphenicol. Colonies arising after 24 hours 
incubation at 37 °C were then replica plated to determine which of the selection 
markers had been deleted. The results of the replica plating from colonies that arose 
from the 5 jnl aliquot from the pBAC14567/TK/3'HPRT molecule, following Cre- 
mediated SSR are summarised in Fig. 4.12.
4.9 Summary
This chapter describes the genetic modifications made to the cloned insert of 
pBAC 14567 in order to introduce the lox511/kan/hx5JJ/HSVtk and then the 
bsd//oxP/3'HPRT targeting constructs. These sequences were targeted to positions 
that result in flanking the entire alpha-globin locus with loxP and Iox511 in 
preparation to test the RMCE strategy, as outlined in section 1.5.4(a).
These modifications were achieved using the relatively new technology of 
recombination mediated cloning. From the experience of implementing this 
technology a number of important generalisations can be made concerning the 



























































































































































































































































































































































































































































































































































































































































































































































Fig. 4.11 Xhol restriction analysis of pBAC14567, pBAC14567/TK and 













0 1 5 15 30 0 1 5 15 30 01 5 15 30
Analysis of B AC DNAs following in vitro Cre reactions carried out for the reaction times indicated 
(0, 1, 5, 15 and 30 minutes). Fig. 4.10 describes the predicted Xhol sites for this analysis. A is the 
untargeted pBAC14567. B is pBAC14567 targeted with lox511/kan/lox511/HSVtk to give 
pBAC14567/TK. C is pBAC14567/TK targeted with bsd//ox/V3'hprt/I See llfrt, to give 
pBAC14567/TK/3'HPRT.
116
Fig. 4.12 The results of replica plating chloramphenicol resistant colonies 
arising from in vitro Cre-mediated SSR on pBAC14567/TK/3'HPRT





































The table summarises the resistance profiles of the E. coli cells following Cre-mediated SSR. 
Key: Chlor11 - Chloramphenicol resistance; KanR - Kanamycin resistance; Blast* - Blasticidin 
resistance. The grey shading indicates resistance and each clone is grouped by its resistance 
profile. 14% of the clones were kanR/bsdR and were therefore unchanged following SSR 
(yellow). 17% were kans/bsdR and had therefore deleted \hefloxed kanamycin selection marker 
alone (blue). 33% were kanR/bsds and had therefore deleted the floxed blasticidin selection 
marker alone (red). 36% were kans/bsds and had therefore deleted both the kanamycin and 
blasticidin selection markers (green).
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Firstly, the PCR strategies tested to produce a linear targeting DNA were found to 
be inefficient to produce adequate quantities of DNA that could drive the efficiency 
of the recombination mediated cloning technique and achieve BAC targeting. For 
this reason restriction based strategies were employed to produce the linear 
targeting DNA for both the recombination cassettes. Although this involved using 
additional cloning steps to generate the linear targeting DNA, this approach at least 
eliminated some of the other concerns previously discussed concerning the use of 
PCR.
Secondly, it was necessary to conduct a primary screen of colonies arising 
from electroporation to distinguish targeted colonies from background non-targeted 
colonies. Most of these background colonies were found to arise from the 
contamination of the targeting fragment, by the plasmid the fragment had been 
derived from. In the case of generating the targeting fragment by PCR, the 
incomplete digestion of the template plasmid by Dpn I caused its persistence. In the 
case of generating the targeting fragment by restriction, the incomplete digestion 
and subsequent inefficient gel purification of the template plasmid caused the 
contamination of the targeting fragment.
A primary screen was therefore employed to distinguish those colonies that 
harboured a BAC in which the linear targeting fragment had targeted, from those in 
which harboured the intact template plasmid, as a result of electroporating a 
contaminated linear targeting DNA.
Thirdly, although a primary screen could have been conducted by PCR, the 
definitive analysis of a targeted event required restriction of the targeted BAC 
DNA. However, in order to perform thorough restriction analysis on targeted 
colonies the recombination plasmid needed to be eliminated from the E. coli cells. 
Since the recombination plasmid exists within the E. coli cell at a high copy 
number, and the BAC as a single copy, preparation of the BAC DNA by the 'Quick 
Prep.' method resulted in a large amount of recombination plasmid DNA included 
in the total DNA preparation. Therefore upon restriction analysis, the bands arising
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from BAG DNA restriction were obscured from view by those arising from the 
recombination plasmid.
Thus, although in principle the recombination mediated cloning technique 
appears straightforward, in practise it was found to be quite tedious. However, on a 
positive note, the disadvantages associated with recombination mediated cloning, of 
undesirable re-arrangements to the target molecule during targeting, was not 
encountered to any great extent here.
Once the BAG was successfully targeted with both recombination cassettes 
it was necessary to determine whether the lox sites could participate in Cre- 
mediated SSR. The in vitro Cre experiment demonstrates that thefloxed selection 
markers could be deleted from the BAG by Cre-mediated SSR and therefore 
retained functionality. In addition, the deletion of the markers with the in vitro 
reaction does not go to completion but reaches a state of equilibrium. This results in 
generating a mixed population of BAG molecules that harbour either excised or 
non-excised versions of either of the bacterial selection markers (see Fig. 4.11). It 
was therefore possible to isolate, by electroporation of Cre recombinase treated 
pBAC14567/TK/3'HPRT, a variety of recombinant BACs that had deleted neither, 
either or both of the selection markers, illustrating further the potential ways in 
which BACs may be variously manipulated (see below).
The other motivation to performing the in vitro Cre analysis on the targeted 
BAC was to observe the tendency for the loxP and Iox511 sites to participate in 
undesirable SSR. No evidence was generated to suggest that the loxP and Iox511 
sites underwent SSR with each other. It was therefore predicted that any 
undesirable SSR that may be taking place, was occurring at such a frequency as to 
be out-competed by the desired SSR reactions between identical lox sites. This was 
encouraging for the success of the proposed large interval RMCE experiment, since 
it suggested that the lox sites in the BAC would preferentially interact with their 
identical sites in the ES cell genome, thereby generating the desired large interval 
RMCE event.
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The ability to identify and recover recombination intermediates from an in 
vitro Cre reaction by replica plating illustrates the potential by which the BAG 
could be manipulated. Specifically with regard to the alpha-globin locus it would be 
possible to flox each of the structural genes sequentially, reporting each targeting 
event with a different antibiotic selection marker, which would be included within 
the floxed region. Upon Cre-mediated deletion of the floxed gene the recombination 
events could be determined by replica plating to report the loss of the selection 
marker. Using this method it would be possible to rapidly isolate BACs with any 
combination of deleted and re-arranged structural genes. Currently it is not possible 
to rapidly generate deletion constructs by such a directed method. The ability to 
then transfer these mutations to an ES cell in vitro system for functional analysis 
would further expediate the study of the alpha-globin locus. For example, the 
mutated ES cell lines could be differentiated along an erythroid lineage (Baird et 
al., 2001) and the effect of mutation on the role of the structural genes during 
erythroid specification and blood island formation determined.
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Chapter 5
LARGE INTERVAL RECOMBINASE MEDIATED
CASSETTE EXCHANGE
5.1 Introduction
Thus far, this thesis has described the production of the components 
necessary to accomplish a large interval RMCE event. Chapter 2 described the 
production of double targeted ES cell lines (CAT lines) and Chapter 3 described the 
experiments that were conducted to test whether the lox sites targeted to the CAT 
lines were functional and in a desired arrangement. The production of a targeted 
BAC and the functional assessment of the lox sites targeted to its cloned insert, 
were described in Chapter 4.
This chapter now describes the results of experiments that brought together 
the CAT ES cell lines and the targeted BAC, in order to achieve large interval 
RMCE. The experiments aimed to mediate a RMCE event of 64 kb, representing 
the exchange of the entire murine alpha-globin locus in ES cells with its equivalent 
locus from a BAC.
Fig. 5.1 illustrates the arrangement of all of the components of the large 
interval RMCE strategy. Additionally, Fig. 5.1 illustrates one of the possible 








































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 5. Id illustrates the reconstruction of the hprt minigene around the loxP site 
in the ES cell genome, concomitant with the generation of the desired RMCE event. As 
illustrated, the reconstructed hprt minigene is flanked on either side byfrt sites, which 
enables its deletion by the transient expression of FLP recombinase in cells with this 
genetic arrangement. The frt sites were included to incorporate flexibility into the 
strategy by enabling HAT selection to be implemented, should it be required, for 
subsequent targeting events. Additionally the removal of the hprt minigene would 
leave just a singleyh and Iox511 site flanking the exchanged interval, thereby reducing 
the chances of disrupting normal gene expression from the locus.
The production of a HATR phenotype is not necessarily indicative of a large 
interval RMCE event, since the integration of the entire BAG via loxP SSR may 
generate a co-integrant structure that would also be HATR (see Fig. 5.1c). It was 
therefore important to be able to distinguish clones that had a co-integrant structure 
from those that had undergone large interval RMCE and this was achieved by 
including an HSVtk gene in the BAG downstream targeting construct. As shown in Fig. 
5.1c, the HSVYA: gene persists in the co-integrant structure, but is deleted (along with 
the original ES cells globin locus) upon SSR between the Iox511 sites, to achieve the 
desired RMCE event and generate clones that are both HATR and ganciclovirR .
In addition to relying on drug resistance phenotypes to identify clones that had 
undergone loxP and Iox511 SSR, Southern blotting strategies were designed to 
determine the genetic arrangement around each of the upstream and downstream target 
sites. The blotting strategies were also designed to detect the presence of co-integrant 
structures. This was done to verify that the drug resistance phenotypes of the clones 
accurately represented the genetic arrangement they predicted.
To achieve a large interval RMCE event loxP SSR need not be the initial SSR 
































































































































































































































































































































































































































































































































































































































































































































































































































































As mentioned above, SSR around both the loxP and Iox511 sites were required 
to generate the desired RMCE event. However, as shown in Figs. 5.1 and 5.2, SSR 
between Iox511 sites to resolve a co-integrant structure may only occur if the sites 
become located on the same chromosome, which was predicted to occur for in cis 
targeted lines alone. In contrast, the integration of the BAG via SSR of loxP sites to an 
in trans line should not to locate the Iox511 site on the same chromosome. This is 
because, for the in trans lines, the loxP and Iox511 sites were targeted to the alternate 
chromosomes. Therefore, integration of the BAG via loxP SSR into an in trans line, 
positions the Iox511 site from the BAG on the alternate chromosome to the Iox511 site 
originally targeted to the ES cell chromosome. The prediction was that SSR between 
Iox511 sites from in trans generated HATR clones would not to resolve the co-integrant 
structure created by an initial loxP SSR event. If this prediction holds, then the 
occurrence of co-integrant structures from in trans generated HATR clones would be 
more likely than from in cis HATR clones.
Furthermore, the persistence of Cre activity in an in trans generated HATR co- 
integrant clone could equally drive SSR between the loxP sites and thereby cause the 
excision of the integrated BAG (see Fig. 5.2). It was therefore predicted that the 
generation of HATR clones from in trans lines would have the characteristics of an 
integration-excision system, similar to those SSR systems that rely on the insertion of a 
circular molecule into a target site by a single SSR event between a pair of compatible 
sites (Sauer and Henderson, 1990). It has been proposed the main factor reducing the 
efficiency of single site integration systems compared with RMCE systems, is the 
equal probability of the integrative and excisive SSR reaction occurring (Bethke and 
Sauer, 1997). The recovery of HATR clones from the in trans targeted line was 
therefore predicted to be lower than for the in cis line. By comparing the efficiencies of 
generating HAT resistant clones from the in cis and in trans targeted lines it was 
therefore anticipated that the dynamics of large interval RMCE may be better 
understood.
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The targeting of ES cells to generate lines that could participate in the large 
interval RMCE event generated lines that had targeted either in cis or in trans (see 
Chapter 3). In order to test the strategy for large interval RMCE event the CAT-B3 
line, which was assigned as targeted in cis, was selected. In parallel, it was decided to 
perform the equivalent experiment in the CAT-C10 line, which had been putatively 
assigned as targeted in trans. Although the CAT-C10 clone had generated data which 
conflicted with its in trans assignment (see Chapter 3), it was still chosen since the I 
See I restriction analysis had been clearly suggestive of an in trans targeted line and the 
other conflicting results were not conclusive in their challenge of this assignment.
To determine the outcome of SSR events the HATR clones that were generated 
from the CAT-B3 and CAT-C10 lines were profiled for their drug resistance 
phenotypes and then Southern blot analysis performed on their DNA.
5.2 Experimental Outline
Cre-mediated SSR was conducted in cell lines previously established as 
targeted either in cis or in trans, as described in Chapter 3. The in cis line chosen for 
further study was CAT-B3 and the in trans line CAT-C10. For each cell line 2 x 108 
cells were electroporated with either 50 ug or 100 ug of BAG DNA and in each case 
with 50 ug of the Cre expression plasmid, CP#99.
Following electroporation cells were plated and cultured for 24 hours, viable 
cells were then counted and plated at densities of 5 xlO7 or 1 xlO7 and HAT selection 
added to the culture media. In addition, 2 plates with 1 xlO7 cells had blasticidin 
instead of HAT added to the culture media. The blasticidin selection marker in the 
BAG is floxed, it was predicted that this marker would be deleted with efficiency 
should the BAG encounter Cre recombinase activity. Therefore, the plates with 
blasticidin selection alone represent the frequency with which cells have incorporated 
the BAG in the absence of Cre recombinase. Additionally, the resultant blasticidinR 
clones were analysed by Southern blot to determine whether the BAG targets the alpha-
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globin locus by homologous recombination (in the absence of Cre) or whether it 
integrates at random into the ES cell genome by illegitimate recombination.
After 5 days in selection colonies appeared and 20 days after electroporation 
colonies were picked into a 96 well plate. The clone numbers for each experiment are 
shown in Fig. 5.3.
Cells were cultured for a further 3 days and then split 1:3 into fresh 96 well 
plates. One of the three plates was frozen immediately, another was cultured to perform 
the drug resistance profiling and the cells of the remaining plate used for DNA 
preparation. The clones in the plate designated for drug resistance profiling were 
cultured to an adequate density before being split by replica plating into six 96 well 
plates. The culture media in each replica plate was supplemented with various drug 
selections and resistance was scored after a time interval appropriate to the selection in 
question, as recorded in Fig. 5.4.
Following the determination of the drug resistance profile for each clone, the 
genomic arrangement around the hprt minigene was investigated by Southern blot 
analysis. All of the viable clones underwent a primary screen for reconstruction with 
the UpRP, which detects fragments that are indicative of hprt minigene reconstruction, 
as detailed in Fig. 5.5. The results of the Southern blot analysis for clones generated 
from the CAT-B3 line are shown in Fig. 5.6 and for the CAT-C10 in Fig. 5.7. A 
number of clones were then selected for further characterization by Southern blot 
analysis.
The arrangement of the region external to the exchanged interval, that is 
upstream of the loxP site, was determined by Southern blot for a selected number of 
clones and the results of these analyses are shown in Fig. 5.8.
The predicted deletion of the hygromycin selection marker to leave a single 
Iox511 site and absence of the HSV/& gene downstream of the Iox511 site and the 
globin structural genes, was determined by flanking probes internal and external to the
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Fig. 5.3 A table of the number of HAT resistant clones from each transfection
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Fig. 5.4 records the drug resistance phenotypes for clones derived from the electroporation of 
pBAC14567/TK/3'HPRT into either the CAT-B3 or CAT-CIO double-targeted ES cell lines. 
Abbreviations: G418 = G418; Hyg. = hygromycin; Bsd. = blasticidin; Ganc. = ganciclovir; HAT = HAT. 
All of the clones were selected primarily in HAT supplemented media, with the exception of those 
marked with (*), which were selected in blasticidin supplemented media (clone Fl from the CAT-B3 
line and clones DIO, Dl 1 and D12 from the CAT-CIO line). S denotes that the clone was sensitive to the 
selection, whilst R indicates that the clone is resistant. Some of the clones gave ambiguous results and 
are annotated with R ?, which signifies that most of the cells were sensitive, but that a small number 
continued to grow in the drug supplemented media.
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exchange, as outlined in Fig. 5.9. The results of the analysis on selected CAT-B3 and 
CAT-C10 derived clones of the DnRP are shown in Fig. 5.10.
The reconstruction of the hprt minigene was further investigated by screening a 
selected number of clones with a 3'hprt probe internal to the reconstructed minigene 
(gift from Melville Richardson), the results are shown in Fig. 5.1 la. The same selected 
clones were then screened using a neomycin probe (gift from Stephen Meek), which 
was the same probe used to detect the I See I fragment on the PFGE blot to assign in 
cis and in tram targeting (see section 3.2.1). The results of this analysis are also shown 
in Fig. 5.1 Ib. For both of these analyses the position of the probes and restriction sites 
are illustrated in Fig. 5.5 (as above). Finally, Fig. 5. lib shows the results of the DnLP 
hybridisation of clones generated from the CAT-B3 and CAT-C10 lines, whose DNA 
was Kpn I restricted (see Fig. 5.9 for predicted fragment sizes).
5.3 Analysis of the efficiency with which HATR clones were generated from the 
CAT-B3 and CAT-C10 lines
It was predicted that the efficiency of generating HATR clones from the CAT- 
63 would be significantly higher than for the CAT-C10 line (see section 5.1). 
However, the data presented in Fig. 5.3 suggest that in fact, HATR clones are generated 
with greater frequency from the CAT-C10 line. Although these figures represent just 
two experiments (one with 50 ug of BAG DNA and one with 100 jug) in each case the 
frequency of generating HATR clones from the CAT-C10 line was higher. Clearly, this 
is contrary to prediction and to the reports of comparisons of RMCE with single lox 
site strategies, with intervals of less than 10 kb.
It was noted however, that the CAT-B3 line shows an increase in the generation 
of HATR colonies when 100 |ug of BAC DNA is used compared with 50 ug. In 
contrast, the CAT -CIO line does not demonstrate the same increase in the frequency of 
HATR clones. This may suggest that the SSR events in the CAT-C10 line have reached 
an optimum level for generating HATR clones, whilst the frequency of generating
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HATR clones from the CAT-B3 line could be further increased, possibly by the 
introduction of more BAG DNA or by increasing the efficiency with which the BAG is 
delivered to the ES cells. This is consistent with the observations of 
integration/excision systems that reach an optimum level of integrated product due to 
the competing reverse excision reaction, compared with the dynamics of an RMCE 
system for which the reverse reaction is thought to be negligible (Bethke and Sauer, 
1997) (refer back to sections 3.4.1 and 5.1). However, in order to verify this tentative 
hypothesis the ES cells would have to be electroporated with quantities of BAG DNA 
in excess of 100 ug. The introduction of such quantities of DNA by electroporation 
may be detrimental to cell survival and therefore make this line of investigation 
impractical.
The blasticidin resistant clones were generated from each line with an average 
frequency of 1 x 10"7 and 1.5 x 10"7 , for the CAT-B3 and CAT-C10 lines respectively.
5.4 Analysis on the drug resistance phenotypes of clones generated from the CAT- 
B3 and CAT-C10 lines
The predicted outcome of SSR between pBAC14567/TK/3'HPRT and the in cis 
targeted CAT-B3 line was that RMCE would occur and for the in trans line, which was 
CAT-C10, the generation of a co-integrant would persist (see Fig. 5.2). Before 
Southern blotting was performed on the clones generated from the CAT-B3 and CAT- 
C10 lines it was anticipated that their genetic arrangement could be predicted from 
their drug resistance profiles. Fig. 5.4 records the drug resistance phenotypes from the 
HATR and blasticidinR clones generated from each line.
As predicted in Fig. 5.2, following RMCE the predicted drug resistance 
phenotype for the CAT-B3 generated clones was: HATR; ganciclovirR ; blasticidin8 ; 
G418S and hygromycin8 . As Fig. 5.4 records, almost 100% of the HATR clones from 
the CAT-B3 line gave the predicted drug resistance phenotype (with the exception of
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clone C4, for which sensitivity to blasticidin was not absolute). This initial observation 
suggested that the large interval RMCE had been achieved.
Assuming that a co-integrant forms (see Fig. 5.2), the predicted drug 
resistance phenotype for the CAT-C10 generated clones was: HATR; ganciclovir5 ; 
blasticidin8 ; G418R and hygromycin5 . As Fig. 5.4 shows, the status of blasticidin 
resistance for some of the clones was not established (no data). However, with respect 
to the other clones and markers, all of the clones demonstrate the predicted sensitivity 
to hygromycin and blasticidin.
The generation of co-integrant structures from the CAT-C10 line predicts that 
the HSVM: gene would be introduced to the genome following SSR via the loxP or 
Iox511 sites to integrate the entire BAG (see Fig. 5.2). Furthermore, the neomycin gene 
would be retained in co-integrant structures. It was therefore unexpected that the clones 
generated from the CAT-C10 line were all sensitive to G418 selection and furthermore 
that the majority were also resistant to ganciclovir selection (except clones C6, C7 and 
D2, which although not obviously ganciclovir resistant, did show some cell death and 
may therefore represent co-integrant clones). The resistance phenotypes for the CAT- 
C10 clones were obviously contradictory to the predicted results, however it was 
anticipated that Southern blot analysis would clarify the genetic arrangement with 
respect to this line.
The blasticidin resistant clones generated from each line were all resistant to 
blasticidin and sensitive to HAT, which is consistent with the prediction that these 
clones represent the random integration of the BAG. Clone Fl, which was generated 
from the CAT-B3 line was resistant to all the other selections, which would indicate 
that Cre has not been active in this clone, since the floxed hygromycin and blasticidin 
genes would most likely be deleted if Cre had been present. Clone Fl can be most 
readily explained by a random integration event that involved parts of the BAG, but not 
including the HSV/Vt gene. Clone Dll from the CAT-C10 line has an equivalent 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































D10 and D12 show sensitivity to hygromycin, which indicates that these clones have 
undergone Cre-mediated SSR. It was concluded however that an accurate idea of the 
genetic arrangement of these clones would only be possible by Southern blotting.
5.5 Southern blot analysis of clones derived from electroporation of CAT-B3 and 
CAT-C10 with pBAC14567/TK/3'HPRT
The southern blot analysis, on the clones generated from the CAT-B3 and CAT- 
C10 lines, had the following aims: to test whether reconstruction of the hprt minigene 
had occurred around the loxP site; to determine whether the hygromycin selection 
marker had been deleted between the Iox511 sites; to determine whether the regions 
outwith the exchanged interval were intact, both upstream and downstream; and to 
determine whether there was any evidence for co-integrant structures from either line, 
but most significantly from the CAT-C10 in trans line.
5.5.1 The initial screen for the desired recombinants
The initial Southern blot screen of the clones generated from the CAT-B3 and 
CAT-C10 lines was with UpRP, which is a probe that hybridises with alpha-globin 
sequences and that is internal to the exchange interval (see Fig. 5.5). It was anticipated 
that this screen would not only indicate whether the hprt minigene had been 
reconstructed but also provide evidence for co-integrant structures.
As shown in Fig. 5.5 the 10.4 kb Hindlll fragment from the upstream target site 
decreased to 5.6 kb following the reconstruction of the hprt minigene, therefore the 
absence of the 10.4 kb fragment and the presence of the 5.6 kb fragment were taken to 
be indicative of the reconstructed hprt gene. Additionally, if a co-integrant structure 
were to be present the UpRP should detect a 13kb fragment spanning the neomycin 
gene, as shown in Fig. 5.5d.
The results from the CAT-B3 line (see Fig. 5.6) demonstrate that 44 out of 47 
of the HATR clones gave the predicted fragment sizes that are consistent with 
reconstruction of the hprt minigene. The blasticidinR clone CAT-B3/F1 also indicates
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the presence of an 5.6 kb fragment, which is thought to arise from the randomly 
integrated BAG sequences and the 10.4 kb band from the upstream target site that has 
not undergone SSR. These results for the Fl clone are further consistent with its 
assignment as a random integrant clone.
The results from the CAT-C10 line (see Fig. 5.7) demonstrate that 13 out of 15 
HAT clones tested generate Southern blot data that are consistent with the 
reconstruction of the hprt minigene. However, just one clone, CAT-C10/D2, generated 
a fragment that would suggest that this clone represents a co-integrant. This result for 
CAT-C10/D2 is consistent with its drug resistance phenotype (see Fig. 5.4). If this 
clone does indeed represent a co-integrant the HSVM: gene should be present and 
thereby cause ganciclovir sensitivity and although the majority of the cells for the D2 
line were sensitive, a small number were found to be persistently viable.
The CAT-C10/D11 blasticidinR clone, which gave a similar drug resistance 
phenotype to the CAT-B3/F1 clone, also generates equivalent Southern blot data to the 
CAT-B3/F1 clone, which further confirms that these two clones represent equivalent 
random integrant events.
The other two blasticidinR clones, CAT-C10/D10 and CAT-C10/D12 gave 
unusual Southern blot data: both clones generate a fragment of about 9 kb, which can 
not be explained and whereas clone CAT-C10/D10 demonstrates the presence of the 
5.6 kb fragment that arises from randomly integrated BAG sequences, clone CAT- 
C10/D12 does not. These results can not be explained at this time.
It was anticipated that not all the HATR clones generated from the CAT-B3 and 
CAT-C10 line would generate the predicted results from Southern blot analysis, due to 
the usual occurrence of anomalous results that are experienced with any genetic 
manipulation experiment. However, the fact that the majority of the CAT-B3 generated 
clones did generate the anticipated fragment sizes was indicative that these clones 
probably harboured the predicted and desired genetic arrangement.
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5.5.2 Checking the integrity of the genome outwith the RMCE interval
To verify that the region upstream of the reconstructed hprt minigene was intact 
a selected number of clones were restricted with Sac I and then probed with UpLP. The 
fragments that should result are illustrated in Fig. 5.5. The Sac I sites that generate the 
fragment to which UpLP hybridises are outwith the RMCE interval and so the 
Southern blot data for all of the clones should remain unchanged from the original 
double targeted clones. Therefore a fragment of 5.2 kb was expected from the 
untargeted chromosome and 6.5 kb from the targeted chromosome. The data in Fig. 5.8 
demonstrate that all of the clones screened demonstrate these expected fragments and 
are therefore consistent with the region upstream of the exchanged interval being 
intact.
Similarly, in order to verify that the region downstream of the interval outwith 
the Iox511 site was intact, the same clones were investigated using a southern blot 
analysis described in Fig. 5.9, with the DnRP. According to Fig. 5.9, the floxed 
hygromycin gene is deleted during the desired large interval RMCE event. There is 
however no concomitant change in fragment size since the BamHl sites that border the 
Iox511 site persist. Therefore the predicted BamHl fragments sizes are -10 kb for the 
untargeted locus, ~7.3 kb for the targeted locus and following deletion of the 
hygromycin, the persistence of the same ~7.3 kb fragment (in addition to the fragment 
that arises from the untargeted chromosome). Fig. 5.10 demonstrates that the region 
downstream of the Iox511 site has the predicted genetic arrangement for all of the 
HATR clones tested.
Unusually, this probe does not detect fragments arising from the random 
integration of the BAG for the blasticidinR clones. However, since all of the 
blasticidinR clones were ganciclvovirR (see Fig. 5.4), this result is consistent with their 
drug resistance phenotype, which suggests that the BAG has randomly integrated but 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































5.5.3 Reconstruction of the hprt minigene
Thus far, analysis with the UpRP around the loxP site was consistent with the 
reconstruction of the hprt minigene, however to further confirm that this was the case 
and that the 5.6 kb band was not generated by sequences from a randomly integrated 
BAG, selected clones were digested with BamRl and hybridised with a probe 
complementary to the 3' region of the reconstructed hprt minigene. As the data in Fig. 
5.1 la show, fragments generated by clones A1, A3, BIO and Bll from CAT-B3 line 
and clones A7 and A8 from CAT-C10 line confirmed that reconstruction of the hprt 
minigene had indeed occurred.
This analysis also generated data that were consistent with previous results 
obtained for the CAT-B3/F1 and CAT-C10/D11 clones, which are believed to harbour 
equivalent random integrations of the BAG. The reconstruction of the hprt minigene 
was therefore, as predicted, not evident for these clones. The CAT-C10/D10, which
o
was also selected in blasticidin and was HAT , also generated data that were consistent 
with it being a random integrant clone from this analysis.
5.5.4 Southern blot analysis to establish evidence of co-integrant structures
To further establish whether the CAT-C10/D2 clone did harbour a co-integrant 
structure, the same clones that were analysed for reconstruction of the hprt minigene 
with the 3'hprt probe, were restricted with Hindill and hybridised with the neomycin 
probe. As shown in Fig. 5.5, this probe should have hybridised with a 10.4 kb fragment 
from the chromosome targeted with thefrt/l See I/5'hprt//0jt/Vneomycin construct and 
with a fragment of 13 kb if a co-integrant structure was present. Clones that 
demonstrate the presence of the 10.4 kb fragment are: the control CAT-B3 double- 
targeted line and CAT-B3/F1 and CAT-C10/D11.
The presence of the 10.4 kb fragment for clones Fl and Dll is further 
verification of these clones as random integrants, it was surprising therefore that the 
D10 clone did not generate the same fragment.
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Fig. 5.11 Southern blot analysis on selected clones generated from the CAT-B3 and 
CAT-C10 lines, with 3'hprt probe, neomycin probe and DnLP
Fig. 5.11 shows the Southern blot analysis on selected clones generated from both the CAT-B3 and CAT- 
C10 lines. WT denotes E14Tg2a genomic DNA and the other control DNA was from the CAT-B3 
double-targeted ES cell line. The CAT-B3 generated clones Al, A3, BIO, and Bl 1 were HATR and gave 
results consistent with the reconstruction of the hprt minigene (see Figs. 5.6 and 5.8). The CAT-B3 
generated Fl clone was blasticidinR and was proposed to represent the random integration of 
pBAC14567/TK/3'HPRT in the absence of Cre. The CAT-C10 derived clones A7, A7 and D2 were all 
HATR , however clone D2 generated a fragment that suggested that this clone represented a co-integrant 
clone (see Fig. 5.7). The CAT-C10 derived clones DIG and Dll were blasticidinR and are proposed to 
represent the random integration of pBAC14567/TK/3'HPRT in the absence of Cre. Fig. 5.1 la shows the 
hybridisation of BamHl restricted genomic DNA hybridised with the 3'hprt probe (gift from Melville 
Richardson). A 6.3 kb fragment indicates reconstruction of the hprt minigene, which is evident for clones 
Al, A3, BIO and Bl 1 generated from CAT-B3 and clones A7, A8, and D2 for the CAT-C10 generated 
clones. Fig. 5.lib shows the hybridisation of Hindlll restricted genomic DNA hybridised with the 
neomycin probe (gift from Stephen Meek). This probe should hybridise with a 10.4 kb fragment from the 
chromosome targeted wither//! See I/5'hprt//oArP/neomycin and with a fragment of 13 kb if a co-integrant 
structure is present. Clones that demonstrate the presence of the 10.4 kb fragment are: the control CAT- 
83 double-targeted line and clones Fl and Dll. No clones demonstrate the presence of the 13 kb 
fragment. Fig. 5.1 Ic shows the hybridisation of Kpn\ restricted genomic DNA hybridised with the DnLP. 
Fig. 5.9 predicts that the targeted fragment of 8.1 kb should be reduced to 6.5 kb following deletion of the 
hygromycin marker, as evident for all of the CAT-B3 HATR clones. The CAT-B3/F1 clone indicates the 
presence of an 8.1 kb fragment, which is consistent with its assignment as a random integrant clone. The 
CAT-C10 clones A7 and A8 show fragments consistent with the deletion of the hygromycin gene. The 
CAT-C10 clone D2 shows the presence of an additional fragment, which may be the 7.1 kb fragment that 
arises from the Kpn I fragment caused by the presence of the HSV/Jt gene in a co-integrant structure. This 
result is in accordance with that in Fig. 5.7, for which the CAT-C 10/D2 clone indicates the presence of a 
13 kb band with UpRP, which is also indicative of a co-integrant structure. The CAT-C 10 blasticidin 
resistant clones should give identical fragment sizes to the CAT-B3 double-targeted line, however only 
clone Dll gives this result, clone D10 appears to have deleted the hygromycin gene. In addition the 
DnLP probe is detecting a background fragment, that appears to be about 15 kb and is present in all the 
lanes, including the controls.
Fig. 5.11 Southern blot analysis on selected clones generated from the CAT-B3 
and CAT-C10 lines, with 3'hprt probe, neomycin probe and DnLP
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None of the clones demonstrated the presence of the 13 kb fragment. Most 
surprising was the result for the CAT-C10/D2 clone, which was indicated as 
harbouring a co-integrant from data in Fig. 5.7. This result suggests that either CAT- 
C10/D2 is not a co-integrant or that the neomycin gene has somehow been deleted, 
which would be consistent with this clone being G418S .
The final analysis that was undertaken to try to establish whether co-integrant 
structures had been generated was to restrict genomic DNA with Kpn I and hybridise 
with the DnLP. Fig. 5.9 predicts that a fragment of 8.1 kb arising from the downstream 
target site should be reduced to 6.5 kb following deletion of the hygromycin gene. 
Additionally, this probe recognises a 7.1 kb fragment should a co-integrant occur and 
indicates the presence of the HSVM: gene. The CAT-B3 generated clones A1, A3, BIO 
and Bl 1 all demonstrate the absence of the 8.1 kb fragment and the presence of the 6.5 
kb fragment alone, which is consistent with the deletion of the hygromycin gene. The 
CAT-C10 generated clones A7 and A8, also show equivalent fragments that are 
consistent with the deletion of the hygromycin gene.
The CAT-C10/D2 clone that was initially predicted to be a co-integrant shows 
the presence of an additional fragment, which may be the 7.1 kb fragment that is 
indicative of a co-integrant structure. This result is in accordance with that in Fig. 5.7, 
for which the CAT-C10/D2 clone indicates the presence of a 13 kb band with UpRP, 
which is also indicative of a co-integrant structure. However this result conflicts with 
the results from the analysis with the neomycin probe, therefore CAT-C 10/D2 can not 
be definitively established to represent a co-integrant structure.
The blasticidinR clones CAT-B3/F1 and CAT-C 10/D11 again generate data that 
are in accordance with the data in Fig. 5.8 and their resistance profiles. The data 
generated here for these two clones would further suggest that the HSVtk gene appears 
to be absent from the randomly integrated BAG sequence, since a fragment of 7.1 kb is 
not detected in these clones.
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Clone CAT-B3/D10 appears to have deleted the hygromycin gene, which is 
consistent with its resistance phenotype.
The DnLP probe appears to detect a fragment of about 15 kb, however since 
this is present in each line, including the controls, it is presumed to be background and 
therefore not informative of the genetic arrangement of the clones.
5.6 Summary
The analyses on the HATR clones generated from the CAT-B3 in cis targeted 
line gave results that were consistent with the achievement of large interval RMCE in 
these clones.
The generation of blasticidin resistant clones are indicative that the BAG DNA 
will undergo random integration into the ES cell genome and this event is thought to 
occur if Cre recombinase activity is low or absent from these lines, as determined by 
the persistence of floxed selection genes in these clones.
The confidence of achieving the large interval RMCE would be strengthened 
had the CAT-C10 clone generated data that were consistent with the predicted 
generation of co-integrant structures from this line. However, all of the HATR clones 
generated from the CAT-C10 line appear to have deleted the neomycin gene and 
furthermore most do not indicate the presence of the HSVtk gene (except CAT- 
C10/D2), which is contradictory to the predicted co-integrant structure that should 
result for this line, but consistent with the CAT-C10 line being targeted in cis.
The analysis of the CAT-C10 clone, as described in Chapter 3, was not 
conclusive in establishing this clone as targeted in trans and this could explain the 
anomalous results obtained from this line in this chapter. Alternatively, it is possible 
that the CAT-C10 line is a genuine in trans line but events other than SSR, such as 
homologous recombination are occurring to give rise to the anomalous results for this
line.
If SSR and homologous recombination are occurring within the CAT-C10 line, 
it is plausible that these events would also occur in the CAT-B3 line. Therefore, 
Chapter 6 discusses the possibility for a combination of homologous recombination
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and SSR events to occur during large interval RMCE experiments and the effects that 





The aim of the experiments described within this thesis, were to test whether a 
strategy that employs the rationale of RMCE could be applied to the study of whole 
genes, gene clusters and large gene loci. To this end, the application of RMCE with 
larger intervals than previously reported, required demonstration.
The alpha-globin locus was chosen as an example of a locus spanning a 
genomic region of tens of kilobases, since the exchange of an interval of this size 
should be representative of technology that may be applied to encompass the average 
gene locus (Lander et al., 2001; Venter et al., 2001). In addition, the exchanged interval 
includes structural and regulatory sequences, whose co-ordinated interaction provides a 
highly informative model to further study mechanisms of gene-regulation.
The Southern blot analysis, presented in the Chapter 5, sought to determine 
whether the genetic arrangement at each end of the exchanged interval was consistent 
with the arrangement of a locus that had undergone the predicted SSR events. For the 
in cis line tested (CAT-B3) this was anticipated to be a Cre-mediated large interval 
RMCE event. The data gathered from the HATR clones generated from the CAT-B3 (in 
cis} line are consistent with the achievement of the large interval RMCE event in these 
clones, on three points.
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First, the reconstruction of the hprt minigene was definitively established, 
which was absolutely dependent on the SSR between the loxP site in the BAG and the 
loxP site targeted to the ES cell chromosome upstream of the locus.
Second, following the reconstruction of the hprt minigene, it was predicted that 
the entire BAG molecule would be integrated to the ES cell chromosome. However, the 
absence of both the HSVtk gene and the hygromycin gene from the CAT-B3 generated 
HAT clones would suggest that SSR around the Iox511 has occurred to resolve this 
structure and cause the large interval RMCE event.
Thirdly, if large interval RMCE has occurred the HATR clones should not 
harbour the neomycin gene and this was also established by resistance profiling and 
Southern blotting.
Alternative interpretations of the data are possible and would be consistent with 
data gathered thus far reflecting alternative recombination events, other than SSR to 
generate RMCE proposed thus far. These events are discussed later in section 6.3.
However, this chapter first describes the analysis that would be performed to 
determine that the entire interval that has been exchanged intact, this analysis is 
particularly relevant to the application of large interval RMCE, for example to 
introduce mutations within the exchanged interval.
6.2 Characterisation of the exchanged interval
The exchange described within this thesis was mediated between an ES cell line 
and a BAG harbouring an isogenic cloned DNA insert. It was therefore impossible by 
restriction site polymorphisms between the two molecules to determine whether the 
interval in the BAG had exchanged into the interval of the ES cell intact.
Another strategy to characterise the exchanged interval would take advantage of 
the fact that the BAG and ES cell interval were identical by determining that the 
interval following SSR events was unchanged. This could be achieved by designing ten
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to twenty overlapping long range PCR amplifications of 5 to 10 kb, throughout the 
interval. The results of this analysis on the HATR clones generated from the CAT-B3 
line and controls of untargeted ES cell and BAG DNA would be predicted to 
demonstrate that each generates the same size PCR products. This analysis would 
therefore be able to determine any re-arrangements made to the interval of 500 bp or 
more but would not be useful to definitively determine re-arrangements smaller than 
this.
In order to establish whether the strategy developed within this thesis is useful 
to facilitate the mutational analysis of large genomic regions (as intended) the 
definitive experiment would be to introduce mutations to the BAG interval and then 
determine whether all of the intended mutations had been delivered by PCR or 
Southern blotting techniques. In addition, this experiment would establish whether the 
intact interval had been exchanged.
Alternatively, a BAG that contained non-isogenic DNA could be used to 
mediate the exchange and H. Wallace is currently undertaking this experiment. The 
experiment involves exchanging the human alpha-globin sequence from a BAG into 
the alpha-globin ES cell locus. This experiment thereby provides human specific 
restriction fragment length polymorphisms and human specific PCR primer sites that 
can be used to characterise the interval that is anticipated to undergo exchange,
6.3 The effects of undesirable recombination on large interval RMCE
The introduction of the BAG to ES cells could produce a variety of genomic re­ 
arrangements: alone or combined, homologous recombination (HR), illegitimate 
recombination (IR) and SSR of one, or more, BACs introduced to the ES cell could 
generate these genomic re-arrangements.
The BAG vector used to deliver the exchanged interval has, due to its cloned 
insert, a large region of homology with the alpha-globin loci of the ES cell genome. 
The possibility that this homology could mediate HR between the BAG and ES cell
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genome therefore requires consideration. Moreover, the propensity for HR, or IR, to 
occur in combination with SSR needs exploring, since the outcome of these events may 
be highly detrimental to the efficiency and application of this strategy.
In order to isolate RMCE events a selection strategy that reconstructs the hprt 
minigene and excludes the HSVtk gene was therefore implemented. In addition, 
following clonal selection, Southern blot analysis further elucidated the genetic 
arrangement of HAT resistant (HATR) clones.
The isolation of HATR clones is absolutely dependent on the reconstruction of 
the hprt minigene, which in turn implicates a SSR event around the loxP sites. As 
proposed in the previous chapter, the reaction may proceed via the production of a co- 
integrant structure, which may have then resolved by a second SSR event. However the 
possibility exists that the HATR clones may be generated by alternate recombination 
events. Briefly, HATR clones may theoretically be generated by a combination IR 
followed by SSR (see Fig. 6.1) or by a combination of HR either preceding or 
following SSR (see Fig. 6.2). The subsequent drug resistance profiling and Southern 
blot analysis of HATR clones was therefore performed in an order to identify whether 
the HATR phenotype represents the desired RMCE event.
6.3.1 Genetic arrangements arising from IR followed by SSR
The production of HATR clones from in cis targeted lines, by the integration of 
the BAG to a random genomic location by IR followed by SSR is shown in Fig. 6.1. As 
illustrated, reconstruction of the hprt minigene and deletion of the HSVY& selection 
marker occur, events that are also outcomes of the desired RMCE event. Therefore, by 
Southern blot analysis alone it is not possible to distinguish RMCE from IR followed 
by SSR. However, following RMCE the lox sites are predicted to remain in cis, 
whereas for IR followed by SSR the lox sites become positioned in irons. In order 
therefore to exclude clones with a HATR phenotype generated by IR followed by SSR, 
two analyses could be performed: the in cis or in trans arrangement of the lox sites 
could be determined by performing PFGE, followed by Southern blot analysis; or FISH
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Fig. 6.1 Proposed model to generate HATR clones from in cis targeted ES cell lines 
by illegitimate recombination followed by SSR
The diagram illustrates the production of HATR clones by integration of the BAG to a random genomic 
location by IR, followed by resolution by SSR to produce a genomic arrangement that would appear to be 




































































































































































































































































































































































































































































































































































































































































analysis could determine whether alpha-globin sequences were properly restricted in 
their location to chromosomes 11.
To advocate the mechanism described above as a probable means to achieve 
HAT clones it is necessary to consider the efficiency of each of the recombination 
events proposed to occur, those of IR and SSR. In order to integrate the BAG to a 
random genomic location, IR must be proceeding with a higher efficiency than that of 
SSR. IR may be more efficient due to an absence of Cre recombinase or a high level of 
IR activity within the cell. Although in order to then reconstruct the hprt minigene, the 
level of Cre recombinase must be competent to mediate an inter-chromosomal SSR and 
further, a deletion of approximately 60 kb to remove the USVtk marker. It seems 
unlikely that such a level of Cre recombinase that would produce inter-chromosomal 
SSR and deletion would be permissive of an initial IR to integrate the BAG at random. 
However, without further investigation this mechanism can not be excluded as a means 
to generate HATR clones.
6.3.2 Genetic arrangements arising from a combination of SSR and HR
The desired production of HATR clones by RMCE is described in the previous 
chapter (Chapter 5, Fig. 5.1). However, the possibility of generating HATR clones from 
a combination of HR either preceding or following SSR, as described in Fig. 6.2, 
requires consideration. Fig. 6.2 shows that HR combined with SSR could generate 
HATR clones and would result in the partial exchange of thefloxed locus. The Southern 
blot data around the reconstructed hprt minigene and Iox511 site would appear identical 
to data generated by the desired RMCE event and furthermore, PFGE could not be 
used in this instance to distinguish these events.
In effect, the locus that would result from HR combined with SSR would only 
be partially contributed to by sequences from the BACfloxed interval, the remainder of 
the locus being derived from the original ES cell locus. Further, the extent of the BAG 
locus that is delivered could not be specified since the position of the HR cross-over
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can not be controlled. Clearly this hinders the application of the strategy since 
extensive screening would be required to determine the extent of the exchanged region. 
The following section discusses the likelihood of HR occurring. However the definitive 
experiment that would establish whether this is the case has already been described in 
section 6.2.
6.3.3 Conditions under which the BAC could participate in HR
In order to assess whether the BAC may participate in HR it is necessary to first 
discuss conditions under which HR has been demonstrated to occur. As discussed in 
Chapter 1, HR integrates gene-targeting vectors to their target sequence by virtue of the 
sequence homology to the target within the vector.
An obvious difference between the BAC DNA used here and gene-targeting 
vectors is that the latter is linearised as a course of most targeting protocols. 
Linearisation introduces double-strand break termini to the DNA molecule and these 
are thought to promote HR.
It would seem logical therefore to assume that since the BAC is electroporated 
into the ES cells as a super-coiled circular molecule, without breaks, that the possibility 
for HR to occur would be greatly reduced. The integration of the circular BAC by HR 
to the alpha-globin locus could be predicted therefore to be unlikely. Further, the 
efficiency of SSR may diminish the occurrence of a low level of HR by being a more 
efficient event.
It remains however to establish whether HR with circular molecules, of BAC 
size and homology, could occur with frequency. In addition, the incidence of double- 
strand breaks to the BAC during the experimental procedure may further increase its 
ability to participate in HR and these points are addressed below.
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Fig. 6.2 A diagram to illustrate the generation of HATR clones by the combined 
events of SSR and homologous recombination with in cis targeted ES cell lines
The diagram illustrates the production of HATR clones by a combination of HR and SSR between the 
BAG and ES cell DNA, which have been engineered to generate a RMCE event. As illustrated, the 
combination of HR and SSR in any order results in the partial exchange of the RMCE interval. Although 
the HR and SSR events are shown for an in cis line, the equivalent events could occur in an intrans line 



































































































































































































































































































































































































































6.3.4 The effects of BAC linearisation due to experimental procedure
Following the rationale applied to gene-targeting vectors, the introduction of 
double-strand breaks to the BAC could be predicted to greatly increase its propensity 
for HR. The possibility that double-strand breaks could be introduced to the BAC 
within the course of experimental procedure therefore requires consideration. The BAC 
is electroporated into ES cells as a supercoiled, circular molecule. The rationale behind 
this method being that the super-coiled form is the most compacted form of DNA, 
thereby facilitating its entry through pores created in the cell membrane by 
electroporation. Breaks are known to occur in large DNA molecules due to shearing 
forces, for example as experienced during microinjection or DNA preparation (Chen et 
al., 1994; Gnirke et al., 1993; Schedl et al, 1993). However the electroporation 
procedure does not create shearing forces and so it seems unlikely that DNA breakage 
could occur by this method.
However should a break occur by electroporation or other means, it would be 
most effective to promote HR if present within the genomic cloned insert, or at its 
termini. Since the genomic insert makes up 85 % of the entire BAC molecule the 
probability of a random double-strand break occurring within this region could be 
predicted to be high. BACs with such double-strand breaks could be predicted to target 
the alpha-globin locus with high efficiency due to the size of the homology and this 
event is described in Fig. 6.2a.
In the scenario that random double-strand breaks do occur with frequency, due 
to experimental procedure, then following targeting of the alpha-globin locus with the 
BAC by HR, SSR should occur with efficiency to reconstruct the hprt minigene and 
generate HATR . Therefore the frequency with which HATR clones would arise 
following these events would represent the incidence of random breaks incurred to the 
BAC during the experimental procedure. The efficiency with which HATR clones were 
generated for the in tram line was higher than compared with the in cis line. This result 
is not consistent with clones that have reconstructed the hprt minigene by HR followed
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by SSR, since this event should generate equal efficiencies for both the in cis and in 
tram line. Therefore it is predicted that HR due to the incidence of double-strand 
breaks incurred to the BAG is not a frequent event.
6.3.5 The consequences of a combination of SSR followed by HR
In consideration of the points of the above discussion, the most likely alternate 
mechanism for the production of HATR clones is predicted to be SSR followed by HR, 
as depicted in Fig. 6.2b.
Assuming that the BAG molecule remains circular and thus HR occurs at a low 
frequency, SSR could then be predicted to be the dominant primary recombination 
event. To generate HATR clones SSR must occur via the loxP sites to reconstruct the 
hprt minigene and in doing so generate the co-integrant structure, as outlined in Fig. 
6.2b. The issue pertinent to RMCE then becomes whether the co-integrant is resolved 
desirably, by a second SSR event between the Iox511 sites, or by HR. The Southern 
blot data obtained thus far are unable to distinguish these events, however the 
comparison of data generated from the HATR clones from the in cis and in tram lines 
may provide an indication of which event resolves the co-integrant.
38 HATR clones were generated from the in cis lines, none of which have been 
identified with Southern blotting to harbour a co-integrant structure. In contrast, 1 of 
the 14 clones analysed from the in tram generated HATR clones demonstrates the 
persistence of the co-integrant structure, the remaining clones appearing to have 
resolved, according to Southern blot analysis.
Assuming that all the in tram generated clones may resolve the co-integrant 
structure either by HR or SSR, the frequency of co-integrant clones from the total 
number provides an indication of the activity of HR. Therefore in the absence of a 
loxSll site on the same chromosome HR appears to occur efficiently (13 of 14 clones) 
to cause the resolution of the co-integrant structure for the in tram clones. The 
possibility for a high incidence of HR to occur between in cis sequences is recorded at
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other genomic locations (Baker, 1989; Ng and Baker, 1994), however the alpha-globin 
locus has not been recorded as a 'hot-spot' for homologous recombination.
A measure of the frequency of HR following SSR for the in trans generated 
clones would be obtained by determining the frequency with which CAT-C10/D2 
clone was able to generate clones with a resolved genetic arrangement in the absence of 
Cre. This experiment is currently being undertaken by measuring the number of 
ganciclovir resistant clones that arise spontaneously from this clone. However this 
measurement may not reflect the level of HR that may be occurring for the clones 
generated from the in cis line since resolution by SSR is possible.
Assuming that either HR or SSR may resolve the co-integrant structure for the 
in cis generated clones (HR is active at an equivalent frequency for both the in trans 
and in cis generated clones) then it would be reasonable to predict that from a 
population of 38 HATR clones generated from the CAT-B3 line, at least 2 or 3 would 
exhibit a co-integrant genetic arrangement. Since the Southern blot data suggest that 
none of the in cis generated clones has a co-integrant structure, then either HR is active 
at a higher efficiency in these cells, which is unlikely, or resolution by other means is 
occurring, most likely by SSR via the in cis targeted Iox511 site. This scenario would 
suggest that in a number of HATR clones from this experiment the entire floxed interval 
has undergone exchange, as desired.
Furthermore, it may be that the effects of HR for the in cis generated clones are 
diminished due to the greater efficiency of the desired SSR resolution by Iox511, 
compared with the in trans generated clones. The position of the Iox511 site on the 
same chromosome, for the in cis line, may promote SSR above HR as the dominant 
event which resolves the co-integrant structure. Should this be the case then the 
frequency of recovering clones that have undergone exchange of the entire floxed 
interval, within a population of HATR clones, would be increased. However, the 
distance between the in cis lox sites may affect whether SSR or HR is the dominant 
resolution even.
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One of the aims of developing this strategy was to generate a method that could 
facilitate the functional dissection of a locus of interest. To this end, the ability to 
precisely and rapidly deliver any combination of mutations to a locus of interest was 
required. Currently, to direct the multiple mutagenesis of a locus with conventional 
gene-targeting methods requires multiple, sequential rounds of gene-targeting, a 
process which is both lengthy and possibly detrimental to the cell. In contrast, the 
strategy developed here seeks to facilitate the introduction of multiple mutations by a 
single RMCE event into a pre-disposed locus. The possibility for HR to occur would 
therefore severely hamper the application of this strategy in this respect, since not all 
the mutations engineered into the BAG floxed interval could be guaranteed to be 
exchanged into the floxed ES cell interval.
As outlined above, the HATR clones generated could represent a mixed 
population of clones harbouring various genomic arrangements at the locus of interest, 
with each having undergone varying degrees of exchange with the BAG. In order to 
implement the strategy described here to introduce mutations to a locus of interest, it 
would therefore be necessary to either evaluate the extent of the exchange, or 
implement further screening to identify the mutations transferred during the RMCE 
event.
In order to determine clones that have had all the required mutations delivered 
it would be possible to mark each mutation with a drug selectable marker. Therefore 
following the isolation of HATR clones it would be possible to further select clones, to 
identify those with the full complement of mutations on the basis of their drug 
resistance profile. However, this would compromise one of the main advantages of the 
strategy, which is the ability to position drug selectable markers and other undesirable 
sequences out with the region under investigation. Furthermore, it is possible to deliver 
point mutations alone to the BAG interval and then using this strategy it would be 
possible to deliver such mutations without the concomitant introduction of any other
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sequences. At present the ability to manipulate the ES cell genome with such precision 
can not be achieved and is therefore a useful development.
A more appropriate method therefore would be to screen the DNA from all of 
the HAT clones for the mutations intended for delivery. The methods that could be 
used to do this were described earlier, in section 6.2. The importance of determining 
the extent of the exchange would be of specific relevance on applying this strategy to 
the RMCE of heterologous sequences. Although the propensity for HR to occur with 
heterologous sequences could be predicted to be lower than for the experimental 
conditions described here, there is evidence that non-isogenic DNA participates in HR 
(Deng C, 1992). In the case of heterologous sequence exchange, intensive screening for 
polymorphic sequences between species would therefore be required to determine the 
extent of the exchanged interval.
Finally, the generation of a population of HATR clones harbouring various 
genetic arrangements may be a fortuitous event, since with a single RMCE event it 
would be possible to generate a number of clones with varying mutational profiles. 
However, should a level of HR be undesirable, it may be possible to increase the 
efficiency of SSR within the system by providing more robust Cre expression within 
the cell. This could be achieved, for example, by optimising the ratio of Cre expression 
plasmid to the amount of electroporated BAC, or by using cell lines that have a highly 




MODIFICATIONS TO THE STRATEGY AND
APPLICATIONS
7.1 Modifications to the large interval RMCE strategy in order to expediate 
the experimental process
The strategy developed in this thesis was designed to facilitate the recursive 
introduction of mutations to a specified locus in order to perform functional 
genomics, see Fig. 7.1. By the addition of other technology to this strategy of large 
interval RMCE, it may be possible to flexibly extend this strategy to the study of 
any region of interest and expediate the study. The following section outlines some 
of the modifications that could be made in this respect.
7.2 Modifications to the large interval RMCE strategy to study gene loci that 
can not be accommodated by a single BAC molecule
The ability to exchange intervals of up to 300 kb, harboured in BACs, 
permits the exchange of most genes and gene loci, however, a requirement to 
exchange larger intervals with an equivalent strategy could be met using alternative 
vectors, for example HACs, MACs or whole chromosomes. At present, the ability 
to shuttle whole chromosomes by microcell-mediated transfer is being tested as a 
vector system for RMCE in order to facilitate the replacement of large regions of 
synteny between human and mouse in the murine ES cells using an equivalent 
strategy (Helen Wallace, pers. comms. Centre for Genome Research, Edinburgh 
University, 2001).
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Fig. 7.1 A strategy to rapidly produce a variety of mutated ES cell lines
I I I
Recombination-mediated cloning in E. coli generates a 
collection of BACs harbouring a floxed, mutated locus of 
interest.
RMCE introduces each mutated locus to a
floxed genomic locus in ES cells to facilitate
the generation of a range of mutated cell lines.
The resultant ES cell lines provide the basis
for differentiation and functional in vitro
screens to investigate gene function.
The diagram illustrates how a single ES cell line with a floxed locus of interest can be used to generate a 
variety of mutated cell lines. The mutations are introduced to the locus harboured in the BAG and then 
with a single RMCE event can be delivered to the ES cell floxed interval.
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Alternatively it may be possible to compartmentalize large loci, that are too 
large to be accommodated by a single BAG, into BAC-exchangeable segments 
using exclusive recombination systems. For example, exclusive recombination 
systems have been evolved from Cre-lox (Buchholz and Stewart, 2001). Buchholz 
has developed a mutated Cre recombinase by protein evolution that has SSR 
activity exclusive to loxH, a variant lox sequence found on human chromosome 22. 
By further protein evolution studies it may be possible to generate a repertoire of 
mutated Cre recombinases having SSR activity exclusive to unique and novel lox 
variants.
The study described here employs a single BAG clone that fortuitously 
encompasses the entire alpha-globin locus, however should a BAG clone be 
unavailable to encompass the region of interest it is possible to join overlapping 
BAG contigs (Mejia and Larin, 2000) and eliminate any unwanted insert DNA (Hill 
et al., 2000), thereby negating the requirement for the re-derivation of a fortuitous 
BAG clone by library construction.
7.3 Delivering the hetero-specific lox sites required for large interval RMCE 
with a single targeting vector
To reduce the time taken to generate an ES cell line with afloxed genomic 
interval, an alternative strategy that would flox the target locus with lox sites 
implements the plasmid-based gene-targeting construct, as shown in Fig. 7.2. The 
advantage of using such a construct is two-fold: first, it reduces the number of 
manipulations made to the ES cells; second, it removes the need to test whether the 
lox sites have been targeted in cis. The resultant ES cell line would harbour a 
heterozygous deletion for the locus of interest, which would limit this approach to 
loci that do not contain sequences that are hemizygous lethal.
The efficiency of RMCE that delivers sequences to the resultant floxed- 
deleted locus may be greater than for RMCE that exchanges intervals of equivalent 
size. The plasmid to deliver both loxP and Iox511 to the ES cell alpha-globin locus 
has been constructed and the RMCE efficiencies are to be assessed.
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Fig. 7.2 Creating a floxed ES cell interval by a single gene-targeting event
The locus of interest in the ES cell 
genome and position of the regions 
of sequence homology used for 
targeting.
The neomycin marker, floxed with 
loxP and Iox511 is targeted, along 
with the 5'HPRT minigene region, 
by homologous recombination.
ES cell targeting results in 
neomycin resistant clones and 
creates a heterozygous deletion at 
the locus of interest.
SSR via loxP sites integrate the 
BAG molecule and generates the 
co-integrant structure, as depicted 
below. Type I SSR deletes a 
smaller interval than type II SSR, to 
produce the desirable RMCE event.
I I I I KZ1
Type 1 SSR
I I I I
SSR between the 
BAC and ES cell 
locus results in 
RMCE.
Key /ax/>-blasticidin-/axP-3'hprt-I See \-frt 
frt-l See I-5'hprt-/ojcP-neomycin-/ax5/7
reconstructed HPRT minigene 
/ax.5//-thymidine kinase
To overcome the need for two sequential targeting events to establish the floxed interval in the ES cell 
line, it would be possible to target the plasmid, as shown in the diagram, to the locus of interest by 
homologous recombination. The plasmid simultaneously delivers both hetero-specific lox sites and 
deletes the target locus. The resultant cell line is a heterozygous deletion line for the locus of interest, 
which may limit this approach to loci that do not contain sequences that are hemizygous lethal in ES 
cells.
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Fig. 7.3 Generating homozygous and hemizygous loci following RMCE
The predicted arrangement of a RMCE 
interval following the introduction of a 
mutated floxed BAG interval.
A hetero-specifically floxed neo gene is 
targeted with homology arms that 
simultaneously delete the RMCE 
interval and deliver lox sites to 
identically flox the alternate allele.
The resulting cell line is hemizygous 
for manipulations delivered to the 
RMCE interval.
The arrangement at the manipulated 
loci following DNA replication. The 
expression of Cre in this population of 
cells can effect an inter-chromosomal 
translocation.
Shown here is the arrangement of the 
genome resulting from loxP SSR that 
has mediated a translocation. 
Segregation of this genome by 
subsequent cell division results in the 
four cell types depicted below.
The genetic arrangement of the cell types generated by the experimental scheme above
Hemizygous for the 
— mutations introduced to 
the RMCE interval.
A cell line homozygous 
for the deletion of the 
RMCE interval.
A cell line homozygous 
for the mutations 
introduced by RMCE.
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7.4 Generating hetero-, homo- and hemizygous mutated loci following large 
interval RMCE
The plasmid depicted in Fig. 7.2, could also be used in combination with the 
strategy presented in this section to achieve hetero-, homo-, and hemizygous 
mutations. RMCE of a mutated Jloxed BAG interval into thQ/loxedES cell interval 
results in a cell line that is heterozygous for those mutations, see Fig. 7.3.
It may be advantageous to compare the phenotypic effects of mutations to a 
locus in their hetero-, homo-, and hemizygous states. Further, it would benefit the 
investigation on phenotype to have the hetero- and homozygous deletions of the 
locus as controls for the effects of any delivered mutation and as a basis for rescue 
experiments. Fig. 7.3 illustrates a scheme to achieve these cell types. First the 
plasmid depicted in Fig. 7.2 is targeted to the unmodified globin locus by HR, to 
effect a deletion and deliver the hetero-specific lox sites to flox the locus at 
positions identical to those of the modified locus. The cell line generated would be 
hemizygous for the mutations introduced by RMCE. Next, Cre is expressed in these 
cells to cause a chromosomal translocation. Should the translocation occur in cells 
that are undergoing DNA replication, the segregation of the resultant alleles should 
produce the various cell types, illustrated in Fig.7.3, according to a study by 
Mortensen (Mortensen RM, 1992).
Selection can be applied to isolate homozygous deletion, homozygous 
mutated and hemizygous mutated cell lines. Targeting the deletion plasmid to wild- 
type ES cells would therefore generate heterozygous deletion cell lines, as a further 
control. This illustrates that following manipulation of the locus it would be 
possible to generate a variety of cell types by just one further targeting event and 
the expression of Cre. Further, following characterisation of the homo-, hemi- and 
heterozygous phenotypes RMCE could be implemented to test sequences for their 
ability to rescue the mutant phenotype.
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7.5 Mediating large interval RMCE in somatic cells
This strategy relies on gene-targeting in ES cells to establish the exchange 
interval however this should not restrict the application of this strategy to organisms 
from which ES cells have been derived. A number of somatic cell lineages have 
been demonstrated to support gene-targeting (as reviewed by Sedivy and Dutriaux, 
1999), although due to the selection strategy implemented here the ablation of hprt 
function would be pre-requisite to the RMCE event. The combination of somatic 
cell targeting and nuclear transfer technologies (Campbell et al., 1996) would 
theoretically extend the application of this strategy to any organism, which would 
be most advantageous in the fields of xenotransplantation, bioreactor organism 
generation and orthologous sequence exchange investigations, as discussed later.
In addition to the availability of methods to generate in vivo models, the 
advantage of establishing the floxed interval in ES cells is that they may be 
differentiated into variety of cell types. Most somatic cell types do not support 
targeting by homologous recombination with efficiency, which makes the genetic 
manipulation problematic. However, deriving somatic cell lines from GMOs, in 
which the floxed interval has been engineered, would allow their genetic 
manipulation by RMCE. This would be of particular advantage to investigate cell 
types that do not support homologous recombination with efficiency or cell types 
that can not be obtained by ES cell differentiation.
The generation of mice by nuclear transfer of murine ES cell nucleii has 
been demonstrated (Wakayama et al., 1999). This development has the potential to 
significantly decease the time necessary to generate murine models from 
genetically-engineered ES cells compared with the conventional route involving 
blastocyst contribution. This is because the step to generate a germline chimera is 
eradicated and furthermore the breeding programme required to generate the 
desired mouse model is either eradicated or reduced.
Another route that could decrease the time taken to generate a variety of 
murine models, each harbouring a distinct manipulation, would be to introduce the 
BAG and Cre recombinase at the one-cell embryo stage. This route would require
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that the one-cell embryos be competent to mediate a RMCE event, which could be 
achieved by taking embryos from a mouse line derived from ES cells engineered to 
harbour the desired RMCE interval. In order to generate a variety of murine lines, 
each one-cell embryo would be micro-injected with an individual BAG clone from 
a pool of distinctly manipulated BACs, and Cre recombinase, to mediate the RMCE 
event. However the efficiency of the RMCE event, compounded with the efficiency 
of micro-injection, may make such a strategy impractical.
The methods available to manifest the RMCE in vivo and in vitro are 
summarised in Fig. 7.4.
7.6 Applying large interval RMCE to functional genomics
The strategy implemented here requires two gene-targeting events in ES 
cells to establish the exchange interval and a further Cre-lox mediated RMCE to 
introduce any manipulation to the locus. It could be argued that the desired 
mutation may be more easily generated using a single targeting event and since 
experience with ES cells has shown that increasing the number of manipulations 
may decrease germline capacity, it would therefore be counter-productive to 
perform more manipulations than necessary. However, it is envisioned that the 
strategy presented here will be applied to study loci that require a combination of 
manipulations to decipher function. As in many cases, the initial mutational 
analysis of a locus often leads to the requirement for further, more sophisticated 
genetic manipulations to better understand the function of a locus. The variety of 
manipulations that may be achieved is often time limited and compromised by the 
availability of technology to precisely mediate the desired manipulation. The 
potential of this strategy would be that a single floxed ES cell line could be 
generated and then used to produce many variously manipulated lines in a rapid 
manner, each by the single-step RMCE of BAG-harboured sequences, see Fig. 7.3.
The E. coli recombination system has been used to manipulate BACs in a 
rapid and versatile manner and would therefore facilitate the production of an 
unlimited collection of BACs harbouring the locus of interest with various 
mutational repertoires. Once the floxed ES cell line was established as germline
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The flow diagram illustrates the variety of methods available to produce in vivo and in vitro models 
harbouring the mutated genotypes created by RMCE.
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competent, the likelihood of one further manipulation, that of RMCE, diminishing 
germline competency could be predicted to be low. Further, experience has 
established that ES cells that have undergone three genome manipulations are 
routinely germline competent (A. Smith pers. comms).
Another advantage of this strategy is the flexibility with which any required 
mutation could be delivered to a locus, specifically the ability to introduce 
mutations without the concomitant introduction of any undesirable sequences, such 
as selection markers or recombination sites. Although it is possible by floxing or 
flirting to remove any unwanted sequences, following SSR at least one 
recombination site remains and it is possible that this single recombination site may 
give rise to experimental artefacts. The ability to introduce point mutations and 
other small sequence changes to a BAG by HR in E. coli (Muyrers et al., 2000; 
Lalioti and Heath, 2001) concomitantly implies that these changes could be 
transmitted to the ES cell genome by RMCE of the BAG floxed interval. The 
availability of a strategy to manipulate the ES cell genome with such precision 
would be of particular relevance to the study of the effects of small sequence 
heterologies, for example SNPs (Vignal et al., 2002).
The strategy presented here eventually leaves anfrt and Iox511 site flanking 
the exchanged interval (see section 5.1), however the recombination sites were 
positioned at a significant distance to the alpha-globin locus to reduce the 
probability of complicating any subsequent analysis of manipulations introduced 
during RMCE. To investigate other loci it would be possible to similarly distance 
the position the recombination sites.
7.7 Applying large interval RMCE to orthologous sequence exchange
This strategy is of particular application to the large-scale segmental 
genome replacement of loci with orthologous sequences from distinct species. 
Functionally advantageous sequences are conserved through evolution and so 
orthologous sequence exchange can be implemented to reveal those sequences that 
have conserved function between species and functional significance. Highly
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conserved sequences are indicative of sequences essential for viability and 
comparatively, sequences that have undergone diversification may indicate an 
evolution of function, functional redundancy or a recent loss of functional 
significance.
Orthologous sequence exchange, implementing a strategy equivalent to that 
outlined here, is currently under investigation using a BAG containing the human 
alpha-globin locus to replace the murine locus in ES cells (H. Wallace pers. 
comms., Centre for Genome Research, Edinburgh University, 2001). Essential to 
the successful mediation of any orthologous sequence exchange is the definition of 
the orthologous region. Using comparative sequence analysis it is possible to 
establish the position of hetero-specific lox sites that should mediate a RMCE of 
functionally equivalent regions. The outcome of orthologous exchange of the 
murine alpha-globin locus with the equivalent human sequence should therefore 
determine whether the exchanged region is infact functionally equivalent and 
should also generate useful models for human disease and drug testing. In addition, 
Douboule's group is attempting to apply a similar RMCE strategy utilizing BACs 
to investigate the phenotypic effects of exchanging the murine hox gene cluster 
with its human equivalent (F. Gonzalez pers. comms., Mouse Molecular Genetics 
conference, 2001).
Another potential application of orthologous sequence exchange is to 
optimise the production of organisms for organ xenotransplantation. At present, 
inter-species donation is flawed due to a high incidence of organ rejection. 
Segmental genome replacement could be used to exchange those sequences in the 
donor responsible for rejection to either produce a universal donor or a donor 
tailored to the requirements of the recipient.
7.8 Applying large interval RMCE to optimise transgene expression
In higher eukaryotes the regulation of transcription is determined, to a large 
extent by chromatin structure. This becomes especially important in cases where 
the expression of foreign genetic material is studied or where transgenes are 
introduced for the efficient production of pharmaceutically relevant proteins.
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Although progress has recently been reported (Lipps and Bode, 2001), the 
development of episomal vectors that replicate and segregate in synchrony with the 
host cell is still in its infancy. Therefore, if stable long-term expression is desired, 
standard transfection systems are implemented to integrate transgenes into the 
genome of a bioreactor organism. However, these methods were developed with 
little consideration to control either the position in the genome into which the 
transgene integrated. This resulted in the position of transgenic integrations being 
largely random and lead to unpredictable expression patterns due to chromosome 
position-dependent effects. Additionally, the genetic arrangenment of the transgene 
at its integration site was commonly as concatentated multiple copies of the 
transgene, which again lead to unpredictable transgene expression.
In contrast, the strategy tested in this thesis was designed to enable the 
delivery transgenes to a pre-defined genomic location and in a copy-number 
controlled manner. It could therefore be of advantage to the field of bioreactors by 
improving the efficiency with which the transgene product is produced (Kolb and 
Siddell, 1997). Further, the elucidation of transcriptionally permissive locations 
within a genome would permit the design of gene-therapy vectors to target such 
locations.
7.9 Applying large interval RMCE to investigate in cis regulatory sequences
Another means to optimise the expression of transgenes and gene-therapy 
vectors is to include sequences that buffer the constructs against chromosome 
position effects. The regulatory region of the beta-globin locus has proved to be 
significant since it has been shown to confer position independence and copy 
number dependence when included within transgenic constructs and was therefore 
subsequently termed a locus control region (LCR) (Fraser et al., 1990; Grosveld et 
al., 1987). Recent experiments however have challenged the ability of beta-globin 
LCR sequences alone to mediate characteristic gene expression profiles from 
different genome locations (Guy et al., 1996; Li et al., 2001).
The alpha and beta globin gene clusters result from a duplication event 
(Dickerson and Geis, 1983) and have since undergone sequence diversification.
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Although each locus has similarities, with respect to gene order and developmental 
expression, it is improbable that the c/s-acting distal regulatory regions of each 
locus originate from the same duplication event. Comparative sequence analysis 
between the murine beta-globin LCR and alpha-globin MRE reveals numerous 
differences in the location and number of both HSSs and protein binding domains. 
In addition the alpha-globin MRE is located in the first intron of a gene, Proxl, 
whilst the region surrounding the beta-globin LCR is devoid of gene sequences. 
However both loci are capable of co-ordinated expression throughout development 
to produce the haemoglobin tetramer. Transgenic studies have shown that the MRE 
is not an LCR since it can not produce expression patterns characteristic of 
sequences under LCR influence (Bouhassira et al., 1997). The comparative analysis 
of alpha and beta globin loci therefore provides a useful system to determine 
functionally significant sequences that regulate gene expression.
The strategy presented here facilitates the functional comparison of 
regulatory regions of the alpha and beta-globin loci. Comparative sequence analysis 
between the loci shows a range of sequence diversity and in order to re-capitulate 
each of these variations in a model system by a combinatorial approach using 
conventional gene-targeting technology would be labour intensive, inefficient and 
may produce artefacts due to the introduction of undesirable sequences, such as 
markers or recombination sites, as discussed previously. To exemplify this 
approach, the strategy described here could be implemented to facilitate the directed 
mutagenesis of the MRE harboured in a BAC by introducing sequences thought to 
confer LCR characteristics by successive rounds of targeting in E. coli by HR. The 
manipulated BACs could then be individually introduced to thefloxed ES cell line 
and a comparative in vitro screen of heamatopoietically differentiated ES cells 
could be used to determine the effects of successive mutations.
The investigation of the mechanism by which distal c/s-acting regulatory 
elements function should not only further gene expression research but could also 
be applied to improve the design of transgenes. For example, an understanding of 
cw-acting sequences could be implemented to generate transgenic constructs with
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more robust expression profiles, a facet that could be applied to the generation of 
more efficient bioreactor organisms.
7.10 Development of the large interval RMCE strategy in order to recover the 
exchanged interval
RMCE is thought to be a reciprocal reaction and so it may be possible to use 
this strategy as a basis to develop methods for the recovery of the genomic interval 
that is exchanged in ES cells. The reciprocal exchange of the alpha-globin locus 
residing in ES cells into the BAG vector was not investigated here and at present no 
other study has investigated the reciprocal nature of RMCE with intervals greater 
than 3 kb. To recover the reciprocal BAG molecule it would be necessary to 
develop the BAG vector to promote its stability and replication in mammalian cells 
(Cocchia M, 2000), in order to assist its purification from an overwhelming 
background of genomic DNA. In addition, the inclusion of an affinity tag to the 
BAG vector backbone may further facilitate the isolation of the reciprocal RMCE 
molecule. The tag could be selected for during DNA purification, thereby enriching 
the reciprocal molecule's concentration above that of the host cells' genomic DNA 
(Gates etal., 1996).
The ability to recover the reciprocal DNA molecule would be particularly 
useful in the investigation of chromatin structure. At present, the investigation of 
chromatin structure at specific loci is hampered by an overwhelming amount of 
background data, which is generated due to the presently unavoidable analysis of 
total genomic DNA. Therefore the ability to isolate and recover discrete genomic 
intervals that potentially retain their chromatin profiles would benefit the study of 
chromatin structure, re-modelling and its effects on gene expression, by simplifying 
the analysis of the data generated.
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Appendix I
Software, Materials and Methods
1.1 Software
Sequence analysis and collation was performed using MacVector (v. 6.5.3) 
(http://www.oxmol.com/prods/macvector). Probe sequence analysis was performed 
using BLAST search (http://www.ncbi.nlm.nih.gov/blast/newblast.html).
1.2 Chemicals
Unless otherwise stated all chemicals were of analytical grade and supplied 
by BDH Laboratory (http://www.cnbi.com) supplies or Sigma 
(http://www.sigmaaldrich. com).
1.3 Oligonucleotides
Synthetic Oligonucleotides were supplied by Oswel (http://www.oswel.com 
/code/en/prod_geno_olig.htm), their sequences are recorded by number in 
Appendix II.
1.4 Embryonic stem cells, culture media and solutions 
1.4.1 E14Tg2a ES cells
E14Tg2a ES cells are a feeder-independent and rely on an exogenous source 
of differentiation inhibitory activity, DIA (also known as leukocyte inhibitory 
factor, LIF). By karyotype the cells are male and are originally derived from the 
129/Ola strain of mice. These cells were produced to be HPRT deficient (Hooper et 
al., 1987; Thompson etal., 1989).
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1.4.2 Cell culture medium
The culture medium can be stored for up to 1 month at 4°C
lOx Glasgow MEM/BHK12 (Gibco), stored at 4°C 40 ml
7.5 % sodium bicarbonate (Gibco), stored at 4°C 13.2 ml
Ix MEM non-essential amino acids (Gibco), stored at 4°C 4 ml
200 mM glutamine, lOOmM sodium pyruvate (Gibco), stored at -20°C 8 ml
0.1M 2-mercaptoethanol (Sigma), stored at 4°C for 1 month maximum 0.4 ml
foetal calf serum (Globepharm, Surrey), batch tested, stored at -20°C 40 ml
sterile, deionised water 340 ml
DIA/LIF 0.44 ml
1.4.3 Differentiation inhibitory activity (DIA)
DIA was prepared by D. Rout at the CGR by transient expression of murine or 
human DIA/LIF expression plasmids in COS-7 cells using the method described by 
Smith (Smith et al., 1988). Serial dilutions of the supernatant were tested on ES 
cells. A 100-fold higher dilution than the minimal dilution required to keep ES cells 
undifferentiated was typically used.
1.4.4 Foetal calf serum
Serum batches were tested for their ability to sustain the growth, differentiation and 
viability of ES cells grown at clonal density in the presence and absence of DIA.
1.4.5 Phosphate Buffered Saline
One PBS tablet (Dulbecco A; Oxoid BR014G) was dissolved in 100 mis of water to 
give a PBS solution pH 7.3 that was filter sterilized.
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1.4.6 Trypsin solution
Dissolve 250 mg of trypsin (Difco) and 372 mg EDTA disodium salt (Sigma) in 1 
litre of PBS. Add 10 ml of chicken serum (Flow Labs) and filter sterilize. Stored in 
20 ml aliquots at -20°C.
1.4.7 1 % Gelatin
Add 1 g of gelatin (Sigma) to 100 ml dH2O, autoclave and store in 20 ml aliquots at 
4°C. For a working solution of approximately 0.1 %, melt a 20 ml aliquot of 1 % 
gelatin in a 37°C waterbath and add to 200 ml of PBS.
1.4.8 0.1 M 2-mercaptoethanol
A working solution of 0.1 M was prepared by adding 100 jj,l of 2-mercaptoethanol 
(Sigma) was added to 14.1 ml PBS. Stored for up to 1 month at 4°C.
1.4.9 Freezing Solution
A 2x freeze solution of 20 % DMSO diluted with culture medium was typically 
prepared and used to freeze ES cells.
1.4.10 Quench Medium
Quench medium was prepared by mixing an equal volume of PCS with culture 
medium.
1.5 ES cell culture
Methods for routine culture of ES cells are based on those described in Smith, et al. 
1991. Briefly, ES cells were maintained in a humidified incubator (Heraeus) at 7.5 
% CO2 and 37°C. All ES cell manipulations were carried out in a laminar flow 
sterile hood (ICN, flow). All solutions were warmed in a 37°C water bath prior to 
use. Tissue culture grade flasks and dishes (Corning) were gelatin coated (0.1 % in 
PBS, Sigma) and then aspirated before use. ES cell manipulations methods vary 
depending on whether the cells were being grown in flasks and dishes or in 96 well 
plates, usually following clonal selection of ES cells. This section describes both 
methods.
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1.5.1 Passage and expansion of ES cells
Careful maintenance of ES cells was crucial to maintain the germline capacity 
should the cells be required for further investigation in an in vivo system. Medium 
was changed every other day and cells were not allowed to grow past 100 % 
confluence. Cells were most commonly passaged at a confluence of 80-90 % 
coverage of the culture vessel surface. Cells were passaged according to the 
following method:
1. ES cells were passaged once they had almost reached confluence. First the 
medium was removed by aspiration and cells were rinsed twice with PBS. Each 
wash of PBS was of sufficient volume to cover the surface of the culture vessel. 
Cells were not left without liquid coverage for more than 1 to 2 minutes.
2. Enough trypsin to cover the cell surface area was added (approximately 1 ml / 
25cm2) and the flask incubated at 37°C for 1 to 2 minutes. After this time the cells 
are inspected, the flask tapped gently and re-inspected to ensure the cells are 
completely dislodged from the culture vessel surface. The vessel was returned to 
the 37°C incubator if required but the cells were not left in trypsin for longer than 4 
to 5 minutes.
3. Once totally dislodged cells were made into a single cell suspension by re- 
pipetting 2 or 3 times and an equivalent volume of media added to stop 
trypsinization.
4. Cells were passaged into a new culture vessel at ratios of at least 1:2 and at most 
1:6, depending on experimental requirements, made with culture media. It is 
important to maintain an adequate ES cell density to prevent differentiation.
1.5.2 96 well ES cell passage
1. 96 well plates were prepared by gelatinisation and the addition of 150 ul of 
culture media.
2. The 96 well plate to be passaged was washed twice with 100 ul of PBS using a 
multi-channel pipette.
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3. 30 f^l of trypsin was added to each well and the plate placed in the 37°C 
incubator for 3 minutes.
4. Cells are pipetted and their adherence to the culture vessel observed. Once most 
of the cells were as a single cell suspension 70 ul of quench media (see section 
1.4.10) was added.
5. 50 ul of cells are placed in the prepared 96 well plate and to the remaining 50 ul, 
150 ^1 of culture medium is added, to produce a 1:2 passage.
1.5.3 Freezing ES cells
The cryoprotector dimethyl sulphoxide (DMSO) diminishes the lethal effects of 
ice-crystals formation within the cell cytoplasm upon freezing but is however an 
inducer of ES cell differentiation and so exposure time was minimized before 
freezing and during thawing.
1.5.4 Freezing from a small flask
1. Cells were harvested as in steps 1 to 3, section 1.5.1. Then transferred into a 20 
ml Universal with 4ml GMEM and were pelleted by centrifugation at 1200 rpm 
for 5 minutes at room temperature (Denley BS400 Benchtop centrifuge).
2. Aspirate off media and add 1ml GMEM and 1ml 2x freezing solution.
3. Transfer to 2 cryotubes in the -70°C freezer.
1.5.5 Freezing a 96-well plate
The procedure 96 well plate freezing is identical to ES cell passage as described in 
section 1.5.2, except for step 5. To freeze cells the original plate had 150 jul of 2x 
freezing mix (section 1.4.9) added instead of culture medium. The plates were taped 
and labelled and stored at -80°C.
1.5.6 Thawing vials of ES cells
1) A culture vessel with the required surface area for the number of cells being 
thawed was gelatinized, media added and placed in the 37°C incubator.
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2) Cells were retrieved from liquid nitrogen storage and kept on dry ice until 
the moment to thaw.
3) The vial was held in the 37°C waterbath until the liquid begins to thaw and 
then the cells were transferred to the culture vessel with a plugged pasteur 
pipette.
4) The thawed cells were cultured for 4 to 5 hours to allow the cells to adhere 
to the vessel surface and then the culture medium was changed to reduce the 
concentration of DMSO.
1.5.7 96 well ES cell thawing
1) Warm the plate between hands.
2) Top up the wells with GMEM.
3) Aspirate off media, leaving 2mm (since cells can lift off).
4) Top up the wells with culture media.
5) Incubate until cells are confluent.
1.5.8 Electroporation of ES cells
Plasmid and BAG DNA was introduced into ES cells by electroporation. Cells and 
DNA are mixed in a cuvette and subjected to a high voltage electrical discharge. 
This is thought to lead to the formation of membrane pores through which DNA 
enters into the cell.
(a) Vector preparation for plasm id DNA
Plasmid DNA was prepared as described in section 1.6.1 (c). 
Electroporations typically introduced between 50 jig and 150 jug of DNA. Targeting 
constructs were linearised by restriction digest, phenol/chloroform extracted and 
precipitated with a 1/10th volume of sodium acetate and 2.5x volume of ice-cold 
ethanol. However, in some instances supercoiled plasmid DNA was electroporated 
and therefore did not require phenol/chloroform extraction before precipitation. The 
DNA was pelleted in an eppendorf by centrifugation at 13000 rpm (Heraeus,
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Biofuge Pico centrifuge) for 10 minutes at 4°C. 1 ml of 70 % ethanol was used to 
rinse the inside of the eppendorf, taking care not to disturb the pellet, and then the 
eppendorf taken into the laminar flow hood. The 70 % ethanol was removed by 
pipette and the pellet left to air-dry in the hood. The DNA was thoroughly 
resuspended in 100 u.1 of PBS.
(b) Vector preparation for BAC DNA
BAG DNA for electroporation into ES cells was prepared as described in 
section 1.6.1 (e). Between 50 |j.g and 150 j^g of BAC DNA was electroporated into 
ES cells as supercoiled DNA. The DNA was prepared in an identical way to that of 
targeting vectors with respect to precipitation, the 70 % ethanol wash and 
resuspension in 100 u.1 of PBS. However when pelleting the DNA it was 
centrifuged at 10000 rpm (Eppendorf, Centrifuge 5415C) for 10 minutes at 4°C.
(c) Electroporation of DNA
1) Unless otherwise stated 1 x 108 cells were required for each electroporation. 
This number of cells is most easily harvested from 2 or 3 150 cm2 culture 
flasks. Prior to the electroporation cells were cultured to ensure 70 to 80 % 
confluence on the day of electroporation. 3 to 4 hours before commencing the 
electroporation the culture media was replaced with 40 ml of fresh media per 
150 cm2 flask.
2) Two 150 cm2 flasks were prepared by gelatinization, adding 35 mis of culture 
media and warmed by placing them in the 37°C incubator
3) Cells are washed and trypsinised as described in 2.5.2, steps 1 to 3.
4) After transfer into a 20 ml Universal they were pelleted by centrifugation at 
1200 rpm for 5 minutes at room temperature (Denley BS400 Benchtop).
5) Cells were pooled and resuspended in a total of 10 mis of PBS, then counted
6) The volume of cells required for 1 x 108 cells was measured into a new 20 ml 
universal and re-pelleted, as described in step 3.
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7) The pellet of cells was resuspended with PBS to give a total volume of 600 (il.
8) 100 ^1 of DNA (see 2.5.8 (a) and (b)) was added to the cells and carefully 
mixed by re-pipetting, ensuring no air bubbles were introduced into the mixture.
9) The cells and DNA were transferred to a 0.4 cm electroporation cuvette and 
capped. The cuvette was then pulsed in a Bio-Rad Gene Pulsar unit set at 3uP, 
0.8 kV. The time constant was noted and should be 0.1 msec.
10) Cells are allowed to recover for 10 minutes in the cuvette and then transferred 
carefully to a 20 ml universal. To ensure all the cells are transferred the cuvette 
is washed 2 or 3 times with 500 jul of culture media. The cells in the universal 
are made up to 4 mis with culture media and then split in half between the two 
150 cm2 flasks prepared in step 2.
1 1) Cells were cultured for 24 hours before clonal selection. 
(d) Clonal selection of ES cells using selective media
1) An appropriate number of 10 cm diameter culture dishes were prepared by 
gelatinization, adding 8 mis of culture media and placing the dishes in the 37°C 
incubator.
2) Electroporated cells were inspected for the extent of cell death
3) Cells are washed and trypsinised as described in 2.5.2, steps 1 to 3.
4) After transfer into a 20 ml Universal cells were pelleted by centrifugation at 
1200 rpm for 5 minutes at room temperature (Denley BS400 Benchtop).
5) Cells were pooled and resuspended in a total of 10 mis of culture media and 
then live cells were counted.
6) The volume of the cell suspension was adjusted to obtain a suspension of 5 x 
106 cells.ml" 1 , re-pelletting the cells if necessary.
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7) Serial cell volume dilutions were made with culture media, e.g. 5 x 106 
cells.mr 1 , 1 x 106 cells.mr 1 , 5 x 105 cells.mr 1 and 1 x 105 cells.mr 1 . 1 ml 
aliquots for each dilution were then added to the prepared 10 cm diameter 
culture dishes.
8) 1 ml of a 1 Ox stock of selective media was added to the selective plates. In 
addition control plates with no selection were maintained to enable a 
comparison for cell death to be made. Table 2.1 shows the selections used.





Effective concentration in ES cells
120 u-g.mr 1
240 jiig.mr 1
-lypoxanthine 0.1 mM, Aminopterin 0.4uM,















(e) Picking ES cell colonies
Clonal selection of ES cells in selective media gives rise to visible, discrete 
colonies of cells that have arisen from the expansion of a single resistant cell. In 
order to determine the genetic basis of this resistance it was necessary to isolate the 
colonies from each other and culture the cells to obtain a DNA preparation for 
analysis. This was achieved by using a pipette to take up the cell colony and place it 
in a single well of a 96 well plate.
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1.6 Molecular biology methods
The methods described in this section are based on those described in 
Sambrook et al, 1989, unless otherwise stated.
1.6.1 DNA Isolation and Purification
Overnight cultures grown for plasmid or BAG preparation contain the 
relevant antibiotic addition to the LB broth to maintain and propogate the DNA 
within the E. coli.
(a) Qiagen plasmid miniprep
The Qiagen miniprep method was used to prepare the recombination plasmid 
from overnight cultures of E. coli harbouring both BAG and plasmid. This was 
done to ensure the plasmid had been retained before using the culture to inoculate 
broth to prepare electrocompetent cells. The protocol is outlined at 
http://www.qiagen.com. Unless otherwise stated centrifugation takes place at 13000 
rpm in a Heraeus, Biofuge Pico centrifuge at room temperature.
1) 1 ml of an overnight culture was centrifuged for 5 minutes.
2) The pellet is resuspended in 250 jul in Qiagen Buffer PI.
3) 250 |j,l of Qiagen Buffer P2 was added and the eppendorf was inverted to mix 
the contents.
4) 350 jil of Qiagen Buffer N3 was added and the eppendorf was inverted to mix 
the contents before centrifuging for 10 minutes.
5) The supernatant was applied to the Qiagen column and centrifuged for 1 
minute.
6) 750 fil of Qiagen Buffer PE was added to the column and centrifuges for 1 
minute.
7) The flow-through was discarded and the column centrifuged for a further 
minute.
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8) The DNA was eluted into a fresh eppendorf by adding 50 jil of TE and 
centrifuging for 1 minute.
(b) Plasmid miniprep
1) A single bacterial colony from an agar plate was used to inoculate a 5 ml 
overnight culture.
2) 1.5 ml of culture was transferred to an eppendorf and centrifuged at 13000 rpm 
(Heraeus, Biofuge Pico centrifuge) for 5 minutes at room temperature.
3) The bacterial pellet was resuspended on ice in 50 ^1 of GTE (25mM Tris HC1, 
pH 7.5 (20°C); 1 mM EDTA, pH 8.0; 50mM Glucose).
4) 100 |ul of 0.2 M NaOH/ 1 % SDS was added, the tube mixed by flicking and left 
at room temperature for 5 minutes.
5) 75 p.1 of 3M sodium acetate/acetic acid was added and the tube mixed by 
shaking.
6) The bacterial lysate was centrifuged as in step 2 and the supernatant removed by 
pipette into a fresh eppendorf.
7) A phenol/ chloroform extraction was performed. 100 j^l of dlrbO saturated 
phenol (company order no) and 100 jul chloroform were added, the eppendorf 
was vortexed and centrifuged as in step 2. The top aqueous layer was 
transferred by pipette to a fresh eppendorf.
8) DNA was precipitated by adding 20 jul of salt and 500 ul of ice-cold ethanol 
and centrifuging at 13000 b for 10 minutes at 4°C.
9) The DNA pellet was washed with 200 jil of 70 % ethanol and centrifuged as in 
step 2.
10) After air-drying the DNA pellet it was resuspended in 50 jul of TE (10 mM Tris 
HC1, pH 8.0 (20°C); 1 mM EDTA, pH 8.0) with RNase added to a 
concentration of 0.5 mg.mr 1 .
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(c) Plasmid maxiprep
Large amounts of plasmid DNA for cloning or the preparation of ES cell and BAG 
targeting DNA were prepared by the following method.
1) A single bacterial colony from an agar plate was used to inoculate a 5 ml 
overnight culture.
2) The overnight culture was used to seed a 250 ml overnight culture.
3) Cells were harvested by centrifugation at 3000 rpm (Sorvall Instruments, Du 
Pont, RC5C centrifuge fitted with a GSA rotor) for 20 minutes at 4°C.
4) The bacterial pellet was resuspended on ice in 10 ml of GTE (see section 
1.6. l(b)) and transferred to a 50 ml Corning tube.
5) 20 ml of 0.2 M NaOH/ 1 % SDS was added, the tube invert mixed and left at 
room temperature for 5 minutes.
6) 15 ml of 3M sodium acetate pH 4.8 was added and the tube invert mixed.
7) The bacterial lysate was centrifuged as in step 3 and the supernatant removed by 
pipette and split into two corning tubes, 20 ml in each.
8) DNA was precipitated by adding 25 ml of ice-cold isopropanol to each tube, 
mixing the contents by inverting the tube several times and then centrifuging 
immediately at 3000 rpm (MSE, Centaur2 centrifuge) for 10 minutes at 4°C.
9) The resulting pellets were pooled in 2 ml of TE, 2.5 ml of ice-cold 5 M LiCl 
added and left at 4°C for 15 minutes before centrifuging as in step 8.
10) The clear supernatant was transferred into a fresh tube and the DNA 
precipitated with 2.5 volumes of ice-cold ethanol and centrifuging as in step 8.
11) After the resulting pellet was air-dried it was resuspended in 500 jul of TE and 
transferred to an eppendorf and 20 jul of RNase at 10 mg.mr 1 added. The 
eppendorf was incubated at room temperature for 30 minutes.
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12)500 ^1 of cold 1.6 M NaCl2 , 13 % PEG (6000) was added, the tube was 
vortexed and incubated on ice for 15 minutes before centrifuging at 13000 rpm 
(Heraeus, Biofuge Pico centrifuge) for 10 minutes at 4°C.
13) The NaCl2/PEG solution was removed by pipette, the eppendorf centrifuged at 
13000 rpm (Heraeus, Biofuge Pico centrifuge) for 1 minute at room temperature 
and the remaining NaCl2/ PEG solution removed.
14) Two extractions with an equal volume of chloroform, followed by two 
extractions with an equal volume dH2<D saturated phenol, followed by a final 
extraction with an equal volume of chloroform were performed.
15) The DNA was finally precipitated with 50 ul of 3 M sodium acetate pH 5.5 and 
1000 (0.1 of ice-cold ethanol. The tube was gently inverted until the precipitating 
DNA became visible. The DNA was then pelleted by centrifugation at 13000 
rpm (Heraeus, Biofuge Pico centrifuge) for 3 to 5 minutes at room temperature.
16) The DNA pellet was washed with 70 % ethanol, centrifuged at 13000 rpm 
(Heraeus, Biofuge Pico centrifuge) for 3 minutes at room temperature, air-dried 
and resuspended in TE, typically a volume of 500 p.1.
(d) BAC Quick Prep
This method is used to prepare small amounts of BAC DNA to be investigated by 
restriction analysis, typically following a BAC targeting experiment to screen for 
correct integration of the targeting construct. For restriction analysis the entire 
preparation must be used since the yield of BAC DNA is small. In addition to 
visualize the BAC DNA the E. coll must be first cured of the recombination 
plasmid (see section 1.6.8 (e)). The method is identical to the plasmid miniprep (see 
section 1.6.1 (b)) with the following exceptions: all centrifugations are performed at 
10000 rpm and not 13000 rpm (Heraeus, Biofuge Pico centrifuge); the 
phenol/chloroform extraction is omitted; and the preparation is mixed gently by 
inversion and at no time vortexed to reduce the shearing of the large BAC DNA 
molecule.
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(e) Magnesil BAC Prep
From 500 ml of culture the typical yield was between 50 to 100 jug of BAC DNA.
1) 500 ml of L Broth was inoculated and grown overnight with shaking at 33°C.
2) The cells were pelleted at 3,000 rpm (Sorvall Instruments, Du Pont, RC5C 
centrifuge fitted with a GSA rotor) for 10 minutes at room temperature and 
resuspended in 6.25 ml of Cell Resuspension Solution in a 50 ml Falcon tube.
3) 6.25 ml of Cell Lysis Solution was added and mixed by inversion 4 or 5 times.
4) The suspension was incubated until it cleared (approximately 5 minutes).
5) 8.75 ml of Neutralization Solution was added and mixed by inversion.
6) The bacterial lysate was centrifuged at 4,000 rpm (MSB, Centaur2 centrifuge) 
for 15 minutes at room temperature and the supernatant filtered through fish 
filter wool placed in a 25 ml syringe.
7) The Endotoxin Removal Resin was completely resuspended and 1.25 ml added 
to the filtered supernatant. The tubes were inverted to mix the contents 
periodically during a 15 minute incubation at room temperature.
8) The tube mixed for the last time and then placed in the Magnetic Separation 
Unit and allowed to clear. The supernatant was then poured into a fresh 50 ml 
falcon.
9) 5 ml of 5 M Guanidine Thiocyanate was added to the supernatant and the tube 
mixed by inversion.
10)3.75 ml of MagneSil Paramagnetic Particles were added and the tube incubated 
at room temperature for 15 minutes.
11) The tube was placed in the Magnetic Separation Unit and allowed to clear, the 
supernatant was then discarded.
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12) The particles were washed with 5 ml of 4/40 Wash Solution, magnetically 
separated and the supernatant discarded.
13) The particles were washed three times using the method described in step 12 
using 10 ml of 80 % ethanol. After the final wash the particles were air-dried.
14)6 ml of dH2O, pre-heated to 65°C, was added to the dry particle, vortexed and 
then left to reach room temperature. The particles were then magnetically 
separated and the supernatant containing the DNA transferred to a 1 5 ml Falcon 
tube. The tube was centriftiged at 3,000 rpm (MSE, Centaur2 centrifuge) for 10 
minutes at room temperature to pellet any particles that may have been 
transferred. The supernatant was transferred to a fresh 50 ml Falcon.
15) The DNA was precipitated and pelleted by adding 2.5 volumes of ethanol and 
1/1 0th volume of 3M sodium acetate. The DNA was pelleted at 3,000 rpm 
(MSE, Centaur2 centrifuge) for 10 minutes at 4°C.
16) The DNA pellet was washed with 70 % of ethanol and resuspended in 100 u.1 of 
TE.
(f) PCR purification with Qiagen
Qiagen columns were used to remove nucleotides, enzymes and other PCR reagents 
before electroporating the DNA into E. coll.
1) Five volumes of Qiagen Buffer PB were added to one volume of the reaction 
and then placed onto the column
2) DNA was bound to the column by centrifuging at 13000 rpm (Heraeus, Biofuge 
Pico centrifuge) for 1 minute at room temperature.
3) 750 jul of Qiagen Buffer PE was added to the column and centriftiged for 1 
minute at 13000 rpm (Heraeus, Biofuge Pico centrifuge). To remove all traces 
of buffer the column was centriftiged at 13000 rpm (Heraeus, Biofuge Pico 
centrifuge) for 1 minute at room temperature.
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4) To elute the DNA 30 jul of Qiagen Buffer EB was added to the column, it was 
allowed to stand for 1 minute and then centrifuged at 13000 rpm (Heraeus, 
Biofuge Pico centrifuge) for 1 minute at room temperature.
(g) Gel purification with Qiagen
1) The required DNA restriction fragment was excised from the agarose gel with a 
clean scalpel.
2) The gel slice was placed in an eppendorf and weighed. Three volumes of 
Qiagen Buffer QG were added to one volume of gel.
3) The gel slice was dissolved by incubating the eppendorf at 50°C and then one 
gel volume of isopropanol was added.
4) DNA was bound to the column by applying the sample and centrifuging at 
13000 rpm (Heraeus, Biofuge Pico centrifuge) for 1 minute at room 
temperature.
5) 750 p.1 of Qiagen Buffer PE was added to the column and centrifuged for 1 
minute at 13000 rpm (Heraeus, Biofuge Pico centrifuge). To remove all traces 
of buffer the column was centrifuged at 13000 rpm (Heraeus, Biofuge Pico 
centrifuge) for 1 minute at room temperature.
6) To elute the DNA 50 ul of Qiagen Buffer EB was added to the column, it was 
allowed to stand for 1 minute and then centrifuged at 13000 rpm (Heraeus, 
Biofuge Pico centrifuge) for 1 minute at room temperature.
(h) Gel purification with Geneclean
1) The required DNA restriction fragment was excised from the agarose gel with a 
clean scalpel.
2) Three volumes of sodium iodide solution were added and the agarose melted by 
incubating at 50°C.
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3) The amount of Glassmilk to be added was determined according to the amount 
of DNA in the excised band, based upon the ability of 1 jil of Glassmilk to bind 
between 1 to 2 jug of DNA. DNA was bound to the Glassmilk by incubation at 
room temperature for 15 minutes.
4) The Glassmilk, bound with DNA was pelleted by centrifugation at 13000 rpm 
(Heraeus, Biofuge Pico centrifuge) for 10 seconds at room temperature. The 
pellet was washed by resuspending in 50 volumes of NEW Wash (50 % 
ethanol). This step was repeated twice more but after the final centrifugation the 
pellet was resuspended in 50 jj.1 of TE.
5) The Glassmilk was pelleted and the supernatant containing the DNA transferred 
to a fresh eppendorf. The pellet was resuspended once again in 50 jul of TE and 
re-pelleted and the supernatant added to the first 50 jnl elution.
(i) Removal of nucleotides and proteins by spin column
ProbeQuant™G-50 Micro Columns were supplied by Amersham 
Biosciences (http://www4.amershambiosciences.com/APTRIX/uppO 1077.nsf/ 
content/uk_homepage), product number 27-5335-01.
1.6.2 Enzyme reactions
(a) Plasmid restriction endonuclease digestion
Restriction endonucleases were supplied by either Roche or NEB BioLabs 
(http://www.neb.com). I See I is supplied by Roche (http://www.roche-applied- 
science.com/). Modifying enzymes were supplied by NEB BioLabs.
(b) ES cell genomic restriction endonuclease digestion
Spermidine was added to all genomic DNA restriction digests except those that 
required the addition of BSA. 30mM spermidine was prepared as a lOx solution for 
this purpose.
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(c) PFGE ES cell plug restriction endonuclease digestion
See section 1.6.6 (b).
(d) Alkaline phosphatase
Alkaline phosphatase treatment was used to remove the terminal phosphate group 
from linear DNA cloning vectors thereby reducing the frequency of vector self re- 
ligation and increasing the frequency of the desired ligation product.
1) A volume of TE equal to the digest reaction volume was added to the restriction 
linearised vector.
2) 1 Unit of alkaline phosphatase was added per u.g of DNA and incubated at 37°C 
for 1 5 minutes.
3) 1/100 volume of 0.5 M EDTA was added and the solution heated to 75°C for 10 
minutes to inactivate the enzyme
4) The products were either gel purified or phenol chloroform extracted, quantified 
and then used for further cloning.
(e) Blunting by end-filling with Klenow
1) The reaction constituents were typically 12 (il of DNA in dl-hO, 2 ul of T4 
polymerase buffer, 4 jul of 500 mM dNTPs and 2 jul of T4 DNA polymerase at 
3,000 U.ml' 1 .
2) The reaction was incubated at 12°C for 20 minutes and stopped by incubating at 
75°C for 10 minutes thereafter.
3) 20 )ul of TE was added and DNA was precipitated and resuspended in TE for 
further cloning steps.
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(f) Oligonucleotide probe labeling
1) A 20 p.1 reaction mix containing 10 pmoles of oligonucleotide, 2 (il of lOx T4 
PNK buffer, 2 ul of T4 PNK at 10,000 U.ml' 1 , 10 ul of [32P]-y-ATP and dH2O 
was prepared and incubated at 37°C for 45 minutes.
2) The reaction was stopped by incubating at 65°C for 10 minutes and then passed 
through a spin column (see section 1.6.1 (i)) by centrifuging at 3000 rpm 
(Heraeus, Biofuge Pico centrifuge) for 2 minutes at room temperature.
3) The probe was checked for activity using the Geiger counter and then placed in 
the hybridization solution.
(g) Rediprime probe labeling
Double stranded DNA probes produced by PCR or restriction were labelled 
using the 'rediprime II' random prime labelling kit (code RPN 1633) from 
Amersham Pharmacia Biotech (http://www.apbiotech.com) according to the 
manufacturers instructions.
1) 30 ng of probe DNA and 25 ng of control (A, Hind III restricted) DNA was 
resuspended separately in 45 |ul of TE.
2) The DNA was denatured by boiling in a waterbath for 5 minutes.
3) The DNA was snap-cooled by placing on ice for 5 minutes and then centrifuged 
to gather the tube contents.
4) Each DNA was added to a rediprime dehydrated reaction pellet and 
resuspended by pipette.
5) To the probe 5 jil of radio-labelled [32P]dCTP was added and to the control 
DNA 1 jal was added. In addition 4 jul of 0.5 M dCTP was added to the control 
DNA.
6) The tubes were flick mixed, centrifuged and then incubated at 37°C for 10 
minutes.
192
7) The reactions were stopped by passing them through spin columns (see section 
1.6.1 (i)), centrifuging for at 3000 rpm (Eppendorf Centrifuge, 5415C) 2 
minutes at room temperature.
8) The probes were briefly counted with a Geiger counter to determine their 
activity and then boiled in a waterbath for 5 minutes before being added to the 
hybridization solution.
(h) T4 DNA Ligase
Ligation reactions were performed using T4 DNA Ligase (NEB). The vector to 
insert molarities were typically 1:3 and 1:5. Controls of vector alone and insert 
alone reactions were conducted in parallel when possible to give and indication of 
the frequency of the desired ligation reaction. The reaction volume was typically 
between 20 and 30 ul with no more than a l/10th of the volume constituted by the 
T4 DNA ligase. Other reaction constituents were: T4 DNA ligase buffer, diluted 
from a lOx stock; vector DNA; insert DNA; dH2O to the desired reaction volume. 
The reaction constituents were chilled to 4°C before combining the reagents on ice. 
All ligations were performed at 14°C overnight or for a minimum of 16 hours. The 
reaction products were determined following transformation (see section 1.6.8 (b)) 
of the ligation into E. coli. Typically 10 jil of the ligation reaction was used for each 
50 |^1 of competent cells.
1.6.3 Annealing oligos
30 pmoles of each oligonucleotide were used in a 20 ul reaction containing 
2 ^1 of NEB Buffer 2 and dHbO to make the reaction up to the required volume. 
The thin walled 500 \ii PCR tube was placed into the PTC-200 Peltier Thermal 
Cycler and the annealing programme executed. The annealing programme heats the 
reaction to 100°C and controls the cooling by -1°C per 5 seconds until 24°C is 
reached. The PCR machine then maintains the annealed oligos at 4°C until required 
for the ligation reaction. The reaction contents were serially diluted 1:10 down to 




The concentration of a DNA solution was determined by optical density 
measurements. DNA was diluted to a concentration that produces an optical density 
reading at 260 nm between 0.1 and 1.0. Since 50 jug.mr 1 of pure DNA gives an 
optical density at 260 nm of 1.0 the concentration of the DNA solution was derived 
from the following equation, where 'a' is the optical density reading and 'b' is the 
concentration of DNA in ng.joT 1 :
b = 50 x dilution of DNA sample x a
In addition the optical density ratio of the 260 nm and 280 nm reading was 
calculated with a figure above 1.7 indicating a pure DNA solution.
(b) Gel Quantification
To quantify smaller amounts of DNA (10 to 500 jug) a sample was run on a 
gel alongside known amounts of lambda Hind III restricted marker DNA at 100 
ng.nl" 1 . The band intensity of the known volume of sample was compared with the 
marker to find a band of similar size and intensity. Since the volume and 
concentration of marker loaded was known the amount of DNA in the band could 
be determined (see equation below) and hence the amount of DNA in the sample 
band determined. Once the amount of DNA in the sample band was known, the 
volume loaded and any dilutions that were made were considered to obtain the 
sample concentration.
(Band size in kb/48.5 kb) x 100 ng.uT 1 x Volume of maker = DNA in the
loaded in jal band in ng
1.6.5 Automated sequencing
Sequencing was performed by the Sequencing facility at the CGR, by David 
Kivlichan. Sequencing reactions were performed using the ABI PRISM BigDye 
Terminator Cycle Sequencing Ready Reaction Kit from Applied Biosystems as
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described by the manufacturer, in a reaction that is a modified version of the 
dideoxynucleoside chain termination procedure described by Sanger et al (Sanger 
et al., 1977). Each terminating ddNTP was covalently linked to a fluorescent dye 
and the reaction products were separated on a denaturing 5 % polyacrylamide gel, 
in an ABI 377 automatic sequencer. Following the gel run the samples were 
scanned by the computer to check for correct tracking before extracting sequence 
information. The DNA template was prepared by Qiagen kit method (2.6.1 (a)), 
Maxiprep method (2.6.1 (c)), Magnesil BAG DNA (2.6.1 (e)) or by Qiagen 
purification of miniprep DNA (2.6.1 (a)).
1.6.6 Pulsed Field Gel Electrophoresis 
(a) Making Plugs
1) Require 5x107 cells in each 1ml of agarose plugs, therefore grow up 3 x 150cm2 
flasks of cells, giving approx. 7.5 x 107 cells.
2) On the day to harvest the cells by trysinizing set a waterbath to 50°C and melt 
the 2% agarose gently in a boiling waterbath. Once the agarose is melted 
equilibrate the solution to 50°C and leave whilst trypsinizing cells. In addition 
place an appropriate amount of cell suspension buffer in the waterbath.
3) Label eppendorfs and keep on ice ready to transfer cells to once trysinized.
4) Trypsinize cells, pellet, resuspend in PBS, then pellet again, resuspend in 15 
mis PBS, make a 1:10 dilution, then count.
i) cell number + cell number x dilution (1:10) x 104
(i) 2
5) Should have approx. 0.5 x 106 cells.mr 1 , so take 10 mis and pellet to obtain 5 x 
107 cells. Resuspend the pellet in 1 ml of PBS, transfer to an eppendorf and 
keep on ice.
6) Pellet the cells by spinning at Ik 4°C for 5' (in cold room).
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7) Resuspend the cells in an appropriate amount of Cell Suspension Buffer and put 
at 50°C for 5'.
8) For a 6.5 % agarose/cells use 690 ^1 of Cell Suspension Buffer and 310ul of 2% 
agarose.
9) Add the agarose to the cell suspension using a pipette and mix thoroughly by re- 
pipetting.
10) Transfer to the setting moulds (BioRad 170-3713) and place in the fridge (4°C) 
for at least 20 minutes (5 x 200ul into each well).
11) For each line into a 5ml culture tube add: 2.5ml Proteinase K reaction buffer; 
lOOul of Proteinase K; 1ml total of plugs. Incubate plugs in Proteinse K o/n at 
50°C w/o agitation (can be left longer-up to 4 days).
12) To wash the plugs free of Proteinase K wash with IxWash Buffer (make a 1:10 
dilution of stock) with gentle agitation at room temperature. For each plug use 1 
ml of wash and perform 4 x Ihr washes. Therefore for 5 x 200ul plugs use 5mls 
of Ix wash per hour per line, making a total of 20 mis of Ix wash per cell line.
13) For the second wash add 50 ul of lOOmM PMSF to 5 mis Ix wash (1:100 to 
give a final concentration of 1 mM).
14) The plugs can be stored at 4°C for 3 months in Ix wash buffer. 
(b) Digesting plugs
1) Place one plug (200ml) into a 1.5 ml eppendorf and wash for an hour in 1ml of 
O.lx Wash Buffer.
2) After one hour decant off the wash buffer and add enough O.lx wash buffer to 
cover the plug (for 200jal plug use 200jul O.lx wash buffer).
3) Aspirate off this wash and add 1 ml of diluted lOx reaction buffer: lOOul buffer 
+ 900 |ul dFbO. Leave for 1 hr with gentle agitation at room temperature.
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4) Aspirate off the reaction buffer and add 200^1 of Ix reaction buffer + 100 U of 
enzyme and incubate overnight at the required temperature.
5) Next day, wash the plug in Ix Wash Buffer for about 30 minutes with agitation.
6) Then, whilst waiting to load the gel place the plug into some running buffer.
7) Load about half of the plug into the gel. 
(c) Loading plugs and running gel
Plugs were loaded into the gel slots and run according to the handbook guidelines for 
size separation for the BioRad CHEF Mapper PFGE apparatus (170-3654, 170-3655 
and 170-3688).
1.6.7 Nucleic Acid Hybridisation and Screening 
(a) Colony Hybridisation
Screening large numbers of colonies was preformed by colony 
hybridization. A 9 cm diameter, nylon membrane (Schliecher and Schuell; code 
77500), was placed on top of the bacterial colonies. To orientate the filter it is first 
marked with a pattern of crosses using a pencil, then once placed on the plate the 
location of the crosses was marked on the plate with a permanent marker. Using 
forceps the filter was placed colony side up onto 3MM paper soaked in 5 % SDS / 
2x SSC for 2 minutes. The filters were placed on dry 3MM paper and microwaved 
for between 30 seconds and two minutes until the colonies appeared as shiny discs. 
The filters were stored between 3MM paper until hybridized prior to which they 
were wetted in 2x SSC before being placed in the hybridization dish.
Colony hybridization screening was used to determine the inclusion of 
annealed oligonucleotides in a cloning reaction. The probe was typically one of the 
oligonucleotides and so the hybridization conditions were adjusted according to the 




0.05 % sodium pyrophosphate
lOxSSC
1 Ox Denhardts
100 mg.mr 1 yeast tRNA
The hybridization solution was diluted to a working solution with 
formamide and dl-bO. The percentage of formamide was adjusted depending on the 
length of the oligonueleotide probe.
The hybridization solution was pre-warmed to 42°C before adding the radio- 
labelled probe. The filters were hybridized overnight then washed and exposed to 
photographic film. The film was orientated to the filter using phosphofluorescent 
markers.
(b) Southern Blotting
Restricted DNA was electrophoretically separated and the gel denatured 
(1.5M NaCl2 ; O.SMnaOH for 30 minutes) and neutralized (1.5M NaCl2 ; 0.5M Tris- 
HC1, pH 8.0 for 30 minutes) before the DNA was transferred to positively charged 
nylon membranes (Roche, product number 1-417-240).
Following blotting the filters were air-dried and the fixed using UV 
irradiation, 600 J at a wavelength of 400 nm. The filters were washed briefly in 2x 
SSC before being placed in pre-hybridisation conditions for at least 1 hour. The 
pre-hybridisation solution was then discarded and hybridization solution added to 
the filters along with radio-labelled probes. The filters were hybridized overnight at 
65°C, washed, wrapped in Saranwrap and exposed to photographic film.
Genomic Southern blot filters are hybridized under the following conditions:
20x Denhardt's, stored at -20°C.
Ficoll 400 4 g.r 1 
PVP 4 g.r 1
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BSA Fraction V 4 g.l' 1 
Hybridisation buffer, stored at 4 °C for up to 1 year.
Na3Citrate 22.5 g.l" 1
NaCl2 44.8 g.l' 1
Dextran sulphate 85.2 g.l" 1
20%SDS 2 Uml.r 1
20xDenhardt's 203 mil' 1
The solution was warmed to 65°C and filtered through a 0.45 jum Nalgene filter. 
1.6.8 Recombination mediated cloning
(a) Making CaCl2 competent cells
250 ml of LB broth was inoculated with 5 ml of an overnight culture and 
cultured at 37°C with shaking until an optical density at Aeoo of 0.5 was achieved. 
Two 25 ml aliquots of cell culture were pelleted by centrifugation at 4000 rpm 
(MSA, Centaur2 centrifuge) for 10 minutes at 4°C. The pellet was resuspended in 
12.5 ml of ice-cold 50 mM CaCb and incubated on ice for 15 minutes. Cells were 
again pelletted, 4000 rpm (MSA, Centaur2 centrifuge) for 10 minutes at 4°C, and 
resuspended in 2.5 mis of Freezing Mix. The pellets were pooled and 50 ul aliquots 
dispensed into eppendorfs on dry ice. The cells were stored at -70°C.
(b) Bacterial transformation
Chemically competent cells prepared as described in section 1.6.8 (a) were 
used to introduce circular plasmid DNA to E. coli. The plasmid DNA was typically 
either the products of a ligation reaction or recombination plasmids used during the 
in vivo cloning reactions.
DNA was mixed with an aliquot of competent cells that had been thawed on 
ice. The DNA/cell mix was incubated on ice for 30 minutes on ice and then heat- 
shocked in a 42°C waterbath for 1 minute. 1 ml of LB broth was added and the cells 
were transferred to a loose top tube and then allowed to recover for 60 minutes in a 
37°C incubator with shaking. Cells were then plated onto agar plates with the 
relevant antibiotic selection media included. Plates were incubated at 37°C, no
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shaking, overnight. The colonies that arose were analysed to determine the nature 
of the plasmid DNA they harboured. To test a new batch of competent cells 10 pg 
of pBS(KS )was used and the number of colonies arising on ampicillin plates from 
10 |j,l of plated culture was recorded to give and indication of the cells' competency.
(c) Making electrocompetent cells
During the preparation of electrocompetent cells it was imperative that all 
reagents and materials coming into contact with the cells were kept as cool as 
possible. For this reason the following preparative steps were made:
1) Pipettes were placed in a -80°C freezer for at least an hour before their use.
2) The centrifuge SS-34 rotor was cooled to -4°C by spinning at 3000 rpm (Sorvall 
Instruments, Du Pont, RC5C centrifuge fitted with an SS-34 rotor) for 20 
minutes before use.
3) The centrifuge tubes were chilled in ice for at least 2 hours before use.
4) All solutions were autoclaved and prior to use placed on ice for at least 2 hours 
before use to ensure their temperature was 0°C.
The cells were prepared by the following method:
1) Ten overnight cultures were set up in L-Broth and the relevant antibiotic 
selection in loose-capped tubes and incubated overnight at 37°C with shaking.
2) The next day 4 x 100 mis of L-broth were pre-warmed to 37°C in the incubator 
and 1 ml aliquots were taken of each overnight culture and DNA prepared by 
Qiagen miniprep method. The DNA was restricted and analysed to determine 
whether the cells were maintaining the recombination plasmid. One positive 
culture was selected and used to inoculate the pre-warmed L Broth with 1 ml of 
culture.
3) The cells were incubated at 37°C with shaking and their growth monitored by 
optical density measurements at 600 nm wavelength.
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4) When an OD reading of 0.1 was obtained, a freshly made stock of 20 % 
arabinose was added to the culture to a final concentration of 0.2 %, to induce 
the activity of the genes on the recombination plasmid driven by the pBAD 
promoter. The minimum culture period resulting in maximal induction was 20 
minutes.
5) When the cells had reached an OD of 0.4 (ideal) the cells were removed from 
the incubator and cooled on ice for 5 to 10 minutes.
6) 50 ml of cells were centrifuged in pre-chilled 75 ml centrifuge tubes at 6000 
rpm (Sorvall Instruments, Du Pont, RC5C centrifuge fitted with an SS-34 rotor) 
for 8 minutes at -4°C in a pre-chilled SS-34 rotor. The supernatant was 
discarded and a further 50 ml added and the cells pelleted under the same 
conditions as before.
7) The supernatant was discarded and the cells were resuspended in 10 mis of 10 
% glycerol chilled to 0°C by incubating on ice (minimum 1 hour) using pre- 
cooled pipettes. Before dispensing the 10 % glycerol the pre-chilled pipette has 
liquid drawn through it to further cool the pipette. The cells are thoroughly 
resuspended keeping them on ice and then centrifuged at 6000 rpm (Sorvall 
Instruments, Du Pont, RC5C centrifuge fitted with an SS-34 rotor) for 8 
minutes at -4°C.
8) Step 7 was repeated until the cells were centrifuged for a total three times. The 
supernatant from the last centrifugation is poured away and the remaining liquid 
used to resuspend the cell pellet. The resulting cell volume was typically 500 p,l 
for effective electrocompetent cells.
9) 50 ml aliquots of the cells were made into pre-chilled eppendorfs and used the 
same day for electroporation.
(d) Electroporating bacteria
Aliquots of electrocompetent cells were thawed on ice. The DNA was added 
and mixed thoroughly with the cells by pipetting and then transferred to pre-cooled
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electroporation cuvettes (BioRad E. coli Pulser Cuvette, 0.2 cm gap, 165-2086). 
The cells were kept on ice, electroporated at 2.5 kV (BioRad Gene Pulser, 25 jnF 
with pulse controller set to 200 ohms), returned to ice for 10 minutes and then 
added to 1 ml of L-broth in a loose-capped tube. The cells were allowed to recover 
for 1 hour in a 37°C incubator with shaking and then plated with the relevant 
antibiotic selection.
(e) NiCh curing of E. coli cells harbouring a tetracylineR pi as mid
1) A 5 ml overnight culture was grown from either a single colony on an agar plate 
or from a 100 jul aliquot from a glycerol stock. The L-broth contains relevant 
antibiotics but not tetracycline. In addition 50 (il of 500 mM NiCfe is added to 
give a final concentration of 5 mM, i.e. a 1:100 dilution.
2) 50 jal of the overnight culture was plated onto agar with and without 5 mM 
NiCb and the number of resulting colonies assessed to determine the percentage 
that had lost the tetracycline resistant recombination plasmid.
3) An adequate number of overnight cultures (without NiC^) were prepared from 
the agar plate containing the NiCl2 to ensure that a culture without the 
tetracycline resistant recombination plasmid was obtained.
4) DNA from the overnight cultures was prepared by the Quick Prep method and 
analysed by restriction analysis to determine whether the recombination plasmid 
was lost and also the integrity of the BAG DNA.
5) Overnight cultures with cells harbouring the required DNA were used to 
prepare glycerol stocks, from which large preparations of DNA could be 
prepared using the Magnesil method.
(f) Replica plating
The colonies that resulted from electroporation were initially screened by 
replica plating. Agar plates were prepared with the relevant antibiotics and then 
identically grided as indicated in the diagram below.
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Colonies arising from the electroporation plate were picked with a 20-200 jul 
pipette tip and streaked onto the surface of successive agar plates, within the 
identical perimeter square for each. The order that the plates were streaked was 
significant and therefore maintained throughout the procedure. The last plate that 
was streaked contained chloramphenicol to ensure that any clone containing the 
BAG was maintained and as a positive control for the other plates. In this way, the 
antibiotic resistance profiles for each of the colonies were determined.
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Chapter 2 ES Cell Targeting
Number Name
Plasmids used and generated in the construction of the ES cell downstream targeting 














pBS 15 1 1/ SCE / PGK-HYG 15 1 1
pBS/DnLHA
pBS/ DnLHA / DnRHA
pBS/ LHA 15 1 1/ SCE / PGK-HYG 15 1 1/ RHA (3)
pBS/ LHA 15 1 1/ HYG-PGK / SCE 15 1 1/ RHA (4)
Plasmids used and generated in the construction of the ES cell upstream targeting construct: 






pBS/ UpLHA / UpRHA
frt/Sce/5'HPRT/neo
1171 (hprt-neo) + Up/L/R
Chapter 3 Characterisation of the double-targeted ES cell lines
Number Name
Plasmids used and generated in the construction of the test plasmid to delete the loxP- 



















Chapter 4 BAC Targeting
Number Name














pKaX (HIII to BHI)
pBS/511/Bgl 11/511
jjBS/5 1 1 /kan(r&cV5 1 1 (r&c)
990/pBS-MCltk/-3
TK with A
TK with A (Xhol to BHI)
pBS/ DnLHA / DnRHA
pB S/LH A/kan-TK/RH A
pBS (KS+) Asc I oligos
pBS/ Asc /kan-TK/Asc







HN#381: mPGK pEM7 BSD pA
mPGK Hyg / 3'HPRT
1 172/94(BSD//oxP/3'HPRT/SceFRT)
pBS/ UpLHA / UpRHA
UpL/BSD-3'HPRT/UpR
The plasmid used to mediate the targeting by recombination mediated cloning in E. coll
CP#114 pR6K / BAD /apy (tetR)













PBAC14567/TK "KAN/ 3'HPRT "BSD
Chapter 5 Large interval RMCE
Number Name










IV.a to d probes:UpLP, UpRP, DnLP, DnRP
IV.e to h ES cell targeting homology arms:UpLHA, UpRHA, DnLHA, DnRHA
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Taq Buffer including Mg 15mM
dH2O































IV.b Conditions to make Upstream Right-hand Probe (UpRP) 
Reaction Components:




Taq Buffer including Mg 15mM
dH20































IV.c Conditions to make Downstream Left-hand Probe (DnLP) 
Reaction Components:
E14TG2a ES cell DNA 100 ng.uT 1
Oligo D4331 from stock
Oligo D4332 from stock
dNTPs ImM
Taq Buffer including Mg 15mM
dH20



































IV.d Conditions to make Downstream Right-hand Probe (DnRP) 
Reaction Components:
E14TG2a ES cell DNA 100 ng.jJ' 1
Oligo D4329 from stock
Oligo D4330 from stock
dNTPs ImM
Taq Buffer including Mg 1 5mM
dH20


















































































IV.f Conditions to make Upstream Right Homology Arm (UpRHA) 
Reaction Components:













































IV.g Conditions to make Downstream Left Homology Arm (DnLHA) 
Reaction Components:
pB AC 14567 DNA 100 ng.^r 1


































































IV.h Conditions to make Downstream Right Homology Arm (DnRHA) 
Reaction Components:
pB AC 14567 DNA 100 ng^l' 1
Oligo D6627 x pmol.^r 1
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